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Summary 
  
 
The activities performed during the present PhD thesis were focused on the 
production, synthesis process optimisation and characterisation of calcium silicate 
mesoporous bioactive glasses (MBGs) that could be used for designing advanced 
biomedical devices to promote tissue regeneration when the normal healing process 
is hindered (i.e. in the case of a delayed bone healing and non-healing skin wounds). 
In particular, the efforts were devoted to enrich the binary composition of these 
MBGs with different therapeutic ions in order to impart and enhance specific 
biological functions. The possibility to include these therapeutic species in the 
MBGs and to tailor their release allows to consider these materials as valid and 
potent alternatives to the traditional treatment in bone and wound healing 
applications.  
In this context, a library of ion-containing nanomatrices was developed by 
substituting small amount (1%, 2% or 5% mol) of CaO with the specific ion 
precursor. 
In detail, the following two types of nanomatrices were developed:  
- Nano-sized particles (100-200 nm) with pore size of about 4 nm;  
- Micro-sized particles (0.5-5 µm) with pore size of about 8 nm. 
Both types of nanomatrices were characterized by ordered mesoporous 
structure with high specific surface area and pore volume, especially for the nano-
sized particles, demonstrating that the successful ion incorporation occurred 
without hampering the formation of the mesostructure. Moreover, the bioactivity 
test performed on the nanomatrices demonstrated their good reactivity when soaked 
in Simulated Body Fluid (SBF), confirming that the incorporation of different 
metallic ions did not affect their ion exchange ability. The ion release test proved 
that all the nanomatrices were able to release the therapeutic ion with specific 
kinetics depending on the amount of the incorporated ion, the structural features of 
the nanomatrices and the release medium. 
The second aim was to find the best synthesis procedures in terms of material 
properties, scalability, safety and cost-efficiency. 
In order to achieve this goal, different synthesis procedures were tested. In 
particular, following the objective of avoiding the use of toxic solvents and 
enhancing the synthesis yield, a water-based sol-gel procedure using ammonia as 
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catalyst without sonication was selected as the best route to produce the nano-sized 
particles. 
By following the same aim, the second type of nanomatrices (micro-sized 
particles) was produced by an aerosol-assisted spray-drying approach under mild 
acidic conditions due to its scalability and repeatability in an industrial 
environment. 
To reach the final target of developing multifunctional platform able to promote 
tissue regeneration in the presence of bacterial infection, the MBGs in the SiO2-
CaO system were enriched by the following selected therapeutic ions: 
- Copper for its antibacterial, pro-osteogenic and pro-angiogenic effect  
- Cerium for the pro-osteogenic and antibacterial potential  
- Silver for its well-known antibacterial effect  
In this frame, the third aim was to investigate the therapeutic potential of these 
nanomatrices, in particular their antibacterial effect which was tested through the 
viable count test using both Gram positive (S. Aureus) and Gram negative (P. 
aeruginosa).  
In details, the different sensitivity to Cu-containing samples shown by the 
bacteria strains was attributed to the differences in the bacteria structure and 
surfaces. For what concerns the Ce-containing nanomatrices, although the 
antibacterial test demonstrated a reduction of both Gram positive and Gram 
negative bacteria strains, it was not possible to find a clear correlation between the 
results, the experimental conditions and the bacteria structure. Finally, the 
antibacterial results of the Ag-containing particles were ascribed to the presence of 
accessible metal Ag compounds which, through the direct contact and the formation 
of interactions between silver and the sulfhydryl groups of the bacterial wall, led to 
the reduction of bacterial viable species by blocking their respiration. 
 
The biological assessment performed on the optimized ion-containing 
nanomatrices leads to consider the Cu-containing MBGs as the most promising 
systems due to the possibility to find a proper therapeutic window within which 
they resulted both biocompatible and antibacterial. Among the Cu-containing 
MBGs, the MBG_SG_Cu0.5% and MBG_SD_Cu0.5%, providing the best results 
in terms of biocompatibility, deserve to be taken into account for further 
investigations, especially in terms of multifunctional systems able to release both 
therapeutic ion and specific drugs.  
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Thesis goals 
 
Natural and synthetic materials have been used in the biomedical field in the 
last decades in order to replace or repair damaged tissues [1]. Different studies have 
been conducted in this field and, based on the obtained results and the specific needs 
that have changed over the time, the definition and the type of developed 
biomaterials have adapted to the requirements. The combination of materials 
science and biological science knowledge led to the final concept of biomaterial 
that is now defined as an engineered substance which has to direct a specific 
positive interaction when in contact with the human body. Within the field of 
biomaterials, bioactive bioceramics show the higher biocompatibility and the 
ability to induce  the formation of a hydroxyapatite layer, similar to the natural 
component of bone [2]. Inside this major class, bioactive glasses have gathered an 
even higher interest. First invented in 1967 by Larry Hench, bioactive glasses have 
been used in commercial formulations for different applications, such as tooth root 
repair and ear prostheses. Over the years, the morphological and textural features 
of bioactive glasses have been modified in order to improve their biological 
performances. 
In particular, a promising class of bioactive glasses is represented by 
Mesoporous Bioactive Glasses  (MBGs) which paved the way for multifunctional 
bioactive materials, since their first appearance in 2004 [3]. These biomaterials, 
prepared for the first time by Prof. Dr Zhao’s research group, were produced by 
combining the sol-gel method with supramolecular chemistry of surfactants and 
presented a highly ordered structure with uniform pore size leading to excellent 
bone-forming bioactivity. Thanks to the very high surface area and pore volume, 
which are typical properties of these materials, MBGs are gaining increasing 
interest in the field of tissue regeneration, as in addition to the bioactive properties, 
they can host drug molecules of different size, due to the tailorable pore size, and 
can release them with controlled kinetics [4,5].  
A big step forward in this context is represented by the incorporation of 
therapeutic ions in the glass network of the MBGs in order to impart and enhance 
specific functions. Since the biological effect of some therapeutic ions (i.e. pro-
osteogenic, pro-angiogenic and antibacterial effects) is well-known [6], the 
possibility to include these species in MBG composition and to release them in a 
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tailorable way make these materials interesting candidates for biomedical 
applications. By comparing them with drugs and growth factors, the therapeutic 
ions have the following advantages: 
1) They are less prone to the alteration during the manufacturing; 
2) They could modify cellular functions by interacting with other ions through 
the activation of ion channels or by binding with macromolecules; 
3) They are cheaper than the growth factors and recombinant proteins. 
These characteristics make these species valid and potent alternatives to the 
traditional treatments in bone and wound healing applications. In fact, the 
traditional treatments, which consist in bone grafting procedures and wound 
dressings, are not always suitable/sufficient to allow the full recovery, as 
extensively described in chapter 1.  To deal with these types of disease, pro-
osteogenic and/or pro-angiogenic effects are only two of the requested properties. 
In addition, to treat these pathologies and avoid the non-healing and inflammation 
problems, it is important to guarantee an antibacterial effect [7].  
In this scenario, the MOZART project (Mesoporous matrices for localized pH-
triggered release of therapeutic ions and drugs) was defined and planned. The final 
objective of this project, funded by the European Community (programme Horizon 
2020) and coordinated by Politecnico di Torino (Prof. C. Vitale-Brovarone), is to 
develop a library of mesoporous inorganic nanomatrices (MBGs and ordered 
mesoporous carbons, OMCs) containing therapeutic ions and loaded with specific 
drugs to be used as multifunctional platform in the treatment of delayed bone 
healing and non-healing skin wounds. In MOZART, the release of ions and drugs 
is triggered by a self-immolative polymer and the incorporation in a thermosensitive 
gel allows to introduce and maintain the particles in the site of interest. 
In this context, the present PhD thesis was focused on the study of the influence 
of different synthesis routes and the incorporation of ion on the morphology and 
structure of the developed MBGs. Moreover, the in vitro biological assessment 
allowed the evaluation of the full potential of these MBGs as biomaterials.  
In particular, the first aim of this PhD thesis was to produce calcium silicate 
mesoporous bioactive glass (MBG) particles containing different amount of 
therapeutic ions that could be used for designing advanced biomedical devices in 
tissue regeneration (i.e. the delayed bone healing and non-healing skin wounds). 
The developed MBG particles will be referred to nanomatrices within the whole 
thesis due to the presence of nanopores of regular size and shape. 
The second aim was to find the best synthesis procedures in terms of material 
properties, scalability, safety and cost-efficient synthesis routes. 
The third aim was to investigate the therapeutic potential of these nano- and 
micro-sized matrices, in particular their antibacterial effect. 
In the following figure, the thesis goals are displayed. 
 
 
 
Figure: Thesis goals 
In order to achieve these goals, the activities performed during my PhD were 
devoted to the optimisation of the synthesis procedures, as well as on the study 
regarding the most suitable amount of the ions needed for each targeted application 
and, finally, on the preliminary studies of the antibacterial properties of the ion-
containing MBGs.  
MBGs in the binary system (SiO2-CaO) were produced by using different 
synthesis routes, in order to obtain a library of materials with high specific surface 
area (in the range of hundreds m2/g) and accessible pore volume, characterised by 
different pore size and morphology. 
In details, the synthesis procedures were improved based on the results of the 
morphological and compositional characterisation and the release properties. 
Furthermore, with the aim to obtain scalable nanomatrices, the final selection of the 
synthesis routes was completed, by discarding those involving the use of toxic 
chemical reagents and several synthesis steps. During this selection process, the 
recommendations provided by Nanolith, an industrial partner of the MOZART 
consortium, were followed, in view of the effective scaling-up of the procedures in 
an industrial relevant environment (TRL 5). Among the explored routes, a 
procedure based on the aerosol assisted spray-drying approach was adopted with 
the final aim to obtain a water-based process under mild acidic conditions [8]. 
Furthermore, this approach is particularly attractive due to its scalability and 
repeatability in an industrial environment. The particles obtained through this 
procedure have micrometric dimension (0.5-5 µm) and pores ranging between 7-8 
nm. 
In order to obtain smaller particles, in the range of 100-200 nm with pores 
ranging between 2 and 4 nm, a second synthesis approach was developed by testing 
different procedures, as reported in chapter 2. In details, aiming to achieve both the 
reduction of the toxic solvents and an enhanced synthesis yield, the initial 
ultrasound-assisted method using methanol as solvent [9] was replaced by water-
based ultrasound-assisted methods. Subsequently, based on the cost-analysis 
conducted by Nanolith, the ultra-sonication step was also removed. Based on the 
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characterisation results, the water-based sol-gel procedure using ammonia as 
catalyst was chosen to produce the second type of MBGs [10].  
To reach the target of developing a multifunctional platform able to promote 
tissue regeneration in the presence of bacterial infection, the selected therapeutic 
ions were: 
- Copper for its antibacterial, pro-osteogenic and pro-angiogenic effect [11] 
- Cerium for the pro-osteogenic and antibacterial potential [12] 
- Silver for its well-known antibacterial effect [13] 
In this study, the antibacterial effect of these ions has been considered crucial 
to face the complications induced by the presence of bacteria in an open fracture or 
in a chronic wound and the current limitations and problems regarding the 
administration of antibiotics (resistant bacteria, cost) [14]. 
Focusing on chronic wounds, when the skin is not intact, bacteria could exceed 
the limits considered normal and the commensal microfloras of the human body 
could colonise in a pathogenic way. Although this still represents an open issue, it 
seems that a level of bacteria growth > 105 organisms per gram of human tissue 
(also called colony forming unit, CFU) leads to wound infection [15,16]. When the 
equilibrium between internal bacteria and host response is unbalanced, the normal 
healing process of open fracture and wound could proceed in a compromised way, 
leading to a delay in the recovery, morbidity, mortality and overall to an increase 
in the treatment cost [16,17]. Biomedical materials with antibacterial properties 
should be able to reduce/prevent the bacteria colonisation. For this reason, usually 
antibacterial tests are performed on materials to understand their antibacterial 
potential.  
In this context, during my research activity, several antibacterial tests were 
conducted aiming to understand the potential of the MBG nanomatrices. Among 
them, some antibacterial tests were carried out in a more physiologically relevant 
environment (3D skin model) to obtain a more detailed overview of both 
antibacterial potential and toxic effect of the developed nanomatrices. A 
preliminary antibacterial evaluation was carried out in collaboration with the 
Department of Materials Science and Engineering of University of Sheffield, during 
my six months period in Sheffield in the group of Prof. Sheila MacNeil (consortium 
partner in the MOZART project). Different types of antibacterial tests and 
experimental setups were explored in order to evaluate and optimize the proper 
conditions for testing the nanomatrices, as described in chapter 2. The antimicrobial 
potentials of the MBG particles and of the released ions were studied by viable 
count method using strains of S. aureus and P. aeruginosa (that are considered the 
most common bacteria strains in open wound [18]).  
To study the biological response of the developed MBGs, in vitro biological 
tests were carried out in collaboration with Nobil Bio Ricerche Srl and the 
Department of Materials Science and Engineering of the University of Sheffield, 
both consortium partners in the MOZART project. The test procedures are reported 
in chapter 2; whereas, the results are reported and discussed in the chapter 5. 
 
 
Nobil Bio Ricerche Srl assessed the cytocompatibility of the ion-containing 
nano- and micro-sized MBG particles through qualitatively and quantitatively 
evaluation. The effect exerted by the nanomatrices on fibroblast cells were explored 
by direct observation under the inverted microscope and MTT measurements.  
In addition to the antibacterial test, Prof. Sheila MacNeil’s research group at 
the Department of Materials Science and Engineering of the University of Sheffield 
dealt with the manufacturing of 3D skin models, prepared according to MacNeil et 
al. [19], which were then exploited in order to assess the biocompatibility of the 
nanomatrices and, after causing an infection, their antibacterial potential. The 
related results are presented in chapter 5. 
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CHAPTER 1  
State of the Art 
1.1 Introduction 
 
In this research work, a library of mesoporous bioactive glasses has been 
produced with different techniques in order to obtain scalable materials for 
biomedical applications. Some therapeutic ions were selected with the aim to 
produce multifunctional nanomatrices to be used in advanced devices for promoting 
bone healing and wound healing applications in compromised clinical situations.  
In this chapter, a literature review on bioactive glasses is given. After a brief 
and general description of the concept of biomaterials, a focus on the specific class 
of bioactive glasses is presented in section 1.3. The discovery of the bioactive 
glasses, the requirements which they have to meet, the common production 
techniques and their applications are described. In particular, in sub-sections 1.3.1 
and 1.3.2, bone healing and wound healing applications and the current approaches 
to face these clinical problems are discussed.   
In paragraph 1.4.1, the description of the sub-category related to mesoporous 
bioactive glasses containing therapeutic elements is presented. These materials are 
gaining increasing interest within the scientific community thanks to the wide range 
of possible application and the potential use as alternative treatments in place of 
conventional ones.  
Their versatility is due to the different therapeutic ions which could be used and 
to explain this concept, an exhaustive overview of the biological effect of the most 
common therapeutic ions is given. In particular, the mechanism of action is 
discussed, and an overview of the most representative results obtained for ion-
containing biomaterials is reported.  
  
 
 
1.2 Biomaterials  
The first official definition of “biomaterial”, introduced by the European 
Society of Biomaterials in 1987, stated that a biomaterial is “a non-viable material 
used in a medical device, intended to interact with biological systems”[1]. In 2009, 
Williams, as conclusion of a dissertation on the new types of substance engineered 
to perform functions within health care, provided the new following definition: 
‘‘A biomaterial is a substance that has been engineered to take a form which, 
alone or as part of a complex system, is used to direct, by control of interactions 
with components of living systems, the course of any therapeutic or diagnostic 
procedure, in human or veterinary medicine.’’ 
Williams, therefore, classified as biomaterials all the substances which can 
direct the course of a treatment through the monitoring of the interactions with the 
living systems, so, all the materials which are involved either in promotion of 
events, as in regeneration of tissue, or in prevention of event, as in antibacterial 
activity, or a combination of both. 
Within the field of biomaterials science, bioceramics represent a category in 
large expansion with several applications in restoration and replace of damaged 
tissues. The reason of this increasing interest is linked to the capability of these 
materials to solve some of the issues of an ageing population [2]. 
Bioceramics are divided into two categories based on the properties and the 
timeline. The first generation was formed by inert ceramics whose aim was to 
induce a minimal biological response when introduced in the human body. This 
first attempt of implanted ceramics experimented some problems as the creation of 
a fibrous capsule which led to the develop of the second generation of ceramics. 
These bioactive materials may be resorbable or non-resorbable ceramics which 
could interact with the body and create a controlled bond with bone or soft tissue in 
the physiological environment [2]. The main advantage of bioactive ceramics is 
their high reactivity resulting in the formation of an apatite-like phase, similar to 
the one present in bones. Some representatives of this category of biomaterials are 
calcium phosphates and glasses. 
 
1.3 Bioactive glasses 
Inventions come from a specific need, in every fields. Therefore, also the 
bioactive glasses have been invented to overcome the problem of the formation of 
a fibrous tissue which occurred when materials, supposed to be inert, were 
implanted in the body. Larry Hench in 1967 started to face the problem and 
discovered that specific compositions of glass, in the Na2O–CaO–P2O5–SiO2 
system, were able to repair tissue by forming a bond with them [3]. Small 
rectangular implants of this type of bioactive glass, called 45S5 (commercial name 
Bioglass®), were produced by melting technique, cast and tested in a rat femoral 
implant model. The hydroxyapatite layer developed on 45S5 surface after soaking 
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in solution which did not contain phosphate or calcium was compared to the 
interfacial hydroxyapatite crystals observed in vivo in the rat model [4]. Since this 
discovery, several experiments were carried out in order to understand the nature, 
the formation kinetics and strength of the formed surface bonds. Subsequently, 
Bioglass® has been used in different commercial formulations [4]. In 1984, the first 
Bioglass® device, commercialized in the United States, was used to replace the bone 
and to restore hearing through transmission of sounds from tympanic membrane to 
the cochlea. Compared to other prostheses of that time, this device, which was 
tradenamed as MEP®, was able to create a bond with both soft and hard tissue [5]. 
The second commercial product of Bioglass® was known as ERMI® in 1988 and it 
was used to repair tooth roots in fresh tooth extraction site. This conical-shaped 
device proved to be more stable and long-lasting than the materials available for the 
same purpose at that time. 
The non-widespread clinical use of these types of medical devices finds a 
reason on the surgeon needs: their monolithic shapes made them less suitable in the 
cases where the device had to fit a specific defect site or had to be pressed into it. 
Hence, in 1993 a new product was produced and sold with the name “PerioGlas®”. 
This product, in the form of particles with size ranging from 90 to 710 µm, is still 
used for the regeneration of bone around the root to preserve the tooth [5]. Building 
on the success of PerioGlas®, a particulate-shaped device was considered also in 
orthopaedic disease treatment. The so-called NovaBone® has been introduced in 
2000 into the European market and it is still sold for general orthopaedic bone 
grafting in non-load bearing body parts. 
These are only some examples of commercial devices based on Bioglass® but 
they well represent the progress in research with its ever-changing requirements: 
the initial effort made on the studies of material for the repair of a damaged tissue 
left the scene to the research of an active material able to interact with cells and 
help the regeneration of tissue [4]. 
Apart from silica-based glasses, borate and phosphate glasses received 
increasing interest due to their positive aspects. 
Borate bioactive glasses, for example, are able to convert more rapidly and 
completely to hydroxyapatite than the silica counterpart, due to their reactivity and 
lower chemical durability [6]. In vitro studies showed that borate glasses support 
cell proliferation and differentiation [7]. The main concern associated with borate 
glasses in biomedical application is related to the toxicity of boron released in static 
condition [6]. 
Phosphate-based glasses were introduced in 1980 in medical field and then they 
gained an increasing interest in both hard and soft tissue regeneration due to their 
solubility and tailored dissolution rate [8]. The peculiarity of this type of glass to be 
spun makes them suitable as guide for muscle or nerve repair [9]. 
In general, all the bioactive glass types have to meet the following requirements 
to be considered suitable biomaterial:  
 
 
1. Biocompatibility: the non-toxicity of the glasses is the main point as the 
material has to be cytocompatible and promote the cell proliferation and cell 
adhesion; 
2. No inflammatory response; 
3. Bioactivity.  
Many scientists tried to give a uniform description of the concept of 
biocompatibility but there still exists a deal of uncertainty to explain the manner 
in which a foreign material and the tissue could mutually co-exist. William in 
2008 [10] started his Leading Opinion with the consideration that 
biocompatibility  is the most important factor which distinguishes a biomaterial 
from any other material. In Table 1.1, the major features of the materials which 
may affect the host response are listed. 
It is worth noting that the host response is influenced by surface and bulk 
characteristics which interact with the materials in a different way and extent. 
 
Table 1.1: Some of material characteristics which may influence the host response [10] 
 
Other than the material variables, the reactions that may occur have to be taken 
into account to understand if the implant is successful or not. Some of the main 
phenomena are summarised in Table 1.2. 
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Table 1.2: Some of the main host response phenomena to biomaterials [10] 
 
The interaction between proteins and other macromolecules with the 
biomaterials is a key mediator for the cell behaviour: the protein could stimulate the 
cell in a way which will favour tissue repair or regeneration. Osteoblastic cells, for 
example, showed a dependence on two adsorbed glycoproteins, vitronectin and 
fibronectin, for the initial cell adhesion and spreading [11].  
The final definition of biocompatibility given by Williams is the following:  
“Biocompatibility refers to the ability of a biomaterial to perform its desired 
function with respect to a medical therapy, without eliciting any undesirable local 
or systemic effects in the recipient or beneficiary of that therapy, but generating the 
most appropriate beneficial cellular or tissue response in that specific situation, 
and optimising the clinically relevant performance of that therapy”. 
Closely related to biocompatibility is the concept of inflammatory response: the 
biomaterials cause a sequence of events when introduced in the body, which may 
provoke adverse reactions such as fibrosis, coagulation, infection and device-
mediated inflammation [12]. First of all, the concept that a biomaterial has not to 
induce an inflammatory response is incorrect. 
Anderson in 2008 [13] explained in his review that the host reactions to 
biomaterials are the following: injury, blood–material interactions, provisional 
matrix formation, acute inflammation, chronic inflammation, granulation tissue 
development, foreign body reaction, and fibrosis/fibrous capsule development 
(Figure 1.1). 
 
 
 
Figure 1.1: Sequence of events which occurred during the inflammation and wound healing processes 
[13] 
As mentioned before, the first stage after implantation is represented by the 
interaction between blood and material through the host proteins adsorbed to the 
biomaterial interface. The types, levels and conformation of these proteins 
determine the success or the failure of such implant, and, vice versa, the types, 
concentrations and conformations of the new layer (surface-adsorbed proteins) are 
related to the biomaterial properties. The formed provisional matrix, which is the 
initial thrombus/blood clot at the interface, represents a supply of structural, 
chemical and cellular components for the following processes: the type of bioactive 
agents (cells, cytokines, growth factors..), the amount and their release kinetics 
from the provisional matrix influence the process of wound healing and 
inflammatory response. 
Then acute and chronic inflammations occur: the acute inflammation usually 
lasts less than one week, and it is governed by neutrophil and mast cells; the chronic 
inflammation, instead, is less uniform histologically and is characterised by the 
presence of mononuclear cells (lymphocytes and plasma cells). The persistence of 
the inflammatory response beyond three weeks indicates the presence of an 
infection. 
If the inflammatory responses are controlled, the granulation tissues and the 
formation of a fibrous capsule are identified by the presence of macrophages, 
fibroblasts and formation of capillaries which lead the formation of the new healing 
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tissue. Between the granulation tissue (and the following fibrous capsule) and the 
biomaterial, a one to two cell-layer of monocytes, macrophages and foreign body 
giant cells (derived by the foreign body reaction) is formed [13]. The domination 
of the body giant cell response, without control, could diminish the positive effect 
on the target cells and could lead to the degradation of the implant [13,14].  
Hence, it is clear that the events and the agents involved in the failure of an 
implant are almost the same of the healing process and the difference lies in the 
controllability and the duration of such events [14]. 
As discussed previously, the capability of the biomaterial to interact with the 
bone through the formation of a carbonate substituted hydroxyapatite-like layer 
represented a big discovery and a step forward in the medical application. The 
mechanism of bioactivity has been largely described and studied by several authors  
and it is composed by a sequence of reactions which take place on the surface in 
contact with body fluids [6,15]. As shown in Figure 1.2, the first 5 reactions, which 
occur at the interface with the fluid containing H+ and H3O+ ions, are followed by 
7 cellular-dependent reactions responsible to the proliferation and differentiation of 
osteoblast and the generation of new bone. 
The rapid exchange of Na+ from the glass surface (Si-O-Na+) with H+ and H3O+ 
ions in solution is followed by the breaking of Si-O-Si bonds of the glass which 
causes a release of Si(OH)4 in solution and the formation of silanols (Si-OH) at the 
interface. 
During the third step, the polycondensation of an amorphous SiO2-rich layer 
depleted in Na+ and Ca2+ occurs on the surface. Then, Ca2+ and PO43- groups migrate 
from the glass and from the solution through the SiO2-rich layer, leading to the 
deposition of an amorphous calcium phosphate layer on the top of the SiO2-rich 
layer. 
The calcium-phosphate layer continues to grow through the incorporation of 
calcium and phosphate groups from the solution and starts to crystallize, forming a 
hydroxyl carbonate apatite (HCA). 
 
 
 
Figure 1.2: Sequence of reactions at the interface of a bioactive material and body fluid [15] 
The following steps involve the biological components, such as growth factors, 
followed by the proliferation and differentiation of osteoprogenitor cells. The bone-
forming cells create extracellular matrix which, through the mineralization, 
provokes the formation of nanocrystals and collagen on the glass surface [6,15].  
The most common techniques to obtain bioactive glass are: the melt-quenching 
route and the sol-gel route. 
Considering that the first bioactive glass (45S5) was produced by melt-
quenching technique, this is considered the traditional route. In order to obtain a 
glass by this route it is necessary a fusion of stoichiometric amounts of the different 
precursors (e.g. SiO2, P2O5, Na2CO3, CaCO3) and their following quenching. In 
brief, the different precursors are mixed together, and the as-obtained powders are 
transferred in a platinum or alumina crucible and melted in a high resistance furnace 
at high temperature (between 1100 and 1650°C, up to 3 hours, depending on the 
composition of the glass). The molten glass is then poured into moulds to obtain a 
specific shape or it can be quenched in cold water, obtaining the so-called “frits” 
which is easily powdered through ball milling. Finally, the glass is annealed using 
a temperature below the glass transition temperature in order to remove the internal 
stresses. The main limitation of this technique is linked to the composition suitable 
to be melted: a content of less than 10% of alkali oxide makes the glass viscosity 
too high to be melted [8,16]. 
The sol-gel approach, an alternative to the traditional melt-quenching route, 
involves hydrolysis and polycondensation reactions which lead the formation of a 
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gel (a network composed by interconnected pores and polymeric chains), from a 
sol (dispersion of colloidal particles with a diameter ranging between 1 and 100 nm 
in a liquid), which is later aged, dried and dehydrated. The sol-gel route starts with 
the preparation of the sol which is composed by a mixture of all the alkoxides or 
organometallic precursors. During the second step, the hydrolysis of the liquid 
alkoxide precursors occurs in a solvent. The hydrolysis of the silicon alkoxide (i.e. 
tetraethyl orthosilicate (TEOS)) usually by water elicits the formation of silanol 
groups (Si(OH)4) which interact and form Si-O-Si bonds. Finally, the 
polycondensation process leads to the formation of a silica network (SiO2). 
Reactions 1 and 2 illustrate the hydrolysis and condensation processes, respectively 
(R=CH3, C2H5, C3H7) [16]. 
 
1) Hydrolysis  
 
 
2) Condensation 
 
 
 
 
 
 
 
 
 
The two reactions occur simultaneously, and their kinetics depend on the pH, 
composition, concentration of the species, temperature, precursor, pressure and R, 
where R represents the moles of water on moles of TEOS. 
Therefore, the formation of the sol is followed by the gelation process in which 
the condensation and cross-linking of silica particles elicit the creation of a three-
dimensional network characterised by a sharp increase of viscosity. 
During the gel aging step, the polycondensation and reprecipitation of the gel 
provoke a decrease in porosity, an increase in the strength and the phase 
transformation which causes a marked change of the physical properties. The next 
step is represented by the drying process necessary to remove the liquid from the 
pores of the formed 3D network. The drying is a critical step due to the possible 
formation of cracks caused by capillary stresses within the gel network. Finally, the 
resulting gel is heat-treated to ensure the complete sintering and the pore removal 
[16,17]. 
Compared to the conventional glass production route, the sol-gel technique 
allows to synthesize material with reduced amount of contaminants, resulting from 
the several process steps (grinding, fritting, etc.) typical of melt-quenching route. 
 
 
Furthermore, as mentioned before, there is a compositional limitation dictated by 
the impossibility to produce a glass with high SiO2 content by melting. The low 
content of silica and the big amount of alkali species of the traditional bioactive 
glass produced by melting makes it difficult to maintain high level of purity due to 
its high reactivity and its tendency to incorporate impurities [18].  
In addition, the sol-gel approach offers the possibility to obtain product in 
several forms and shapes, such as fibers, foams and nano/micro sized particles 
[18,19]. In particular, the capability to produce nanoparticles is very appealing in 
the medical field. Considering that cells and biomaterials interact firstly at the 
nanoscale and that the biological components are in the same dimension range, the 
nanoscience is particularly interesting in the tissue engineering approaches [20]. 
The nanosize of a biomaterial affects its bioactive behaviour, cellular response 
and surface reaction kinetics (i.e. ion release, dissolution). For what concerns the 
bioactivity, the nanometric dimensions are strictly connected to high specific 
surface area and, consequently, to very fast ion exchange reactions and high protein 
adsorption ability. As far as cellular responses are concerned, the nanoscale 
properties of materials influence the surface chemistry and the interactions with 
proteins, thus the subsequent cell adhesion [20]. 
1.3.1 Bone healing application 
Bone tissue is the most transplanted tissue, second only to blood [21]. The 
annual fracture rate exceeds 12 million in the United States alone and non-union 
fractures represent up to 10% [22].  
The bone repair is a biologically process which results in the restoration of 
skeletal tissue to normal functionality. The fracture healing could be divided into 
four stages which occur simultaneously and involved the presence of numerous 
growth factors and cytokines: hematoma formation, soft callus and hard callus 
formation, bone remodelling (Figure 1.3) [22,23]. In details, after the injury, the 
disruption of blood vessels causes the formation of the hematoma; during the 
second stage the angiogenesis process, the intramembranous ossification and the 
cartilage formation occur; then the callus starts to mineralize and, finally, the 
remodelling occurs by replacement of large fracture callus with secondary lamellar 
bone. 
 
 
Figure 1.3: Physiological bone healing process 
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The bone grafting procedures represent the gold standard for the treatment of 
several bone defects, such as gaps at fracture sites, delayed unions and non-unions, 
spinal fusion [24].  
The bone grafting procedure consists on transplanting bone from one site to the 
site of defect and the implants are classified as autograft and allograft. These types 
of graft are distinguished by the provenience site of the materials, but they have to 
meet the same requirements [21,25]:  
1) Osteointegration: the ability to create a bond with the bone, avoiding the 
formation of a fibrous tissue 
2) Osteoconduction: the potential to support the growth of new bone through 
blood supply 
3) Osteoinduction: the property to induce the differentiation of stem cells 
towards osteogenic phonotypes  
4) Osteogenesis: the capability to induce bone formation by cells present 
within the graft material (if present) 
The most common and effective bone graft material is the autologous one 
(autograft) and includes cancellous and cortical bone graft. It is usually harvested 
from iliac crest and it respects all the requirements, thanks to the cells which survive 
from the transplantation.  
Nevertheless, the autograft procedure has some downsides: extensive operation 
time, donor site morbidity, limited supply and it is not suitable for all the patients 
(e.g. elderly, infant or patient with a malignant disease) [21,25]. 
An alternative to autograft is represented by allograft, a bone graft from a 
different individual of the same species. Regional tissue bank distributed the 
allograft in different forms (fresh, frozen or freeze-dried) and as cortical or 
cancellous implant. The allografts undergo tissue processing and sterilisation in 
order to avoid any viral transmission and therefore no viable cells are present in 
allograft (this type of graft does not meet the forth requirement). The processing 
involves a change in the mechanical properties of the original bone which becomes 
weaker and prone to fracture [21,25]. 
Considering the limitations of the current strategies and the increasing demand 
due to the gradual aging of the population, the development of bone-graft 
alternatives is highly necessary. Among bone-graft substitutes, bioactive glasses 
possess both osteointegrative and osteoconductive properties [21,26].   
1.3.2 Wound healing application 
Since their discovery, bioactive glasses have been extensively studied for their 
application in bone healing.  Only recently, their use in the treatment of wound has 
gained recognition [6,27].  
The wound healing is a complex process composed by a cascade of events 
which can be affected resulting in chronic, non-healing wounds which represent a 
great burden to both the patient and the health care system [28]. The physiological 
 
 
wound healing process involves 4 steps (Figure 1.4): haemostasis, inflammation, 
proliferation and remodelling. During the inflammatory phase it is important to 
keep the damaged wound clean from pathogens and foreign material. The 
vasodilation permits to localize in the wound site monocytes and neutrophils which 
differentiate into macrophages. The role of macrophages is to phagocytose the 
tissue debris, secrete growth factors and cytokines, small proteins which promote 
tissue proliferation. The proliferative phase is characterised by the production of 
collagen and ground substance which lay the basis for the production of the new 
tissue. The supply of this area is guaranteed by the new blood vessels created by 
the growth of endothelial cells. Finally, after 2-3 weeks, the physiologic wound 
healing process ends with the restoration of the collagen type to the usual one and 
when the wound tissue undergoes to a full cross-linking [28].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Considering the complexity of this process and the multitude of factors 
involved in it, chronic (non-healing) wounds may occur. Among critical factors in 
managing chronic wound, the low oxygen tension (e.g. 5 mmHg) is a limit for the 
cell proliferation and an enhancer of microbial growth, which is related to a longer 
inflammation phase and a delay in the repair [28,29]. Angiogenesis, which is a 
critical step in the wound healing process, is the physiological process of new blood 
vessel formation from pre-existing vasculature; it is involved in all the tissue 
regeneration phenomena due to the need to transport nutrients for the growing cells 
and to remove waste products [30]. The failure of this aspect ultimately results in 
chronic wounds [29].  
There are extreme situations (such as in the presence of haemorrhages) in which 
the use of traditional treatments (e.g. palliative wound dressings) are not sufficient 
and useful to decrease the mortality risk and the potential use of biomaterial 
represents an established challenge by now [30,31]. Several investigations on the 
administration or topical application of growth factors, including the vascular 
endothelial growth factor (VEGF) and fibroblast growth factor (FGF) types, gave 
promising results. Both VEGF and FGF are mitogens which play an important role 
in angiogenesis. Nevertheless, their high tendency to diffuse, their short half-life 
Figure 1.4: Physiological wound healing process 
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and the difficulty to control the release kinetics caused a limited success [32,33]. 
To solve the problems related to the administration of growth factor, the use of gene 
therapy or the incorporation of such growth factor in a structure (e.g. scaffold) have 
been proposed. But also in this case, there are some difficulties due to the high cost 
and the conditions necessary to produce these constructs, such as the high 
temperatures and the solvents which could alter/damage the growth factor [34].  
A robust and appealing alternative is represented by the use of materials which 
could enhance the expression and secretion of the growth factors by the organism, 
instead of administering or delivering them. To this purpose, different studies 
demonstrated that the direct/indirect contact and the dissolution products of 
bioactive glasses can stimulate the secretion of VEGF from fibroblast [5,35]. In 
vivo evidences confirmed the ability of bioactive glasses to stimulate new vessel 
networks [33]. Furthermore, the promotion of the proliferation and the activity of 
fibroblast and the release of Ca2+ from bioactive glass are key factors in the 
promotion of the wound healing process [32,36]. 
 
1.4 Mesoporous bioactive glasses 
According to IUPAC definition, solids can be divided into 3 categories based 
on their pore size, with 100 nm as upper limit. In particular, the so-called 
mesoporous materials are characterised by pore diameters ranging between 2 and 
50 nm [37].  
The possibility to create an ordered mesoporous structure was firstly 
experimented in silica-based materials, in the early 90s, by two research groups 
(Kuroda’s group at Waseda University and Kresge’s group at Mobil Oil Company). 
The mechanism which leads to the formation of the mesoporous structure is the 
combination of the use of a surfactant and the subsequent condensation of inorganic 
silica precursors (Figure 1.5)  [38]. The surfactants are amphiphilic molecules, 
composed by a lyophilic head group and a lyophobic tail which, in water, form 
micelles with the head groups forming the outer surface and the tails pointing 
toward the center [39]. Thanks to the removal of the surfactant, which acts as 
template for the pores, through calcination or solvent extraction, a mesoporous 
structured material with high surface area, large pore volume and abundance of 
silanol groups on the surface is obtained. The first application of this material was 
for catalytic purposes and, only, in 2001 Maria Vallet-Regì proposed the use of 
mesoporous silica for biomedical application, as drug delivery systems due to the 
excellent ability to load and release biological active molecules in a controllable 
way [38].  
 
 
 
 
 
Furthermore, after some years, in the 2006, the same researchers demonstrated 
the bioactive behaviour of mesoporous silicas which were able to induce the 
precipitation of hydroxyapatite when soaked in simulated body fluid (SBF). 
However the kinetics of the hydroxyapatite layer formation, too slow when 
compared to the conventional sol-gel glasses, did not allow to consider the 
mesoporous silica as a real innovation in tissue regeneration field, e.g. bone 
application [38,40]. The real advance was represented by the possibility to produce 
a material combining the compositions of conventional sol-gel glasses and the 
structural features of mesoporous silicas.  
The mesoporous bioactive glasses (MBGs) were firstly synthesized by an 
evaporation-induced self-assembly (EISA) process, using a non-ionic block 
polymer (Pluronic P123 [(ethylene oxide, EO)20(propylene oxide, PO)70(EO)20]) as 
structure-directing agent. The EISA process, described for the first time by Brinker 
et al. [41] in 1999, allowed to overcome the following two obstacles: (i) difficulty 
to obtain an ordered micellar phase using the typical temperature (100°C) requested 
by the aging and drying stages and (ii) the presence of CaO, acting as network 
modifier, which could hamper the interactions between silica and surfactant [38].  
Self-assembly is a spontaneous organisation through non-covalent bonds (Van 
der Waals forces, hydrogen bonds, electrostatic interactions, etc.). This process 
begins with a homogeneous solution of soluble silica species and surfactant 
prepared in ethanol/water with a c0 << cmc, as starting concentration, where cmc is 
the critical micellar concentration (Figure 1.6). The progressive evaporation of 
ethanol leads to a system which becomes more concentrated and drives the self-
assembly of inorganic-surfactant micelles and their organisation into liquid 
crystalline mesophase [38,39,41].  
Figure 1.5: Mesoporous structure formation using CTAB (hexadecyltrimethylammonium 
bromide) as surfactant 
37 
 
 
Figure 1.6: Schematic phase diagram of CTAB [39] 
In a typical MBG synthesis (Figure 1.7), the starting solution is composed by 
inorganic specie precursors (e.g. TEOS, Ca (NO3)2, TEP), surfactant (cationic or 
non-ionic), the volatile solvent (usually ethanol) and a catalyst (usually HCl). The 
sol resulting from the mixing of the starting solution is then transferred in a Petri 
dish and undergoes an EISA process. The following calcination of the dried gel 
allows to remove the surfactant [42].   
 
Figure 1.7: MBG synthesis through EISA process 
The synthesis procedure allows to tailor the structural features and textural 
characteristics by modulating some parameters, such as surfactant nature and 
concentration, solvent, pH, temperatures (as in the case of mesoporous silica) and 
the presence of network modifiers (only in the case of MBGs). 
For what concerns the nature of surfactant, it can be possible to distinguish 
three types of surfactant, depending on their head group chemistry and charge: (i) 
cationic, the hydrophilic group carries a positive charge; (ii) anionic if the head 
group carries a negative charge, (iii) nonionic if the hydrophilic group is not charged 
[39].  
The influence of the nature of the surfactant in MBG structure was investigated 
by Arcos et al. [43], who produced by EISA method three different bioactive 
mesoporous microspheres, using one cationic (CTAB) and two nonionic 
amphiphilic triblock copolymers (Pluronic P123 [(EO)20(PO)70(EO)20] and 
Pluronic F127 [(EO)106(PO)70(EO)106]). This study confirmed that the textural 
parameters depended on the surfactant chain length. The use of a cationic surfactant 
 
 
led to a more ordered structure characterised by smaller pore size and higher surface 
area values, compared to nonionic surfactant-based materials [43,44]. 
In the case of mesoporous bioactive glasses, textural and structural properties 
can be tailored by the addition of CaO and P2O5 in the silica network. In particular, 
CaO acts as network modifier leading to a decrease of the silica network 
connectivity [38,40].   
Although the composition of MBGs exerts an essential influence on bioactive 
behaviour, the textural parameters of these materials are also crucial in this regard. 
The highly uniform and accessible pore-size arrangement allows to obtain higher 
surface area and pore volume values, compared to traditional sol-gel and melt 
bioactive glasses with the same composition. These characteristics have been 
considered to be the main factors for the superior in vitro bioactivity. The 
combination of calcium and high surface area values provokes a faster and larger 
ion leaching, both calcium and silicon ions, when in contact with SBF. The release 
of Ca2+ determines a drop in pH which allows a formation of octacalcium 
phosphate, a precursor of hydroxyapatite [45,46].  
The in vitro bioactive response is influenced also by the pore structure: the 
three-dimensional pore system provides an easier ion exchange with the 
surrounding medium [47].  
As stated before, the silica-based mesoporous materials can be used as drug-
delivery system thanks to the high pore volume which permits to host drug 
molecules in the nanometric scale. The huge amount of silanol groups (Figure 1.5) 
present in the silica surface allows the functionalisation with different organic 
groups (i.e. alkoxylanes) potentially leading to a tailorable drug loading and release 
[40].  
 
1.4.1 MBG containing therapeutic elements and related biological 
response 
Several authors focused their attention to the possibility to enhance the positive 
effects of bioactive glasses and to impart specific biological functions. The most 
common way to move this step forward is represented by the incorporation, into the 
silica framework, of metallic ions which were proved to exert specific functions 
(e.g. antibacterial effect, pro-angiogenic potential, pro-osteogenic potential).  
As shown in the following schematic illustration (Figure 1.8), some ions could 
exert more than one therapeutic effect leading to the production of multifunctional 
platform to be used in several applications.  
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Figure 1.8: Therapeutic effects of the most used metallic ions 
 
Although the same positive effects could be obtained by incorporating growth 
factor, recombinant protein or by using other genetic engineering approaches, there 
are several advantages in using therapeutic ions [48]: 
4) The fabrication methods of biomaterials are not always compatible with 
growth factors, drugs and recombinant protein due to the high temperatures, 
solvent involved and pressure which can provoke the degradation of 
pharmacological molecules; these parameters do not affect, instead, the 
therapeutic ions, which are more stable; 
5) The metallic ions could modify cellular functions by interacting with other 
ions through the activation of ion channels or by binding with 
macromolecules; 
6) The metallic therapeutic ions are cheaper than the growth factors and 
recombinant proteins. 
Inorganic ions present in the healthy human body and involved in bone 
metabolism and in angiogenesis process are maintained at a physiological level and 
follow a specific pathway. Nevertheless, anomalous inorganic ion metabolism 
causes pathology, such as the Wilson’s disease in which copper reaches toxic 
concentration levels in all body tissues [48–50]. 
Therefore, the potential cytotoxicity of the ions released by modified MBGs 
must be carefully investigated. The uncontrolled release, in terms of concentration 
and release kinetics, may lead to adverse reactions such as inflammation or immune 
reactions. Furthermore, some metal ions can change their ionic state and become 
highly toxic, as, for example, Cr (VI), at variance of Cr(III), which acts as calcium 
supplement and promotes insulin sensitivity [49].  
 
Biological response to copper  
Copper is a metal ion present in trace amount in adult male (~100 mg) which 
can exist in biological systems in two oxidation states (Cu+ and Cu2+, reduced and 
oxidized forms, respectively), which allows copper to coordinate different ligands 
(Cu+ prefers sulfur donar ligands, while Cu2+ nitrogen ones). Cu is an essential 
 
 
element as catalyst and cofactor for enzymes which plays a role in blood clotting, 
energy supply, oxygen transport and cellular metabolism [51,52].  
It has been extensively reported that copper is a hypoxia mimicking element. 
The hypoxia is a condition of low oxygen pressure which plays a pivotal role in the 
blood vessel formation. The hypoxia inducible factor-1 (HIF-1) is composed by 
HIF-1α and HIF-1β. While the second is usually expressed by the cells, the 
expression of HIF-1α depends on the oxygen concentration. In fact, under hypoxic 
condition, HIF-1α accumulates and goes into the nucleus where dimerizes with the 
other subunit (HIF-1β) to form the HIF-1.  HIF-1 binds to the hypoxia-responsive 
element (HRE) and leads to the overexpression of VEGF, which is a fundamental 
regulator of blood vessel growth, which stimulates endothelial cell proliferation, 
migration and the creation of tubular structures [53–55]. 
The pro-angiogenic effect was demonstrated in several studies on copper-
containing bioactive glasses. Lin and co-workers [56] carried out a study on silicate 
13-93 scaffold containing different amount of copper (from 0 to 2 wt.%). They 
showed that Cu ions released from the scaffold containing 2 wt.% of copper were 
able to promote the growth of new vessels in the fibrous tissue of rat calvarial 
defects and that the number of new capillaries increased with the increasing of 
copper concentration. More recently, the effect of copper-containing MBGs on 
zebrafish model was investigated [57]. MBG particles based on SiO2-CaO-P2O5 
composition and modified with 5%mol of copper were soaked in DMEM in 
different concentration up to 3000 mg L-1. The extracts after up to 5 days of 
incubation and the suspension prior to start the experiment were tested on bovine 
aortic endothelial cells (BAEC) and in zebrafish embryo in vivo assay, respectively. 
The experiments proved a potential cytotoxicity of both copper-containing and 
copper-free MBGs at high concentration. Nevertheless, the ionic products of 5% 
Cu-containing sample using a concentration of 300 mg L-1 caused a vasodilation 
and an increase in the thickness of sub-intestinal vessel from 6.03 to 7.58 µm, using 
the zebrafish embryo assay. 
The enhanced secretion of VEGF from fibroblast was analysed by Dziadek et 
al. [58], which reported that bioactive glasses containing 1% mol of copper were 
associated to an increase in VEGF secretion compared to sample without copper, 
confirming its essential role in the VEGF expression.  
Concerning the negative effect of copper-containing material, although the 
toxic ion threshold depends on the cell type involved in the experiments and on the 
specific conditions, it seems that a potential cytotoxic effect of copper ion may exist 
due to the formation of an excess of hydroxyl radicals, produced by the copper-
catalysed reaction between superoxide and hydrogen peroxide [56,59–61]. 
In vivo experiment in a goat model after anterior cruciate ligament (ACL) 
reconstruction confirmed the close connection between osteogenesis and 
angiogenesis effect of copper [55]. Polyethylene terepthalate (PET) artificial 
ligament graft coated by copper-containing bioactive glass was pulled into the bone 
tunnel after native ACL removal. After 12 weeks, tibial-graft complexes were 
harvested and analysed through histological and immunohistochemical 
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examinations. As far as Cu-containing BG/PET graft is concerned, histological 
results demonstrated more new bone tissue at the interface and into the graft, 
confirming the osteointegration, compared to BG/PET graft. Furthermore, the 
CD31 (a transmembrane protein involved in the early vascular growth) expression 
was significantly higher in Cu-containing graft. The same authors showed that 
copper-containing coating was effective in promoting HIF-1α, BMP2 and S100A10 
(which are osteogenesis-related genes) and the Ca2+ concentrations in cells. 
The pro-osteogenic potential of Cu2+ ions found further evidence in several 
works on different cell lines. Burghardt et al. [62] proved that Cu2+ ions released 
from a titanium implant were able to stimulate a complete differentiation of human 
bone marrow derived mesenchymal stem cells to osteoblasts which led to the 
expression of collagen type I and the complete mineralization. Alkaline 
phosphatase (ALP), osteocalcin (OCN) and osteopontin (OPN) activity were 
investigated in several studies [56,62–64] which confirmed that copper could 
stimulate the cells to perform osteogenic function.  
The antibacterial effect of copper has been known since ancient Egyptian, 
between 2600 and 2200 B.C. and, from this moment, numerous studies were 
conducted in order to exploit this beneficial effect [65].  
Although the mechanism is not fully elucidated yet, a suggestion on the action 
of copper ions was described by Grass et al. [65]. As shown in Figure 1.9, the 
rupture of the membrane due to the copper ions dissolved in the medium causes the 
loss of cytoplasmic content (Figure 1.9A and B); moreover, the generation of 
reactive oxygen species (ROS) causes stress and a further cell damage (Figure 
1.9C). As last step, genomic and DNA starts to degrade (Figure 1.8D).  
 
Figure 1.9: Mechanism of action of copper ion released [65] 
 
The antibacterial property of copper-containing MBG scaffold was tested by 
Wu et al. [64] against Escherichia Coli (E. Coli). After 7 days of incubation, the 
number of survived bacteria was highly reduced, and the antibacterial mechanism 
was ascribed to the redox potential of copper causing damage to bacteria and 
producing hydroxyl radicals which can participate in some reactions detrimental to 
molecules. In another work [62], Cu2+ ions released in a final concentration of 1.75 
mM from a titanium implant were sufficient to kill adherent Staphylococcus aureus 
(S. aureus) biofilm within 24h. Bacteria within biofilms are more resistant than 
planktonic bacteria and represent the main cause of infection associated to implants: 
bacteria adhere and form the biofilm, which becomes thicker and hinder the 
 
 
penetration of the antibacterial agent [62,66]. Furthermore, some bacteria may 
differentiate into a biofilm specific phenotype and become more resistant. The 
viable count method was used by Mulligan et al. [66] to analyse the antibacterial 
effect of increasing Cu content in phosphate-based glasses on Staphylococcus 
Sanguis (S. Sanguis). By 24h, a 2.6 log reduction of viable bacteria colonies was 
encountered and was ascribable to the presence of copper. 
An in-depth study on copper-containing MBGs was conducted by our group 
[67]  in order to analyse the bacterial viability of two gram-positive bacteria (S. 
aureus and S. epidermidis) and one gram-negative (E. coli) using two different 
experimental conditions to evaluate the antibacterial effect of the synthesized 
nanoparticles and their extracts. Moreover, the effect of both nanoparticles and their 
extract was investigated against on S. epidermidis biofilm. The authors showed that 
with longer incubation time and higher suspension of nanoparticles (2 mg mL-1) the 
bacterial viability for both E. coli and S. aureus has been reduced by 70-75% and 
by 50% for S. epidermidis. For what concerns the extract action, after 24 h a cell 
viability reduction was observed but it was less marked compared to the use of the 
particles. The same evidence was encountered also in the case of biofilm. For 
detailed description of these results see section 3.2.1.2 of the “Results and 
discussion” chapter. 
 
Biological response to boron  
Boron is one of the trace elements present in human body. It has been reported 
that boron intakes equal to 1-3 mg/day have positive effects on bone and brain 
health. Furthermore, it has a key role in several processes including embryo genesis, 
inflammatory and immune response [68,69]. 
Boron-containing MBG scaffold was developed using two different 
concentrations of boron (5 and 10 %mol) by Wu and co-workers [70]. In order to 
understand the effect on osteoblast response, cells were cultured on the surface of 
the scaffolds which were analysed after 1 and 7 days. The number and the spreading 
of the osteoblast increased with time and numerous filopodia ensured the close 
contact between the material and the osteoblast. An in vivo evaluation of B-
modified bioactive glass particles was carried out by Gorustovich et al. [71] by 
implanting them in rat tibia bone marrow. After 15 days of implantation, the 
histomorphometric analysis demonstrated that the partial substitution of silicon by 
boron enhances the bone formation in the early stage and leads to a thicker bone 
tissue, characterised by Ca/P ratio similar to the hydroxyapatite one [72]. 
The pro-angiogenic potential of the ionic dissolution products from different 
boron-containing bioactive glass compositions has been investigated [73]. The cell 
viability, cell morphology and VEGF secretion from bone marrow stromal cell were 
evaluated. The authors speculated that both the cytocompatibility and the VEGF 
secretion depended on the release of Si and B ions and the composition 5.5%Na2O 
11.1%K2O 4.6%MgO 18.5% CaO 56.6%B2O3 3.7%P2O5 0%SiO2 (in wt.) was 
found to be toxic for the cells. On the other hand, the boron released (between 0-10 
ppm) from other compositions (5.9%Na2O 12.0K2O 5.5%MgO 22.6%CaO 
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12.5%B2O3 4.0%P2O5 37.5%SiO2 and 5.9%Na2O 12.0K2O 5.5%MgO 22.6%CaO 
25%B2O3 4.0%P2O5 25%Si in wt.) promoted the cell mitochondrial activity and 
improved the release of VEGF. 
A 45S5 bioglass containing 2% of boron (in wt.) was produced and its ionic 
dissolution products were used to test the pro-angiogenic capacity by evaluating the 
vasculature of the embryonic quail chorioallantoic membrane (CAM assay) [74]. 
The test with 45S5 undoped showed no pro-angiogenic effect but did not affect the 
normal vessel development in the CAM assay. The B-containing glasses, instead, 
allow the release of a sufficient amount of ion able to promote the angiogenesis, 
evidenced by the higher expression of the αvβ3 which is an integrin significantly 
up-regulated during angiogenesis and vascular remodelling. It has been speculated 
by the authors that the effects observed could be explained by the fact that borate 
causes the stimulation of the secretion of cytokines and/or growth factors with pro-
angiogenic potential and the proliferation of endothelial cells of the vessel. 
 
Biological response to cobalt 
Cobalt is another trace element present in human body and represents the metal 
constituent of vitamin B12.  
One of the most studied property of cobalt is its ability to enhance the 
angiogenesis process by miming the hypoxia through the stabilization of HIF-1α 
[75,76].  
The biological response of cobalt-containing bioactive glass/collagen 
composite scaffolds was studied by Quinlan et al. [77] through tests on 
cytocompatibility and pro-angiogenic effect. In this work, two sizes of bioactive 
glass were produced for the composite: (i) cobalt-containing bioactive glass 
particles with an average size of 38 µm and (ii) cobalt-containing bioactive glass 
particles with an average size of 100 µm. They proved that the particle size had an 
effect on the biological response of the composite and, in particular, the larger 
particles gave better results in terms of VEGF gene expression by HUVECs, VEGF 
protein production and vascular tubule formation. These results have been 
associated to the different release kinetics of the samples: the bigger particles at 
later timepoints released a lower concentration compared to the smaller ones. In 
fact, although the released concentration was below the toxic level (3-12 ppm) [78], 
the faster rate influence in a negative way the biological response. 
Wu and co-workers investigated the relation between the Co2+ released from 
MBG scaffold and the hypoxia [78]. They found that both amounts of cobalt (2 and 
5% mol) induced a significant hypoxic cascade with an increase of VEGF protein 
secretion, HIF-1α and VEGF expression in BMSCs. But, the 5%mol Co-containing 
MBG scaffold showed a slightly less cell proliferation compared to 2%mol Co-
containing scaffold.  
What is clear is that cobalt, more than the other ions, could have a beneficial 
effect but, in large dose or with an uncontrolled release kinetics, could produce 
detrimental effect and induce cell apoptosis, inflammatory response and genotoxic 
effect [79]. 
 
 
 
Biological response to strontium 
Strontium is a divalent cation which plays a pivotal physiological role in bone 
metabolism. Considering its effect on osteoclastogenesis, osteoblastogenesis and 
adipogenesis, strontium ranelate, a compound containing two atoms of Sr, is 
considered an alternative strategy to treat osteoporosis disease. Osteoporosis is a 
very common disease which affects predominantly postmenopausal women. The 
bone embrittlement lined to this pathology is caused by an imbalance between 
osteoblast action (bone deposition) and osteoclast action (bone resorption). 
Strontium ranelate was shown in osteopenic models and osteoporotic patients to 
increase the bone quality due to its property to activate osteoblast pathways and 
hinder osteoclast ones [80]. 
The calcium-sensing receptor (CaSR) is capable to sense divalent cations, such 
as Ca2+ which has similar charge, charge to size ratio and electronic configuration 
to Sr2+ and was proposed as a hypothetic mediator of the effect of strontium in the 
bone metabolism (Figure 1.10).  
The activation of CaSR by strontium could have a double effect: promotion of 
osteoblast activity and inhibition of osteoclast activity, as evidenced in Figure 1.10. 
The increase in osteoblastogenesis is due to the activation of different signaling 
pathways (Wnt/ERK1/2-MAPK) which induces to osteoblast differentiation. On 
the other hand, strontium could inhibit the differentiation and resorbing activity of 
osteoclast by activation of CaSR. Furthermore, it could induce osteoclast apoptosis. 
 
 
Figure 1.10: Role of the calcium sensing receptor [80] 
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Other important pathways in bone cells, such as nuclear factor of activated Tc 
(NFATc), Wingless/Integrated (Wnt) and RANK/RANKL/OPG, seem to be 
involved in Sr2+-induced effects (Figure 1.11). 
 
 
NFAT (NFATc1 to NFATc5) are five transcription factors involved in the 
differentiation of several cells. The activation of NFTAc through Sr2+ provokes the 
upregulation of gene expression involved in osteoblastic differentiation. Also the 
Wnt signaling pathway, which is an important mechanism controlling the bone 
metabolism, is influenced by Sr2+ [80]. 
The involvement of Sr2+ in osteoclast differentiation could be explained 
considering RANK/RANKL/osteoprotegerin (OPG), where RANKL is the 
acronym of receptor activator of nuclear factor-kappaB ligand. OPG is important 
in bone density and mass regulation, while RANKL plays a role in 
osteoclastogenesis and bone resorption. As shown in Figure 1.11B, OPG associates 
with RANKL thus preventing its binding with RANK which is an important factor 
for osteoclast differentiation. Sr2+ promote the overexpression of OPG and reduce 
the expression of RANKL, reducing pre-osteoclast differentiation [80]. 
The effect of strontium on osteoclast and osteoblast activities has been studied 
by Gentleman et al. [81] by substituting calcium with strontium in bioactive glasses. 
They showed that the ions released were non-cytotoxic to Saos-2 cells. Moreover, 
the osteoclast differentiation was assessed by measuring the erosion pit area formed 
on calcium phosphate-coated chamber well slides, treated with the dissolution ions 
from strontium-substituted BG. Considering that the erosion pit area is an indicator 
of osteoclast activity, its reduction, as assessed by the authors, confirmed the 
potential of strontium to inhibit the osteoclast differentiation. The proliferation of 
osteoblast and the ALP activity evidenced the ability of the BG to stimulate the 
osteoblastogenesis when directly in contact with cells.  
Fiorilli and co-workers [82] evaluated the biological response of two types of 
Sr-containing mesoporous bioactive glasses characterised by different particle size, 
structure features and ion release kinetics. The fibroblast morphology and the cell 
viability confirmed the non-toxicity of the matrices. Concerning the inflammatory 
response, both materials did not increase the IL6 and of IL1β expression, which are 
A B 
Figure 1.11: Actions of strontium on osteoblast differentiation (A) and on osteoclast differentiation (B) 
[80] 
 
 
two mediators of the inflammatory response. By evaluating of RANKL and OPG 
genes, the authors found that both mesoporous bioactive glasses reduced osteoclast 
activity with a RANKL/OPG ratio in favour of OPG. 
 
Biological response to lithium  
Lithium is another metal element present in trace quantity in the human body 
which has been widely used in the treatment of bipolar disease. It has also been 
proved that lithium ions can be used in bone tissue engineering application because 
they are capable to activate the Wnt signalling pathway by inhibiting glycogen 
synthase kinase 3β (GSK-3β) which is an enzyme that phosphorylates β-catenin in 
the cytoplasm [83,84].  
It has been proved that the activation of Wnt/β- catenin signalling by LiCl 
induced the proliferation, migration and survival of microvascular endothelial cells 
in vitro, which are typical effects of VEGF. Nevertheless, the in vivo experiments 
on mice with oxygen induced retinopathy did not confirm the in vitro results 
suggesting that the β-catenin and Wnt/β-catenin signalling increase is not sufficient 
to induce retinal capillary repair in vivo [85]. The use of lithium as vasculogenesis 
factor needs further studies.  
The cementogenic differentiation ability, which leads to the formation of 
cementum (the substance which covers the tooth root),  of Li+ free and incorporated 
into mesoporous bioactive glass scaffold was investigated by Han et al. [86]. They 
found that both free lithium and lithium incorporated induced a positive effect on 
culture of human periodontal ligament-derived cells (hPDLCs). In particular, the 
incorporation of 5% mol Li+ ion-containing MBG scaffold showed an enhanced cell 
proliferation and differentiation. Furthermore, an increase in ALP, OPN and OCN 
expression was noticed. 
 
Biological response to cerium  
Cerium is the first of lanthanide series, also known as rare-earths elements, and 
is characterised by an ionic radius similar to calcium although with a higher charge. 
Thanks to this feature, Ce3+ can act as Ca2+ ions, hence they can have high affinity 
to Ca2+ sites on biological species [87–89]. 
Differently from the most of lanthanides, cerium is stable in physiological 
solution in both oxidized (Ce4+) and reduced (Ce3+) forms and the successful shift 
between these two states of cerium oxide nanoparticles has been used in some 
studies [90,91]. Cerium oxide nanoparticles (CeONP) adopt a cubic crystalline 
structure in which eight oxygen anions surround a cerium atom and every oxygen 
atom occupies a tetrahedral position. The ability to mutate between Ce4+ and Ce3+ 
and the presence of vacancies, or defects, explain the use of CeONP as catalyst, 
antioxidant-enzyme-like agent (superoxide dismutase mimic, catalase mimic 
peroxidase-like mimic) and as hydroxyl and nitric oxide radical scavenging agent 
[91]. In particular, this last peculiarity has been exploited to target oxidative stress-
related diseases and chronic inflammations. In biological systems, the oxidative 
stress is the result of an imbalance between ROS and nitrogen species production, 
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which can cause (i) toxicity or (ii) act as signalling molecules based on their 
concentration, position and intracellular conditions. In normal situations, an 
excessive production of ROS can be counteracted by cells, through mechanism such 
as enzyme antioxidants. However, beyond a certain limit or in presence of disease, 
these active species can provoke damage or oxidative stress which plays a role in 
aging and in several human diseases, such as chronic inflammation, diabetes, 
cardiovascular diseases. The capability of CeONP to scavenge almost all kinds of 
these active species was tested and makes this nanoparticles potential antioxidant 
agent [88,91–93].  
Apart from the CeONP, the use of cerium compounds in biomedicine has been 
investigated in different applications, such as vomiting-related disease, burn 
wounds characterised by the presence of bacteria. In this last application, the 
combination of Ce(NO3)3 and silver sulfadiazine has been exploited in a 
commercial cream (distributed in Europe with the name of Flammacerium®) due 
to its ability to reduce bacterial colonisation, suppress the immune response and 
allow a more rapid re-epithelialization [89]. 
The antibacterial effect of cerium has been explained through different 
mechanisms and almost associated to the presence of Ce3+ [94–96]. It has been 
reported that Ce3+ ions rapidly bind to E. Coli, inhibit its respiration and enter 
cytoplasm through the penetration of outer and inner membrane. As stated before, 
the antibacterial mechanism of ceria, instead, was attributed to the oxidative stress 
following the reduction from Ce(IV) and Ce(III). 
The osteoconductive and antibacterial properties of cerium-containing glass-
reinforced hydroxyapatite have been elucidated in the work of Morais et al. [97]. 
The addition of cerium did not influence the general features of the composite, 
enhancing the biological effects of the material.  In details, the antibacterial 
properties of the material have been tested against S. aureus, S. epidermidis and P. 
aeruginosa by evaluating the bacterial adhesion on the surfaces. The study revealed 
a different action against the Staphylococci strains and Pseudomonas: the presence 
of Ce decreases the bacterial adhesion of the gram-positive strains, compared to the 
composite without cerium, but it has no effect against the gram-negative. The 
authors speculated that this different action could be related to the bacterial 
morphology: the bacillus shape of the Staphylococci strains has more contact point 
with material with an increase of adhesion; in addition, the gram-negative bacteria 
present a complex wall composed by peptidoglycan layer and lipidic membrane 
being less permeable to cerium ions. 
In the same work, human osteoblastic-like cell was used to test the effect of this 
material on cell attachment, adhesion and spreading. The cerium-substituted 
composite allowed the adhesion with the production of filopodia and a well-
organised F-actin cell cytoskeleton. In addition, they proved that the presence of 
cerium had an inductive effect on cell proliferation and an up-regulation on ALP 
and BMP-2 expression.  
The partial substitution of calcium with cerium in hydroxyapatite nanoparticles 
was examined by Lin and co-workers [98]. The antibacterial test confirmed that the 
 
 
inhibition zone became bigger with the increase of cerium amount, also due to an 
increase of solubility of cerium-substituted hydroxyapatite particles.  
In vivo study [99] on mouse demonstrated that Ce3+ ions were able to promote 
the proliferation of primary mouse osteoblasts (OBs) in all the tested 
concentrations, ranging between 10-9 and 10-4 mol L-1. Differently from the 
proliferation, the effect of Ce+3 ions on differentiation is dose dependent with an 
inhibition of osteoblast differentiation at higher concentration.  
A plausible molecular mechanism of the promotion of bone marrow stromal 
cells (BMSCs) migration and differentiation by cerium ions was explained by Hu 
and co-workers [100]. As shown in the schematic representation in Figure 1.12, it 
seems that cerium promotes the osteogenic differentiation of BMSCs through the 
Smad-dependent BMP signaling pathway.  
In details, BMP, responsible for promoting osteogenic differentiation, binds 
BMPR2, which recruits and phosphorylates BMPR1, leading to the regulation of 
cell differentiation and growth through phosphorylation and translocation in the 
nucleus of the protein Smad1/5/8. This protein leads to an up-regulation of the 
genes related to osteogenic differentiation (Runx2 and SDF-1) [100]. 
 
 
Figure 1.12: Schematic representation of the molecular mechanism of migration and differentiation of 
BMSCs induced by cerium [100] 
 
Biological response to magnesium  
Magnesium is the fourth most numerous cations in human body, present in bone 
tissue and, for only 1.0%, in extracellular matrix. Several cellular functions, such 
as potassium and calcium ion transport, signal transduction, cell proliferation and 
energy source are influenced by Mg [101].  
The role of magnesium on proliferation and differentiation of human bone-
derived cells (HBDCs) has been investigated by Zreiqat [102] in order to obtain 
surface modification of prosthetic implants. They demonstrated that the presence 
of Mg2+ led to an increase of osteoblast adhesion and a higher expression of the 
integrin receptors β1-, α5-, α3β1-, α5α1-. These integrin receptors are the mediator 
between the biomaterial and the cells. The integrins, in fact, regulate the gene 
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expression by transducing the signal from the extracellular to the intracellular 
environment, influencing the cell migration, proliferation and apoptosis.  
The magnesium deficiency is linked with osteoporosis [103]. Several studies 
related to the deficiency of magnesium in humans gave an explanation about the 
relation between bone weakness and lack of magnesium (Figure 1.13). First of all, 
the magnesium deficiency has been linked to several causes such as diet, mutations 
on hereditary single-gene, alcohol, drugs.  
 
Figure 1.13: Link between osteoporosis and magnesium deficiency [103] 
This lack of magnesium influences in a direct and indirect way the bone 
density: 
- Direct effects: the hypomagnesemia influences the dimension of the new 
formed crystals of apatite which are larger than no-deficient Mg individuals 
and, thus, are not able to bear normal load. Furthermore, it leads to a 
decrease of markers related to osteoblastic activity and an increase in 
osteoclast number 
- Indirect effects: the magnesium deficiency affects the parathyroid hormone 
(PTH) and the vitamin D which play a key role in the calcium homeostasis; 
it promotes also inflammation with the promotion of an oxidative stress as 
consequence. It is also speculated by the authors that the hypomagnesemia 
causes endothelial dysfunction followed by a decrease in blood vessel, and, 
as said before, there is a straight connection between blood supply and bone 
formation. 
 
Biological response to silver  
The antibacterial property of silver is well-known and exploited since ancient 
time due to the broad spectrum of action, which is very important when a 
polymicrobial colonisation occurs [104]. 
The antibacterial mechanism of silver is not fully elucidated yet, but three 
different modes of action have been proposed (Figure 1.14): 
 
 
1- Uptake of free silver ions as such or as dissolution product of silver 
nanoparticles followed by disruption of ATP production, DNA mutation 
and cytoplasm shrinkage 
2- Silver nanoparticles and silver ions can catalyse reactions with an excessive 
production of ROS  
3- Silver nanoparticles interact directly with bacteria membrane and penetrate 
inside the cell, increase permeability and disturb the respiration [105] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the frame of dental pulp tissue infection, the antibacterial action of silver 
ions was exploited by Lee et al. [106] by doping with silver ions bioactive glass 
nanoparticles (BGn) and testing them against E. coli, S. oralis, E. faecalis, and S. 
mutans bacteria strains, which are recognised as the most common species in dental 
pulp infection. The antibacterial functions were assessed through in vitro assay by 
counting the colonies forming unit (CFU) and in vivo by using an infected dental 
pulp tissue defect model generated in rat. The in vitro test confirmed that a 
concentration of 40 µg mL-1 was sufficient to reduce the bacterial viability to less 
than 10% for E. coli and S. oralis, a higher amount (160 µg mL-1) was necessary to 
reduce to 20% the bacterial viability of E. faecalis. The Ag-containing BGn was 
not effective against S. mutans. The in vivo test conducted against E. faecalis, 
demonstrated that the BGn containing silver was more effective than free 
tetracycline, an antibiotic drug. 
Silver-containing MBGs were produced by EISA process and investigated for 
their antibacterial potential against S. aureus by Gargiulo and co-workers [107]. In 
this work, the Ag-MBGs, incubated for 20 h in nutrient broth medium killed about 
99% of bacteria colonies. The authors speculated that this effect could be associated 
to the Ag+ ions dissolved from the crystalline AgCl developed after incubation in 
the growth medium, rich of Cl-. 
With the same antibacterial purpose, Dai and co-workers [108] conducted an 
in-depth study in order to obtain mesoporous silica spheres containing calcium and 
silver to control rapid haemorrhage. They demonstrated that only the exchange of 
Figure 1.14: Antibacterial mode of action of silver 
particles [105] 
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silver ions allowed a reduction of > 4log10 of E. coli and S. aureus bacteria strains 
and that the compounds without silver did not show any antibacterial activity. The 
authors proposed another explanation of silver’s antibacterial mechanism in which 
silver ions induce the inactivation of proteins in bacteria by interaction with thiol 
groups. The obtained results on coagulation cascade, platelet adhesion, blood 
clotting, antibacterial activity suggested the potential use of this compound for 
wound dressing. 
 
Biological response to zinc 
More than 1000 human proteins contain zinc, as essential element. 
Furthermore, several key physiological processes are regulated by Zn, such as 
cellular response, oxidative stress, DNA repair and cell apoptosis. While few 
studies are focused on the damages related to Zn excess, various studies confirmed 
that the Zn deficiency may lead to chromosomal mutations, lined to the individual 
cancer risk [109].  
In addition, zinc plays a pivotal role in the growing and maintenance of bone. 
It has been demonstrated that zinc has a stimulatory effect on osteoblastic bone 
formation and mineralization and on inhibition of osteoclastic bone resorption, 
resulting an important factor in osteoporosis [23]. 
The role of zinc in the cell differentiation, cell proliferation and mineralization 
are schematically shown in Figure 1.15. It seems that zinc can stimulate the gene 
expression of different proteins such as Runx2/Cbfa1 (the transcription factor for 
differentiation into osteoclastic cell), collagen I, ALP and OCN. In addition, zinc 
leads to an increase in the production of growth factors involved in human 
osteoblast proliferation (IGF-I and TGF-β1) [23]. 
 
 
Figure 1.15: Osteoblastic bone formation mechanism influenced by zinc [23] 
 
In the case of bone resorption, zinc is able to suppress the activity of osteoclast 
by inhibiting the action of RANKL in pre-osteoclasts, which is a receptor involved 
in osteoclast differentiation (Figure 1.16). Moreover, zinc stimulates the gene 
expression of OPG in osteoblastic cell and induces a factor which influences the 
osteoclastic lineage [23]. 
 
 
 
Figure 1.16: Osteoclastic bone resorption mechanism influenced by zinc [23] 
The incorporation of Zn in bioactive glass has been investigated by different 
authors [110,111]. The studies confirmed the stimulation of osteoblast 
differentiation, proved by an increase of ALP activity with the increase of culture 
time. Furthermore Balamurugan and co-workers [110] investigated the osteoblastic 
cell morphology by scansion electronic microscopy (SEM) and evidenced the 
formation of filopodia and the increase in cell number, confirming the 
cytocompatibility of the zinc-substituted bioactive glass. 
Varmette et al. [112] conducted a study on Zn-containing bioactive glasses to 
investigate the reduction of inflammation on murine macrophage cells after 
induction of inflammation by lipopolysaccharide (LPS) which is a large molecule 
composed by lipid and polysaccharide, found in the outer membrane of gram-
negative bacteria. They discovered that bioactive glass in the ternary system 
containing 5 and 11% mol of zinc induced a reduction of tumor necrosis factor 
alpha (TNFα), which represents the “first in line” cytokine promoting the cascade 
of pro-inflammatory cytokine production. 
The antibacterial potential of both zinc oxide nanoparticles and Zn2+ were 
analysed in different works [113,114]. The antibacterial activities of zinc ions were 
tested against five microorganisms and proved that the contribution of the overall 
antimicrobial activity was the complexation of Zn2+ by molecules present in the 
broth which caused a higher and faster dissolution of ions from ZnO. Apart from 
zinc ions dissolved from ZnO, also the same ZnO was found to have antibacterial 
properties against a broad spectrum of bacteria strains. The SEM investigation 
showed a dramatic change in bacteria cell morphology due to the increased levels 
of oxidative stress after administration of ZnO.  
 
In Figure 1.17, the most relevant biological effects of the therapeutic ions are 
summarized. 
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Figure 1.17: Summary of relevant biological effects of therapeutic ions 
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CHAPTER 2   
Materials and methods 
2.1 Introduction 
The aim of this PhD research was to develop a library of ion-containing 
mesoporous nanomatrices which can exert different therapeutic effects to meet the 
needs of tissue regeneration applications and overcome the limitations of the 
traditional treatments, as widely described in the previous chapter. The amount and 
the type of therapeutic ions added during the synthesis were selected to create 
agents with peculiar features, such as antibacterial, pro-osteogenic and pro-
angiogenic properties. To this purpose, different synthesis routes were tested and 
optimized in order to produce two main different categories of nanomatrices: nano-
sized particles with diameter ranging between 100 and 200 nm and pores in the 
range of 2-4 nm, and micro-sized particles with size in the range of 500 and 5 µm 
and bigger pores of about 7-8 nm.  
In this chapter, the synthesis procedures adopted to obtain the mesoporous 
nanomatrices are described.  
In particular, a selection process (Figure 2.1) was carried out following the 
general aim to reduce/avoid inflammable organic solvents, strongly acidic solutions 
and energy-consuming steps in view of an easier scaling-up of the manufacturing 
process.  
 
 
 
Figure 2.1: Flow chart of the synthesis procedure selection process 
 
 In this regard, in paragraphs 2.2, 2.3 and 2.4 the different synthesis procedures 
and the sample compositions are presented, followed by the description concerning 
the morphological, structural and compositional characterization techniques, the 
different ion release procedures and the method followed to assess the bioactive 
behaviour. Subsequently, a large part of this chapter is dedicated to the biological 
assays carried out through the collaboration with different research groups, as 
highlighted in the specific sub-paragraphs. In details, the biocompatibility and the 
antibacterial tests using selected nanomatrices are described.  
Finally, an advanced biological assessment by using 3D skin models is reported 
in section 2.8.3.  
2.2 Synthesis of MBGs assisted by ultrasonication 
In order to produce nano-sized particles with pores around 3 nm, different 
procedures were tested. Among them, the first route investigated was a methanol-
based ultrasonicator-assisted sol-gel procedure obtained by modifying a procedure 
reported by El-Fiqi et al. [1]. The ultrasound waves allow a better disintegration of 
the particles and the production of fine dispersions thanks to the cavitation 
phenomenon. The results were promising (described in section 3.2.1 of “Results 
and discussion” chapter) but the involvement of toxic inflammable solvent and the 
use of an energy-consuming step (ultra-sonication) did not meet the sought safety 
and scalability requirements.   
2.2.1 Methanol-based sol-gel synthesis 
In details, the as-synthesized nanomatrices, the molar composition and the 
amount of the ion precursors used during the synthesis are listed in Table 2.1. The 
therapeutic ion-containing nanomatrices were obtained by substituting part of 
calcium with the chosen amount of therapeutic ion. 
For this synthesis, the reagents were all purchased from Sigma-Aldrich. 
Part of the work described in this chapter has been  published during the PhD 
period [2]. 
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Briefly, 5 g of cetyltrimethylammonium bromide (CTAB, ≥ 98%) was 
completely dissolved by stirring in 120 mL of absolute methanol, whose pH was 
adjusted to 12.5 by adding about 30 mL of NH4OH. Into this solution, proper 
amounts of calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, 99%) and therapeutic ion 
precursor (see Table 2.1) were dissolved. In a separate batch, 0.895 g of tetraethyl 
orthosilicate (TEOS, 99%) were dissolved in 30 mL of absolute methanol and was 
then added to the first solution with the simultaneous application of ultrasounds 
using a SONOPULS Ultrasonic Homogenizers HD 3200. The output power was 
150W in a 10 s on/10 s off cycle for 20 min. This solution was stirred at room 
temperature for 24 h. Then the precipitate was separated by centrifugation (Hermle 
Labortechnik Z326) at 5000 rpm for 5 min, washed one time with distilled water 
and two times with absolute ethanol. The final precipitate was dried at 70 °C for 12 
h and calcined at 600 °C in air for 5 h at a heating rate of 1 °C/min using a Carbolite 
1300 CWF 15/5.  
 
Table 2.1: Sample composition and reagent amount used in the methanol-based ultrasonicator-assisted sol-
gel synthesis 
Name Composition 
(%mol) 
Reagents (g) 
TEOS Ca(NO3)2·
4H2O 
Therapeutic ion 
precursor 
MBG_US_m_SiO2/CaO 85 SiO2/15 CaO 0.895 0.179 / 
MBG_US_m_Cu2% 85 SiO2/13 CaO/2 
CuO 
0.895 0.156 CuCl2: 0.014 
MBG_US_m_Cu5% 85 SiO2/10 CaO/5 
CuO 
0.895 0.119 CuCl2: 0.034 
MBG_US_m_Sr1% 85 SiO2/14 CaO/1 
SrO 
0.895 0.168 SrCl2 6H2O: 0.014 
MBG_US_m_CuSr2% 85 SiO2/13 CaO/1 
CuO/1 SrO 
0.895 0.156 CuCl2: 0.007 
SrCl2 6H2O: 0.016 
 
2.2.2 Water-based sol-gel synthesis 
With the aim of avoiding the use of toxic solvent and improving the synthesis 
yield, two different water-based procedures assisted by the ultrasonicator were 
adopted and the related description are reported in sections 2.2.2.a and 2.2.2.b. 
2.2.2a Ammonium fluoride-catalysed water-based sol-gel synthesis  
A water-based ultrasonicator-assisted approach, using NH4F as catalyst, was 
adopted with the aim to produce mesoporous silicate-based systems by carrying out 
changes to a procedure previously reported in literature [3]. Table 2.2 reports the 
samples, the molar composition and the reagent amounts used during this synthesis. 
As can be noticed, the same route was followed to produce both ion-containing 
mesoporous bioactive glass (MBG) and mesoporous silica (MSn) systems. 
As previously, the reagents were all purchased from Sigma-Aldrich. 
 
 
In details, 1.8 g of CTAB, 3 g of NH4F (Sigma-Aldrich) and a specific amount 
of Ca(NO3)2·4H2O (only for MBG systems) were dissolved in 500 mL of distilled 
water and left under stirring for 1 h at 80 °C. Subsequently, a proper amount of 
therapeutic ion precursors, previously  dissolved in 1 mL of ethanol, was mixed 
with 9 mL of TEOS. The latter solution was added drop wise to the first one, with 
the simultaneous application of high-power ultra-sounds (150 W in a 10 s on/10 s 
off cycle for 20 min) using a SONOPULS Ultrasonic Homogenizers HD 3200.  
After 4 h of stirring, the supernatant was separated by centrifugation (Hermle 
Labortechnik Z326) at 5000 rpm for 5 min and washed, and redispersed one time 
with distilled water and one time with ethanol. The final precipitate was dried at 70 
°C for 12 h. Finally, the surfactant was removed by calcination at 600 °C in air for 
5 h at a heating rate of 1 °C/min using a FALC FM 8,2.  
 
Table 2.2: Sample composition and reagent amount used in the water-based ultrasonicator-assisted sol-
gel procedure, using NH4F as catalyst 
Name Composition (%mol) Reagents (g) 
TEOS Ca(NO3)2·
4H2O 
Therapeutic ion 
precursor 
MBG_US_w_I_Cu2% 85 SiO2/13 CaO/2 
CuO 
8.460 1.470 CuCl2: 0.128 
MSn_US_w_I_Ag2%* 98 SiO2/2 AgO 8.460 / AgNO3: 0.141 
MSn_US_w_I_Ce2%* 98 SiO2/2 CeO 8.460 / CeCl3 7H2O: 0.308 
 
2.2.2b Ammonia-catalysed water-based sol-gel synthesis 
A base-catalysed water-based route, involving the use of ammonia as catalyst, 
was used to produce the calcium-silicate nano-sized sample 
MBG_US_w_II_SiO2/CaO (Table 2.3). By adding the ultrasonication step, a 
procedure developed by Wu et al. [4] was modified. In particular, 6.6 g of CTAB 
and 12 mL of NH4OH were dissolved in 600 mL of double distilled water. After 30 
min of stirring, 28.2 g of TEOS and 5.64 g of Ca(NO3)2·4H2O were added with the 
simultaneous application of high-power ultra-sounds (150 W in a 10 s on/10 s off 
cycle for 20 min) using a SONOPULS Ultrasonic Homogenizers HD 3200 and left 
under stirring for 3 h. The as-obtained products were separated using a centrifuge 
(Hermle Labortechnik Z326) and washed one time with distilled water and one time 
with ethanol. Finally, the collected powders were dried 70 °C for 12 h and calcined 
at 600°C for 5 h (heating rate of 1 °C/min). 
Table 2.3: Sample composition and reagent amount used in the water-based ultrasonicator-assisted sol-
gel procedure, using NH4OH as catalyst 
Name Composition 
(%mol) 
Reagents (g) 
TEOS Ca(NO3)2·4H2O Therapeutic ion 
precursor 
MBG_US_w_II_SiO2/CaO 85 SIO2/15 CaO 28.20 5.64 / 
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2.3 Ammonia-catalysed water-based sol-gel synthesis 
(without sonication) 
Based on the cost-analysis conducted by Nanolith, a Swedish partner of the 
MOZART project, the ultra-sonication step, introduced in the base-catalysed sol-
gel synthesis described in section 2.2.2b, was removed and the procedure reported 
by Wu and co-authors [4] was carried out by incorporating specific amount of 
therapeutic ion to replace part of calcium in order to obtain ion-substituted nano-
sized particles, as illustrated in Table 2.4.  
Part of the work described in this chapter has been already published during the 
PhD period [5].  
In this synthesis, the reagents were all purchased from Sigma-Aldrich and the 
samples were produced by following the same ammonia-catalysed water-based sol-
gel procedure reported in section 2.2.2b without the sonication step. 
Table 2.4: Sample composition and reagent amount used in the water-based sol-gel procedure, using 
NH4OH as catalyst 
 
2.4 Synthesis of micro-sized MBG particles assisted by 
spray-dryer  
Among the explored routes, a procedure based on the aerosol assisted spray-
drying approach was adopted with the final aim to obtain a water-based process 
under mild acidic conditions.  By modifying a spray-drying method reported by 
Pontiroli et al. [6], MBG microspheres and ion-containing mesoporous silica 
microspheres (MSm) were synthesized. The aforementioned technique is very 
appealing for its scalability to an industrial environment and for its good 
repeatability. 
Part of the work described in this chapter has been already published during the 
PhD period [5].  
Briefly, 2.030 g of the non-ionic block copolymer Pluronic P123 
(EO20PO70EO20, average Mn ∼5800 Da, Sigma-Aldrich) were dissolved in 85 g of 
double distilled water. In a separate batch, a solution of 10.73 g of TEOS was pre-
Name Composition (%mol) Reagents (g) 
TEOS Ca(NO3)2·4H2O Therapeutic ion 
precursor 
MBG_SG_Cu0.5% 85 SiO2/14.5 CaO/0.5 
CuO 
28.200 5.430 CuCl2: 0.106 
MBG_SG_Cu2% 85 SiO2/13 CaO/2 
CuO 
28.200 4.880 CuCl2: 0.428 
MBG_SG_Ce1% 85 SiO2/14 CaO/1 
CeO 
28.200 5.260 Ce(NO3)3∙6H2O: 
0.691 
MBG_SG_Ce2% 85 SiO2/13 CaO/2 
CeO 
28.200 4.880 Ce(NO3)3∙6H2O: 
1.383 
MBG_SG_Ag0.1% 85 SiO2/14.9 CaO/0.1 
AgO 
28.200 5.600 AgNO3: 0.027 
MBG_SG_Ag2% 85 SiO2/13 CaO/2 
AgO 
28.200 4.880 AgNO3: 0.541 
 
 
hydrolysed under acidic conditions using 5 g of an aqueous HCl solution at pH 2 
until a transparent solution was obtained. The solution with TEOS was then poured 
drop by drop into the template solution and kept stirring for 1 h. Then, the amount 
of ion precursor and of Ca(NO3)2·4H2O, as reported in Table 2.5, were added.  
The final solution was stirred for 15 min and then sprayed (Büchi, Mini Spray-
Dryer B-290) using nitrogen as the atomizing gas with the following parameters: 
inlet temperature 220 °C, N2 pressure 60 mmHg and feed rate 5 mL/min. The 
obtained powder was finally calcined at 600 °C in air for 5 h at a heating rate of 1 
°C/min using a Carbolite 1300 CWF 15/5. 
Table 2.5: Sample composition and reagent amount used in the spray-drying synthesis 
Name Composition 
(%mol) 
Reagents (g) 
TEOS Ca(NO3)2·4H2O Therapeutic ion 
precursor 
MBG_SD_SiO2/CaO 85 SiO2/15 CaO 10.730 2.150 / 
MBG_SD_Cu0.5% 85 SiO2/14.5 
CaO/0.5 CuO 
10.730 2.070 CuCl2:0.041 
MBG_SD_Cu2% 85 SiO2/13 CaO/2 
CuO 
10.730 1.860 CuCl2: 0.163 
MBG_SD_Sr1% 85 SiO2/14 CaO/1 
SrO 
10.730 2.000 SrCl2 6H2O: 0.162 
MBG_SD_CuSr2% 85 SiO2/13 CaO/1 
CuO/1 SrO 
10.730 1.860 CuCl2: 0.081 
SrCl2 6H2O: 0.162 
MBG_SD_Ce1% 85 SiO2/14 CaO/1 
CeO 
10.730 2.000 Ce(NO3)3∙6H2O: 
0.263 
MBG_SD_Ce2% 85 SiO2/13 CaO/2 
CeO 
10.730 1.860 Ce(NO3)3∙6H2O: 
0.527 
MBG_SD_Ag0.1% 85 SiO2/14.9 
CaO/0.1 AgO 
10.730 2.130 AgNO3: 0.010 
MBG_SD_Ag2% 85 SiO2/13 CaO/2 
AgO 
10.730 1.860 AgNO3: 0.206 
MSm_SD_Ce2%* 98 SiO2/2 CeO 10.730 / Ce(NO3)3∙6H2O: 
0.456 
MSm_SD_Ag2%* 98 SiO2/2 AgO 10.730 / AgNO3: 0.178 
 
2.5 Morphological, structural and compositional 
characterization  
The analysis of the mesoporous nanomatrices developed through the different 
synthesis routes was performed in order to study the morphology, the particle size, 
the structural features and the composition of the as-synthesized samples. The data 
obtained through the characterization techniques, described in the following 
sections, allowed to verify the sample features and to select the best performing 
procedures.  
These characterizations were used throughout the present research activity to 
investigate the properties of the prepared nanomatrices or to monitor their evolution 
during specific experiments (e.g. bioactivity test, ion release test...). 
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2.5.1 Morphological analysis: Field Emission Scanning Electron 
Microscopy (FE-SEM) and High-Resolution Transmission 
Electron Microscopy (HRTEM) 
FE-SEM. The FE-SEM technique is a non-destructive characterization analysis 
adopted to investigate the morphological features, size and shape of the particles. 
The FE-SEM working principle consists in a high energy electron beam generated 
by an electron gun and focused at specimen surface, after being processed by 
magnetic lenses (Figure 2.2A). The interaction between the electron beam and the 
sample surface leads to the generation of a variety of signals.  
In order to reduce the surface charging which can hinder the electron path, non-
conductive specimens are generally coated with a very thin (~5-10 nm) layer 
conductive heavy metal (such as gold, chromium or platinum). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: FE-SEM functioning (A) and interaction between the electron beam and the sample (B) [7] 
In Figure 2.2A the FE-SEM functioning is displayed. In details, the electrons, 
generated by the electron gun and accelerated through a potential difference, pass 
through a system of lenses which deflects and focuses the beam on the specimen 
surface. The interaction between the beam and the sample gives rise to a generation 
of different signals (Figure 2.2B), which include secondary electrons (SE), 
backscattered electrons (BSE), photons (characteristic X-rays), visible light 
(cathodoluminescence-CL), diffracted backscattered electrons (EBSD), and heat. 
Among these signals, the SE and the BSE are exploited to obtain morphological 
and topographical information. In particular, SE are low energy electrons generated 
by inelastic scattering, with energy <50 eV. Considering that only the SE produced 
by the surface are able to be collected by the detector, it follows that the SE signal 
provides a superficial topographical image. Differently, the BSE signal comes from 
deeper region of the sample due to the greater energy of BSE (>50 eV). The 
information obtained through this signal is closely linked to the chemical 
B A 
 
 
composition of the specimen, since more primary electrons are scattered from 
higher average atomic number of the element in the sample, resulting in a brighter 
image [8,9]. 
Samples. The FE-SEM analysis was performed on all the nano- and micro-sized 
particles produced by all the synthesis routes. Moreover, the FE-SEM 
characterization was carried out on the samples after soaking in SBF to investigate 
the formation of HA layer (see section 2.7 for more details). 
Pre-analysis preparation methods. Micro-sized samples produced by spray-
drying technique were placed on sample holders using conductive carbon tape and 
coated with 10 nm of Cr layer. 
At variance, in order to obtain a better dispersion of the nano-sized particles, 
the latter (~10 mg) were dispersed in 10 mL of isopropanol (Sigma-Aldrich) using 
an ultrasonic bath (Digitec DT 103H, Bandelin) for 5 min to create a stable 
suspension. Subsequently, 5 μL of the as-obtained suspension were dropped on a 
carbon-coated copper grid and coated with Cr layer (10 nm). 
The samples were analysed by a ZEISS MERLIN instrument.  
 
HRTEM. The transmission electron microscope (TEM) represents a very 
powerful tool for analysing material. This technique uses the interaction between 
the source, represented by energetic electrons, with the sample to provide different 
types of information (i.e. morphological, compositional and crystallographic 
information). The functioning principle consists in an electron beam emitted from 
a filament which passes through a condenser lens system and an objective lens 
system and reaches the sample. In the HRTEM, both the transmitted and the 
scattered beams from the sample are used to create an interference image. The 
HRTEM provides data of crystal and internal structures. 
Samples. MBG_US_m_Cu2% and MBG_US_m_Cu5% samples produced by 
methanol-based ultrasonicator-assisted sol-gel procedure were analysed by 
HRTEM technique in order to investigate the inner structure of the samples. 
Moreover, the EDS (Energy Dispersive Spectroscopy) mapping coupled to TEM 
allowed to explore the distribution of Cu ions and of the other elements within the 
particles. 
Pre-analysis preparation methods. MBG_US_m_Cu2% and 
MBG_US_m_Cu5% nanomatrices were ultrasonically dispersed in n-butanol and 
placed on carbon-coated nickel grids. 
HRTEM imaging and related local EDS were performed at the Departamento 
de Química Inorgánica y Bioinorgánica, Universidad Complutense de Madrid, 
CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN) by the 
Prof. Maria Vallet-Regì’s research group. The instrument used to perform the 
analysis was the JEOL JEM300FEG electron microscope equipped with an ISIS 
300 X-ray microanalysis system (Oxford Instruments). 
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2.5.2 Compositional analysis: Energy Dispersive Spectroscopy 
(EDS), X-ray fluorescence spectroscopy (XRF), X-ray 
Photoelectron Spectroscopy (XPS) and Inductively Coupled 
Plasma Atomic Emission Spectrometry (ICP) 
EDS. The Energy Dispersive Spectroscopy (EDS) allows to explore the 
elemental composition of the samples through the detection of the characteristic X-
rays coming from the sample after the exposure to a high-energy electron beam. 
The energy of the generated X-rays depends on the atomic number of the element; 
thus, it can be used to obtain information about chemical composition. These X-
rays, reaching the detector, cause the ionization in the detector and the production 
of an electrical charge which, after the analysis, allows the obtainment of a spectrum 
reporting the number of counts per channel as a function of the energy of the 
detected X-rays (keV). The detector and the related preamplifier are cooled with N2 
liquid at -192 °C to reduce the electronic noise [10].  
Samples. The EDS investigation was carried out on all the nano- and micro-
sized particles with the aim to study the chemical composition and the incorporation 
of the therapeutic ion. 
Pre-analysis preparation methods. A small amount of powders was dispersed 
on the conductive carbon tape placed on the sample holders and the Aztec EDS 
equipment was used for the analysis. 
 
XRF. The Energy dispersive X-ray fluorescence spectroscopy (XRF) is 
performed on the samples for qualitative and quantitative study of the elemental 
composition. During the process, the excitation of the specimen with a high energy 
primary X-rays causes the electrons of the inner orbital to be knocked. As a result, 
the electrons from the outer shells fill the resultant vacant spaces, by emitting X-
rays fluorescence radiation characteristic of a specific material, which reaches the 
detector. The as-obtained spectrum shows the intensity of X-rays as a function of 
energy (keV) [11]. 
Samples. The XRF was adopted, as a non-routine technique, in order to analyse 
the elemental composition of MBG_US_m_Sr1% and MBG_SD_Sr1%. As 
described in detail in the following chapter, the overlapping of strontium and silicon 
peaks in the EDS spectrum and the low amount of the incorporated strontium led 
to the need of the XRF characterization technique.  
Pre-analysis preparation methods. About 10 mg of the powders were pressed 
into pellets by using a die and applying a pressure of 2 t. The Rigaku ZSX100E 
instrument was used to perform the analysis.  
 
XPS. Is one of the most widely used characterization technique for chemical 
surface analysis providing quantitative and chemical state information. In a typical 
spectrometer, the excitation of the sample surface with mono-energetic Al kα X-
rays causes the emission of photoelectrons by the sample surface. The electron 
energy analyser measures the energy of the emitted photoelectrons. The elemental 
 
 
identity, the amount and the chemical state of the specific detected element can be 
identified by the binding energy and the intensity of the resulting photoelectron 
peak. A typical analysis depth of an XPS instrument is less than 5 nm [12].  
Samples. In order to investigate the nature of the copper species incorporated 
inside the MBG_US_m_Cu2% and MBG_US_m_Cu5% glass framework, XPS 
analyses were performed on these samples. 
Methods. A PHI 5000 Versaprobe II Scanning X-ray Photoelectron 
Spectrometer (XPS), equipped with a monochromatic Al K-alpha X-ray source 
(1486.6 eV energy, 15 kV voltage and 1 mA anode current), was adopted to analyse 
sample surface chemical composition. The photoelectron signal for both the high 
resolution (HR) and the survey spectra were collected by using a spot size of 100 
mm. Different pass energy values were exploited: 187.85 eV for survey spectra and 
23.5 eV for HR peaks. The core level spectra were deconvoluted with a nonlinear 
iterative least squares Gaussian fitting procedure. 
 
ICP. This analysis allows to determine the concentration (in ppb) of a specific 
chemical element in a water-dissolved sample. The functioning principle exploits 
the presence of argon plasma (which is a neutral conducting gas which contains the 
same amount of cations and electrons) generated in a stream of Ar. This Ar plasma, 
at high temperature (6000-10000 K), acts as excitation source for the sample 
electrons which emit energy at a specific wavelength, peculiar to its atomic 
environment, when they return to ground state. A peristaltic pump introduces the 
solution to the nebulizer chamber which produces a fine mist of liquid particles. 
Then, they pass through a torch which creates the plasma; in the torch, different 
processes occur, such as the evaporation of the solvent, the atomization and the 
excitation or ionization of the atoms. The plasma is continuously supplied by a 
radio-frequency generator which produces an oscillating magnetic field around the 
torch, causing the heating of the charged gas. Finally, the atoms leave the high 
temperature zone and relax by emitting specific photon which reaches the detector 
after the crossing of the monochromator that allows the separation of the 
wavelength. 
Sample. With the aim to assess the released ion concentration from the 
nanomatrices, the ion released test were performed by following the procedures 
reported in section 2.6 and the as-obtained supernatant solution was analysed by 
ICP.  
In addition, the ICP analysis was carried out on MBG_SD_CuSr2% and on 
MBG_US_m_CuSr2% with the purpose of investigating the capability of the 
nanomatrices to simultaneously incorporate two therapeutic ions.  
Pre-analysis preparation methods. The supernatant solutions resulted from the 
ion release test were first diluted in order to reach a suitable concentration 
detectable by the ICP instrument and then analysed through this technique. The 
results, expressed as ppb and multiplied for the specific dilution factor, represent 
the concentration of the ion released by the sample. 
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The co-substituted Sr-Cu-containing samples were analysed by ICP after the 
dissolution of the powder by strongly acid medium (0.5 mL of HNO3 and 2 mL of 
HF for 10 mg of powder). 
The ICP-MS, Thermoscientific, ICAP Q was exploited to perform the analysis 
during this PhD work. 
 
2.5.3 Textural properties: N2 adsorption-desorption measurements 
Textural features such as the pore size, pore shape, pore distribution, together with 
the specific surface area and pore volume were explored through N2 adsorption-
desorption measurements. This non-destructive technique is based on the 
physisorption phenomenon which occurs between an adsorptive, an adsorbable gas, 
and an adsorbent, the surface of a solid. The forces which are involved in this 
phenomenon are the intermolecular forces. The desorption, at variance, is the 
counterpart of the physisorption, where the amount of the adsorbed gas decreases. 
The not-perfect coincidence between the adsorption and desorption process gives 
rise to the hysteresis loop.  
The isotherm obtained through this technique depicts the amount of gas 
adsorbed as a function of relative pressure (p/p0). According to IUPAC 
classification [13,14], six types of isotherm are recognised, as visible in Figure 2.3: 
• Type I isotherms: typical of microporous (pores <2 nm) solids. Two 
different types of isotherms belong to this category: Type I(a) and Type I(b). 
Type I(a) isotherms correspond to material with narrow micropores with < 
1 nm; Type I(b) isotherms are obtained for materials with broader pore size 
distribution, ranging from micropores to narrow mesopores; 
• Type II isotherms: characteristic of nonporous or macroporous (pores >50 
nm) adsorbents; point B represents the completion of monolayer coverage; 
• Type III isotherms: related to nonporous and macroporous materials where 
the interactions between the adsorbent-adsorbate are weak; 
• Type IV isotherms: representative of mesoporous solids, where the 
adsorption phenomenon depends on the interaction between adsorbent-
adsorptive, as well as between the molecules in the condensed state. The 
adsorption at very low p/p0 corresponds to the monolayer-multilayer 
adsorption of N2 on the walls of the mesopores, as already observed in Type 
II isotherm, but, in the mesoporous material, it is followed by the capillary 
condensation, indicating the condensation of a gas in the pore at a pressure 
<p0. Typically, the Type IV isotherms end with a plateau. As visible in 
Figure 2.3, two different isotherms belong to this category. Type IV(a) 
isotherms with its characteristic hysteresis loop in the capillary 
condensation region, represent materials with pores larger than a critical 
width (using nitrogen as adsorptive at 77K, it corresponds to 4 nm); the 
Type IV(b) isotherms, with the completely reversible process, are typical of 
adsorbents with smaller pore width; 
 
 
• Type V isotherms: as Type III, they correspond to weak adsorbent–
adsorbate interaction, with the addition of the hysteresis loop; 
• Type VI isotherms: typical of highly uniform nonporous solids where a 
layer-by-layer adsorption is observed. 
Figure 2.3: Physisorption isotherm classification [14] 
 
Five types of hysteresis loops (from H1 to H5) are reported, depending on the 
pore structure and the specific adsorption mechanism (Figure 2.4). The Type H1 
loop is typical in mesoporous material with narrow range of uniform mesopores; 
the Type H2 is usually associated to more complex pore features. Type H2(a), for 
example, could be ascribed to interconnected pores, where the evaporation occurs 
only from the pores directly connected to the surface; Type H2(b) loop is linked to 
the presence of pores with larger neck widths. 
Type H3 occurs in presence of aggregates of plate-like particles; the H4 
hysteresis loop is often associated to the elongated and narrow pore size. Finally, 
the Type H5 hysteresis loop is ascribed to solids containing both open and partially 
blocked pores [14]. 
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Figure 2.4: Hysteresis loop classification [14] 
Among the data obtained through the N2 adsorption-desorption measurements, 
the specific surface area (SSA) value represents the effective accessible area of the 
sample. One of the most widely adopted methods to calculate the SSA is the 
Brunauer–Emmett–Teller (BET) method [14]. This method is based on the theory 
that the adsorption enthalpy is constant during the multilayer formation. 
The BET equation can be written as follows: 
 
𝑝
𝑉 (𝑝0 − 𝑝)
=
1
𝑉𝑚𝐶
+
𝐶 − 1
𝑉𝑚𝐶
𝑝
𝑝0
 
 
Where: p = equilibrium pressure (torr) 
p0= saturation pressure at 77 K (torr) 
 V= adsorbed volume/g of solid 
 Vm= monolayer volume of N2 (mL) 
 C= parameter associated to the energy of monolayer adsorption 
By plotting p/(V (p0-p)) as a function of p/p0, a linear correlation in a limited 
range of p/p0 (0.05 and 0.3) is obtained and the values of Vm and C can be 
calculated. Finally, the SSA value is determined by the following equation [14]: 
 
𝑆𝑆𝐴 =
𝜎 𝑉𝑚 𝑁𝑎
𝜈
 
 
Where: SSA= specific surface area (m2/g) 
σ = molecular cross-sectional area occupied by the adsorbate molecule 
in the monolayer, which corresponds to 13,5 Å for N2 
 Na= Avogadro number (6.02·1023) 
 ν= molar volume of the adsorbed gas (22414 mL/mol for N2) 
In addition to the SSA, the pore size distribution and the pore volume can be 
obtained through this characterization technique by means of different methods. 
Among them, one of the most exploited is the Non-Local-Density Functional 
 
 
Theory (NLDFT) based methods. These methods, based on statistical mechanics, 
allow to calculate a series of theoretical isotherms (kernel), for a particular 
adsorptive/adsorbent system and for a given pore shape. The calculation of the pore 
size distribution function is obtained by solving an equation which correlates the 
isotherm kernel with the experimental isotherm [14]. 
Samples. After each synthesis, the as-produced samples were analysed through 
the N2 adsorption/desorption measurements in order to investigate the mesoporous 
structure and the textural features.  
Pre-analysis preparation methods. The samples were analysed through the 
ASAP2020 (Micromeritics) instrument, using nitrogen as adsorptive at -196 °C. The 
nanomatrices were outgassed at 150 °C for 5 h before analysis in order to remove 
gas adsorbed on the sample surface. After an overpressure of He, the samples were 
analysed through the administration of increasing amount of pressure.   
 
2.5.4 Structural analyses: X-Ray Diffraction (XRD) and UV-visible 
Spectroscopy (UV-vis) 
XRD. The X-ray diffraction (XRD) provides qualitative and quantitative 
information about the structure of the sample, with focus on the crystalline phases 
present. The analysis is based on the diffraction phenomenon of X-rays, peculiar to 
crystalline materials, by the crystal lattice of the analysed solid. The X-rays are high 
energy radiation with wavelength ranging between 0.01 and 10 nm and frequency 
in the range of 3·1016 and 3·1019 Hz. The wavelength of the X-rays is of the same 
order of d (Figure 2.5) that represents the distance between the parallel planes in 
which the atoms of a crystalline material are arranged.  
 
 
Figure 2.5: Diffraction phenomenon 
Considering a monochromatic X-ray beam which reaches the crystalline 
material with λ as wavelength and an angle θ, the diffraction phenomenon occurs 
only when the distance travelled by the incident X-ray reflected from successive 
beam differs by a complete number n of wavelengths (Bragg’s law, nλ = 2d sinθ). 
As visible in Figure 2.5, by varying the angle θ, different d-spacings satisfy the 
Bragg’s law condition in polycrystalline solids. The resulting diffractogram, obtained 
by plotting the intensities of the diffracted X-rays as a function of the angular positions, 
is characteristic of the material. 
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A typical diffractometer is composed by a source of radiation, a 
monochromator to select the wavelength, some slits to tailor the shape of the beam 
and a detector.  
The characteristic diffractogram of a crystalline material consists of sharp 
peaks, resulting from the diffracted beams arising from the different planes. Several 
data can be obtained from the diffractogram analysis such as the crystal cell 
symmetry and the type of phases. In particular, the quantitative composition can be 
derived from the intensity of the peak; whilst the peak shape gives information 
about the crystal dimension. 
In the amorphous material, the diffractogram consists on a broad peak centred 
around the θ which shows a sharp peak in the diffractogram of the crystalline material 
with the same composition. 
Samples. The micro- and nano-sized particles were analysed through XRD in 
order to investigate the structure of the sample and the presence of any segregated 
oxidic phases due to the incorporation of therapeutic metallic ions. Moreover, the 
powders after soaking in SBF (see section 2.7) were explored to confirm the 
bioactivity of the sample by searching the hydroxyapatite peaks. 
Methods. The powders, prepared as plane surface, were placed on the sample 
holders and analysed through a wide-angle (2θ within 10°-80°) X-ray diffraction 
(XRD, X’Pert PRO, PANanalytical) diffractometer. 
 
UV-vis. The UV-Visible Spectroscopy (UV-vis) can be employed to identify 
the metal ion coordination and the oxidation number of the species hosted in the 
mesoporous systems.  
The basis of this spectroscopy technique is the absorption of monochromatic 
electromagnetic radiations in the ultraviolet (200-350 nm) and visible (350-700 nm) 
spectral region by species composed by specific functional groups, called 
chromophores. In detail, a chromophore is an atom or a group of atoms responsible 
for ultraviolet and/or visible radiation adsorption. 
The absorption in the UV-visible region is associated with excitation of 
electrons from lower to higher energy levels by using excitation with precise 
amount of energy. Most of the molecules require very high energy radiation to be 
excited, thus the absorption of UV-visible light results only in the presence of atoms 
with non-bonding orbitals.  
A typical UV-visible spectrometer is composed by a light source (which is a 
combination of tungsten/halogen and deuterium lamps), a monochromator and the 
detector. In brief, the light from the source reaches the monochromator which splits 
the light into its component colours of different wavelengths. After passing through 
the sample, the light reaches the detector which converts the intensity of the light 
in electric signal which undergoes to amplification and returns a diagram reporting 
the absorbance as a function of the wavelength. 
Considering I the intensity of the incoming light in the sample and I0 the 
resulting light after the absorption by the sample, the main considered phenomena 
are: 
- Absorbance (A= -log (I/I0)) 
 
 
- Reflectance 
Through the application of the Lambert-Beer law, by knowing the absorbance, 
it is possible to obtain the concentration of a substance: 
𝐴 =  𝜀 𝑐 𝑑 
 
Where: ε= molar extinction, which is peculiar for a substance (mol-1 L cm-1) 
 d= optical path length  
 c= concentration of the solution (mol/L) 
In some cases (e.g. powder sample), the scattering light phenomenon resulting 
from the shape of the analysed sample makes difficult to acquire directly the 
absorbance spectrum. By equipping the spectrometer with an integrating sphere 
covered by a highly reflecting material (usually MgO o BaSO4), the diffuse 
reflectance light can be collected. Considering that absorbance and diffuse 
reflectance are strictly connected, through the diffuse reflectance phenomenon, 
information about the absorption phenomenon can be obtained. 
Sample. Cerium- and silver-containing samples were analysed through diffuse 
reflectance UV-visible spectroscopy in order to investigate the oxidation state of 
the incorporated ion, since the ion clusters result in peaks in the visible region due 
to the plasmonic resonance.   
Pre-analysis preparation methods. First, a baseline is recorded with reference 
disk covering the reflectance port, then, about 10 mg of powders were mounted 
over the port and the instrument VARIAN CARY 5, Agilent was used to obtain the 
diffuse reflectance UV-visible spectra of the samples.  
2.6 Ion release tests  
The capability of the ion-containing nanomatrices to release the incorporated 
therapeutic ion was explored by adopting different procedure and media, in order 
to study the influence of the experimental setups on the ion release kinetics. In this 
section, the detailed description of the followed procedures is reported.  
Part of the work described in this chapter has been already published during the 
PhD period [2,5]. 
2.6.1 Ion release test performed in SBF 
The first medium used to investigate the ion release from the nano- and micro-
sized particles was SBF, prepared according to Kokubo recipe [15] in order to 
correlate the ion release property with the bioactive behaviour (see section 2.7) of 
the samples. In details, 30 mg of ion-substituted nanomatrices were placed in a 
plastic container with 30 mL of SBF (final concentration of 1 mg/mL of SBF). The 
samples were kept immersed for different times up to 14 days at 37 °C in an orbital 
shaker Excella E24 with an agitation rate of 150 rpm. At each time point (3 h, 24 h, 
3 d, 7 d and 14 d), the suspension was centrifuged (Hermle Labortechnik Z326), 
and 1 mL of the supernatant solution was collected and analysed by ICP through 
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the ICP-MS, Thermoscientific, ICAP Q spectrometer. The experiment was carried 
out in triplicate. Table 2.6 listed a summary of the experimental setup.   
Table 2.6: Experimental setup of ion release test in SBF 
Medium Concentration Time point Refill 
SBF 1 mg/mL 3 h, 24 h, 3 d, 7 d, 14 d No 
 
2.6.2 Ion release test performed in DMEM 
Dulbecco’s modified eagle medium (DMEM) (Sigma-Aldrich), as a mimetic 
cell culture environment, was used in order to perform some experiments and to 
analyse the ion release kinetics in a more complex environment.  
As in SBF medium, 30 mg of ion-containing powders were soaked in 30 mL of 
DMEM (final concentration of 1mg/mL) and placed in the orbital shaker (Excella 
E24) by setting 37 °C and 150 rpm as temperature and agitation rate, respectively. 
At each time point (3 h, 24 h, 3 d, 7 d and 14 d), the suspensions were centrifuged 
(Hermle Labortechnik Z326), and 1 mL of the DMEM solution was collected. The 
experiment was carried out in triplicate. The supernatant was analysed by ICP (ICP-
MS, Thermoscientific, ICAP Q) in order to investigate the therapeutic ion 
concentration released in DMEM.  
Compared to SBF medium, the DMEM required to be used in aseptic 
conditions under biological hood in order to avoid any contamination. 
Table 2.7 listed a summary of the experimental setup. 
Table 2.7: Experimental setup of ion release test in DMEM 
Medium Concentration Time point Refill 
DMEM 1 mg/mL 3 h, 24 h, 3 d, 7 d, 14 d No 
 
2.6.3 Ion release test performed in Tris HCl 
The samples were suspended in Tris HCl buffer (Tris(hydroxymethyl) 
aminomethane (Trizma) (Sigma-Aldrich) 0.1 M, pH 7.4) at a final concentration of 
250 μg/mL, according to the protocol described by Shi et al. [3]. Specifically, 5 mg 
of the samples were kept immersed in 20 mL of buffer up to 14 days at 37 °C in an 
orbital shaker Excella E24 with an agitation rate of 150 rpm. At each predefined 
time point (3 h, 24 h, 3 d, 7 d and 14 d) the suspensions were centrifuged for 5 min 
at 10000 rpm (Hermle Labortechnik Z326), half of the supernatant was collected 
and replaced by the same amount of fresh buffer. Each experiment was carried out 
in triplicate. The concentration of ions was measured by ICP (ICP-MS, 
Thermoscientific, ICAPQ), after appropriate dilutions. 
In Table 2.8 the followed experimental setup is summarized. 
 
 
 
Table 2.8: Experimental setup of ion release test in Tris HCl 
Medium Concentration Time point Refill 
Tris HCl 250 μg/mL 3 h, 24 h, 3 d, 7 d, 14 
d 
Half of medium replaced by fresh 
medium 
 
By comparing this ion release procedure with the previous ones, the refill of 
the medium was introduced in order to better mimic the physiological conditions 
characterized by a continue liquid exchange. The refill of the medium, together with 
the lower concentration, allowed to avoid the saturation of the solution and hinder 
the ion release.  
2.7 Bioactivity test 
Part of the work described in this chapter has been already published during the 
PhD period [5].  
Since the bioactivity of the MBGs is considered one of the main aspect of these 
materials, as largely reported in chapter 1, bioactivity test was performed on the 
MBG samples by following a methodology reported in ref [16], where a unified 
method for the evaluation of HA-forming ability of bioactive glasses in powder 
form is proposed. In particular, 30 mg of powders were soaked in 30 mL of SBF 
for 3 h, 24 h, 3, 7 and 14 days. The bottles were placed inside an orbital shaker 
(Excella E24) at a fixed temperature of 37 °C. At each selected time point, the 
powders were removed by centrifugation at 5000 rpm for 5 min, rinsed with double 
distilled water and dried in oven at 70 °C for 12 h. The pH of SBF was measured at 
each time point. The powders were analysed by FE-SEM, EDS and XRD to detect 
the HA phase formation. 
2.8 Biological assessment  
2.8.1 Biocompatibility test of ion-containing nanomatrices  
The cytocompatibility test was performed on ion-containing nanomatrices with 
the aim to explore their effect on fibroblast L929 in view of the potential clinical 
applications. The biocompatibility test was performed by the group of Dr. Marco 
Morra at Nobil Bio Ricerche Srl, one of the industrial partners of the MOZART 
project involved in the biological assessment of the nanomatrices. 
Sample. The optimized micro- and nano-sized samples were considered for the 
biocompatibility test. In details, the Cu- containing samples (both 0.5%mol and 
2%mol concentrations) the Ce-containing samples (both 1%mol and 2%mol 
concentrations) and the Ag-substituted samples (0.1%mol and 2%mol 
concentrations) were analysed in order to investigate whether the incorporated 
metallic ions exert toxic effects on the cells.  
Pre-analysis preparation methods. Fibroblasts L929 were used in the cell 
adhesion experiments. Experimental cell culture medium (Biochrom KG) 
81 
 
(Minimum Eagle’s Medium without L-glutamine, 10 % fetal bovine serum, 
streptomycin (100 g/L), penicillin (100 U/mL), and 2 mmol/L of L-glutamine) was 
introduced in 250 mL plastic culture flask (Corning TM). The fibroblasts were 
cultured at 37 °C in a humidified incubator equilibrated with 5 % CO2; 
subsequently, the fibroblasts L929 were harvested prior to confluence by means of 
a trypsin-EDTA solution (0.5 g/L trypsin, 0.2 g/L EDTA in normal phosphate 
buffered saline (PBS), pH 7.4), re-suspended in the experimental cell culture 
medium, and diluted in order to obtain 1 x 105 cells/mL. 
The biocompatibility was evaluated by means of two different assessments: a 
qualitative evaluation through direct observation using an inverted microscope, and 
the cell viability investigation through MTT assay in Transwell® membrane insert. 
The latter allows to take into account the role of the ion released by the 
nanomatrices, avoiding the direct contact of the particles with the cells. In order to 
perform the MTT assay, 1 mg/mL of ion-containing particles was placed into the 
Transwell®, whilst the cells were seeded on polystyrene plate, under the insert. In 
addition, the effect of nanomatrices containing the highest amount of copper 
(2%mol) were also investigated using a lower concentration of particles (100 
µg/mL). The cell viability was assessed after 72h of incubation. By evaluating the 
efficiency of the mitochondrial succinate dehydrogenase (SDH) enzyme, which is 
normally involved in the citric acid cycle, the MTT assay identifies any toxic effects 
of the tested material by analysing the decrease in the enzyme activity. The MTT 
test requires to incubate the cells with 1 mg/mL solution of soluble tetrazolium salt 
(specifically, 3-(4.5-dimethylthiazol – 2yl)-2.5 diphenyl tetrazolium bromide) at 37 
°C for two hours, during which the succinate dehydrogenase enzyme causes the 
tetrazolium salts to be transformed into the formazan precipitate, a blue water-
insoluble product. By quantifying the amount of precipitate, the degree of the 
enzyme activity and, consequently, the number of metabolically active cells can be 
deducted [17].  
Finally, the formazan precipitate was dissolved in dimethylsulphoxide and 
measured spectrophotometrically at 570 nm, providing the optical density (OD) 
measurement. Cell growth on the polystyrene plate without any stimulus was used 
as a negative control. 
2.8.2 Antibacterial tests 
Ion-containing MBG nanomatrices underwent antibacterial in vitro tests in 
order to assess the effective antibacterial potential of the incorporated copper, 
cerium and silver ions. The tests described in sections 2.8.2.1 and 2.8.2.2 were 
performed in collaboration with the group of Prof. Livia Visai (Molecular Medicine 
Department, Center for Health Technologies, UdR INSTM, University of Pavia); 
whereas, the in vitro antibacterial tests explained in sub-paragraphs 2.8.2.3 and 
2.8.2.4 were carried out in collaboration with Prof. Sheila MacNeil’s research group 
(Department of Materials Science and Engineering, Kroto Research Institute, 
University of Sheffield), one of the MOZART partners involved in the biological 
assessment of wound healing nanomatrices. 
 
 
Part of the work described in this chapter has been already published during the 
PhD period [2]. 
2.8.2.1 Investigation of antibacterial effect of ion-containing sample on E. Coli, 
S. epidermidis and S. Aureus bacterial planktonic growth using MTT assay 
The antibacterial properties of the copper-containing MBG synthesized by 
methanol-based ultrasonicator-assisted sol-gel method (MBG_US_m_Cu2%) and 
their ionic extracts were tested using E. coli, S. epidermidis and S. aureus bacterial 
strains.  
The present antibacterial test was performed in collaboration with Prof. Livia 
Visai’s research group (Molecular Medicine Department, Center for Health 
Technologies, UdR INSTM, University of Pavia). 
Samples. Copper-containing sample produced by ultrasonicator-assisted sol-
gel method (MBG_US_m_Cu2%) was used in order to confirm the antibacterial 
potential of copper [18]. The SiO2/CaO sample synthesized through the same 
procedure (MBG_US_m_SiO2/CaO) was investigated using the same antibacterial 
tests in order to ascribe the results to the presence of that specific therapeutic ion. 
Methods. The microorganisms used in this study were Escherichia coli RB (E. 
coli RB), Staphylococcus aureus 8325-4 (S. aureus 8325-4) and Staphylococcus 
epidermidis (S. epidermis RP62A). E. coli RB was provided by the ‘‘Zooprofilattico 
Institute of Pavia” (Italy) whereas S. aureus 8325-4 and S. epidermidis RP62-A 
were kindly supplied by Timothy J. Foster (Department of Microbiology, Dublin, 
Ireland). All bacteria strains were routinely grown in their culture medium 
overnight under aerobic conditions at 37 °C using a shaker incubator (New 
Brunswick Scientific Co., Edison): E. coli RB in Luria Bertani Broth (LB) (Difco), 
S. aureus 8325-4 in Brian Heart Infusion (BHI) (Difco) and S. epidermidis RP62A 
in tryptic soy broth (TSB, Difco). These cultures were statically incubated at 37 °C 
under aerobic conditions and reduced to a final density of 1x1010 cells/mL as 
determined by comparing the optical density (OD600) of the sample with the 
standard curve relating OD600 to cell number. 
Two different experimental conditions were used to evaluate the antibacterial 
activity of un-doped (MBG_US_m_SiO2/CaO) and copper-containing 
nanoparticles (MBG_US_m_Cu2%). For the first experimental condition, 
MBG_US_m_SiO2/CaO or MBG_US_m_Cu2% suspensions in sterile PBS with a 
final concentration of 2 mg/mL were prepared, sonicated by using an ultrasonic 
bath (FALC Instruments) for 5 min at room temperature, and properly diluted to 
obtain concentrations of 31, 63, 125, 250, 500, 1000 and 2000 mg/mL. The obtained 
suspensions were further sonicated for 5 min at room temperature prior to the direct 
incubation with bacterial cells.  
The second experimental condition was analogously performed, but in order to 
evaluate the antibacterial properties ascribable to the released Cu2+ ions from 
MBG_US_m_Cu2%, un-doped and MBG_US_m_Cu2% particles were dispersed 
in sterile PBS (2 mg/mL) and kept soaked for 3 h and 24 h, then centrifuged and 
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the supernatants collected for antibacterial activity tests. Bacterial strains were 
incubated without (control) or with increasing serial dilutions of the extracts 
collected after 3 h and 24 h from the MBG_US_m_SiO2/CaO and 
MBG_US_m_Cu2% suspensions, respectively. The control samples of both the 
experimental conditions were performed by addition of the same volume of PBS. 
Each experiment condition was repeated three times. 
For both experimental conditions, a predefined number (104/mL) of Gram 
negative (E. coli RB) and Gram positive (S. aureus 8325-4 and S. epidermidis 
RP62A) cells were incubated in their culture broth at 37 °C in 96-well microtiter 
plates. For the first experimental condition, bacterial cells were untreated (control) 
or treated with nanoparticle suspensions at increasing concentrations, ranging from 
31 up to 2000 mg/mL, for 1 and 3 days, respectively. For the second experimental 
condition, bacterial cells were untreated (control) or treated with increasing serial 
dilutions of extracts previously collected at 3 and 24 h from of 
MBG_US_m_SiO2/CaO or MBG_US_m_Cu2% suspensions (2 mg/mL) and 
incubated for 1 day. For both experimental conditions, at fixed incubation times, 
the quantitative MTT assay was performed to assess the dehydrogenase activity, as 
an indicator of the metabolic state of cells, as previously described [17]. The 
bacterial viability was expressed as percentage related to the control set equal to 
100%. 
2.8.2.2 Investigation of antibacterial effect of ion-containing sample on S. 
epidermidis biofilm by metabolic activity evaluation  
In recent years, the number of infections associated with antibiotic-resistant 
bacteria has greatly increased. Many of these infections are caused by 
microorganisms growing in biofilms, complex bacterial communities surrounded 
by a self-producing extracellular polymer matrix, able to resist both to antibiotic 
action and to human immune system [19]. The formation of biofilm is a peculiar 
characteristic of S. aureus and S. epidermidis [20] that quite frequently colonise 
medical devices, causing persistent body-related infections. Differently from 
planktonic populations, bacterial cells embedded in biofilms are characterized by 
intrinsic resistance to antibiotics due to several specific defence mechanisms given 
by the biofilm environment, including the inactivation of anti-microbial agents by 
exopolysaccharide (EPS), over expression of stress-responsive genes, oxygen 
gradients within the biofilm matrix and differentiation of a sub-population of 
biofilm cells into resistant dormant cells [21]. These aforementioned features of 
biofilms place them amongst the most serious problems currently faced by medicine 
and thus considerable efforts are devoted to identifying novel therapies to prevent 
or treat biofilms. To this purpose, a potentially promising treatment implies metal 
or metal oxide nanoparticles, showing antibacterial and antibiofilm activity [22].  
In this frame, the biofilm antibacterial test was tested in collaboration with Prof. 
Livia Visai’s research group (Molecular Medicine Department, Center for Health 
Technologies, UdR INSTM, University of Pavia). 
 
 
Samples. To evaluate the antibacterial activity against staphylococcal biofilms, 
S. epidermidis cultures were incubated with MBG_US_m_SiO2/CaO and 
MBG_US_m_Cu2% suspensions or with related extracts collected after 24 h of 
incubation, either during the biofilm formation or in the presence of pre-formed 
biofilm. 
Methods. The experimental conditions adopted in the antibacterial effect 
evaluation against S. aureus, S. epidermidis and E. coli planktonic bacterial strains 
(see section 2.8.2.1), were also exploited in order to investigate the antibacterial 
potential of MBG_US_m_SiO2/CaO and MBG_US_m_Cu2% nanoparticles (first 
experimental condition) and of MBG_US_m_SiO2/CaO and MBG_US_m_Cu2% 
extracts collected after 24h of incubation (second experimental condition) against 
S. epidermidis RP62A biofilm.  
For biofilm experiments, overnight culture of S. epidermidis RP62A was 
diluted in its broth culture medium with the addition of 0.25% glucose. Aliquots 
(100 µL) of the diluted bacterial suspensions were inoculated into 96-well flat-
bottom sterile polystyrene microplates (Costar, Corning) as follows: i. without 
(control) or with a suspension of 2 mg/mL of MBG_US_m_SiO2/CaO or 
MBG_US_m_Cu2% nanoparticles in PBS; ii. without (control) or with extracts 
collected after 24 h of incubation with MBG_US_m_SiO2/CaO or 
MBG_US_m_Cu2% suspension (2 mg/mL) in PBS. In both cases (i and ii) the 
experiments were performed in two different types of settings: a. nanoparticle 
suspensions or nanoparticle extracts were contemporarily incubated with biofilm 
growing cultures in order to evaluate their effects during biofilm formation; b. 
nanoparticle suspensions or nanoparticle extracts were added after the biofilm 
formation, to assess their effects on the formed biofilms. After fixed incubation 
times, biofilms were washed twice with PBS to remove planktonic cells and loosely 
adhering bacteria [23]. Viability quantification of microbial cells inhabiting the 
biofilms was performed by MTT test, as described above. 
In addition, the biofilm antibacterial effect of the samples was studied through 
morphological evaluation technique. In this frame, the biofilm untreated (control) 
or treated with nanoparticle suspensions or their extracts for both the experimental 
settings (as described above) were grown in plastic cell culture coverslip disks 
(Thermanox Plastic, Nalge Nunc International) seeded on the bottom of a 24-well 
culture plates and incubated for 24 h at 37 °C. Briefly, the disks were washed 
several times and then fixed for SEM with 2.5% glutaraldehyde in 0.1 M cacodylate 
buffer, pH 7.2 for 1 h at 4 °C. After additional washes, they were incubated with 
increasing concentrations of ethanol (25%, 50%, 75% and 96%) for 10 min each, 
dried to the critical point using an Emitech K-850 apparatus and placed on a 
mounting base. Finally, the disks were examined through SEM analysis (Zeiss 
EVO-MA10 scanning electron microscope), after a gold layer deposition. 
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2.8.2.3 Investigation of antibacterial effect of ion-containing samples on S. 
Aureus and P. Aeruginosa by viable count method 
In order to explore the effect of the incorporated ion in presence of bacteria, the 
antibacterial studies were performed by using in vitro tests. Among the countless 
different types of antibacterial tests, the viable count method was selected with the 
aim to count the viable bacterial cell number after the treatment with the produced 
nanomatrices. In microbiology, a “viable” organism is defined as an organism able 
to multiply via binary fission under controlled conditions. The results are expressed 
as colony forming unit (CFU), since ascribing a bacterial colony to one cell or to 
one group of cells is considered almost impossible.  
The viable count tests were performed at the Department of Materials Science 
and Engineering (University of Sheffield), in the group of Prof. Sheila MacNeil, 
during my external research staying. 
Samples. The optimized ion-containing micro- and nano-sized particles were 
tested by viable count method with the aim to explore the antibacterial potential of 
copper [18], cerium [24] and silver [25]. In details, the following samples were 
analysed: MBG_SG_Cu2%, MBG_SD_Cu2%, MBG_SG_Ce2%, 
MBG_SD_Ce2%, MBG_SG_Ag2% and MBG_SD_Ag2%. 
Methods. The antibacterial properties of the ion-containing nanomatrices were 
tested against clinical isolate strains of S. aureus (S235) and P. aeruginosa (SOM1), 
representative of Gram positive and Gram negative bacteria, respectively. Both 
strains were cultured in BHI broth (Oxoid) at 37 °C overnight and stored at 4 °C on 
BHI agar (Sigma-Aldrich). 
Two experimental conditions (Figure 2.6) were adopted in order to investigate 
the antibacterial effect exerted by the samples. In the first experimental condition 
(named “suspension”), the powders were suspended in PBS at a final concentration 
of 2 mg/mL, sonicated for 5 min and vortexed to obtain a stable suspension. Then, 
50 µL of this suspension were incubated with 50 µL of the overnight suspension of 
bacteria for 24 h. The second experimental condition was carried out with the aim 
to study the antibacterial potential of the released ion. In this case, the powders were 
kept immersed in PBS for different time points (1, 3 and 8 days) at 37 °C in a static 
incubator to allow the particles to settle. At each time point, 50 µL of the 
supernatant were incubated with 50 µL of the overnight bacterial suspension for a 
further 24 h. 
In both experimental conditions the control samples were obtained by adding 
50 µL of PBS to the overnight bacterial suspension.  
 
 
Figure 2.6: Viable count method experimental conditions 
Following the 24h of incubation, serial dilutions of each suspension containing 
bacteria and tested samples were performed and viable colony count was carried 
out according to the standard Miles & Misra technique [26] by spotting out dilutions 
onto BHI agar plates and counting the numbers of CFU/mL after incubating plates 
for 24h at 37 °C. 
The number of CFU/mL was calculated as follows: CFU/mL = number of 
colonies x dilution factor x 100 
2.8.2.4 Investigation of antibacterial effect of ion-containing samples on S. 
aureus and P. aeruginosa biofilm through metabolic activity and biofilm mass 
evaluation 
As evidenced previously, the bacterial biofilm represents one of the main issues 
in chronic infections. The bacterial biofilms are complex, heterogeneous 3D multi-
layered bacteria communities embedded in a polysaccharide matrix. Traditional 
antimicrobials and treatments are not effective in reducing the bacterial biofilm [27] 
for several reasons, as extensively described earlier.  
The as-synthesized nanomatrices could represent a valid alternative to the 
traditional drugs. In this context, antibacterial effect of the copper-containing nano-
sized matrix was tested against S. aureus and P. aeruginosa biofilm, which 
commonly colonized chronic skin wounds [28]. This evaluation was carried out in 
collaboration with the Department of Materials Science and Engineering 
(University of Sheffield), in the group of Prof. Sheila MacNeil. 
Samples. The potential of copper-containing nano-sized particles 
(MBG_SG_Cu2%) to prevent the formation and to disrupt a pre-formed biofilm 
developed by SOM1 and S235 bacterial strain was investigated. 
Methods. The antibacterial activity of the sample against prevention and 
disruption of bacterial biofilms was evaluated by two different techniques. Clinical 
isolates of P. aeruginosa (SOM1) and S. aureus (S235) were used to form 48h 
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biofilms in BHI broth (Oxoid). MBG_SG_Cu2% was suspended in PBS to a final 
concentration of 100 µg/mL.  
To test the ability on preventing the biofilm formation, 1 mL of suspension was 
added at the same time of bacteria inoculation in BHI broth; whereas, the addition 
of the same amount of suspension occurred after 48h, to test the ability to disrupt 
the pre-formed biofilm. In the latter experiment, the sample was left incubated with 
the bacteria for 24h before performing assays. 
In Figure 2.7, the experimental setup of antibacterial test against S235 and 
SOM1 bacterial biofilm is represented.  
 
 
Figure 2.7: Experimental setup of antibacterial test against S. aureus and P. aeruginosa biofilm 
 
In order to measure the antibacterial activity of the sample, the biofilm was 
assayed as follows:  
i) Absorbance of the whole sample (planktonic and biofilm bacteria) was read 
at 600 nm to measure the entire biomass using the spectrophotometer (Tecan) 
equipped with Magellan software. Following this, planktonic bacteria were 
removed and absorbance at 600 nm was read in order to measure the biofilm mass 
alone  
ii) PrestoBlue assays were carried out with the aim to measure the biofilm 
metabolic activity. Briefly, biofilms cultured in 12 well plates were incubated with 
1 mL of PrestoBlue reagent (ThermoFisher) at 37 °C for 1 hour. The 
spectrophotometer (Tecan) was used to read the fluorescence with 
excitation/emission wavelengths of 560nm/590nm to obtain an evaluation of cell 
metabolism, indicating the cell viability. 
2.8.3 Biological assessment on 3D tissue engineered skin model  
The development and the use of reconstituted human tissue models is gaining 
increasing interest due to the presence of multiple cell types and naturally 
developed extracellular matrix which result in a more physiologically relevant 
environment to perform laboratory test (such as antibacterial, biocompatibility or 
anti-inflammatory tests) and for clinical application, such as graft substitutes 
[29,30].  
 
 
In this context, the group of the University of Sheffield (UK), under the 
supervision of Prof. Sheila MacNeil conducted the in vivo-like evaluation of the 
optimized ion-containing nanomatrices on the own-produced 3D skin model. 
2.8.3.1 Production of 3D tissue engineered skin model  
3D tissue engineered skin constructs were prepared as described previously 
[31]. Briefly, human dermal fibroblasts were isolated from split-thickness skin 
biopsies received from abdominoplasties and breast reductions performed at the 
Northern General Hospital (Sheffield, UK). Cells were maintained in DMEM high 
glucose (4500 mg/L glucose), 10% v/v foetal calf serum (FCS), 2 mM l-glutamine, 
0.625 mg/mL amphotericin B, 100 IU/mL penicillin, and 100 mg/mL streptomycin. 
Research Ethics approval was obtained from the Sheffield Research Ethics 
Committee. Keratinocytes (HaCaT) cells were purchased from Promega and 
maintained in Greens’ media (DMEM high glucose (4500 mg/L glucose) and 
Ham’s F12 medium in a 3:1 ratio, 10% v/v FCS (UK), 10 ng/mL human 
recombinant epidermal growth factor, 0.4 mg/mL hydrocortisone, 10−10 M cholera 
toxin, 18 mM adenine, 5 mg/mL insulin, 5 mg/mL apo-transferrin, 20 mM 3,3,5-
tri-idothyronine, 2 mM glutamine, 0.625 mg/mL amphotericin B, 100 IU/mL 
penicillin, and 1000 mg/mL streptomycin). Decellularised dermis (DED), produced 
by removing cells using 1 M NaCl, as detailed in MacNeil et al. [31], from human 
cadaver skin (Euro Skin), was used as a base scaffold. Rings of DED (15 mm in 
diameter) were cut and placed within 12 mm tissue culture inserts with 4 mm pores 
in the base (Greiner). Inserts were suspended from the edges of 12-well plates into 
the wells. Greens’ medium containing 10% foetal calf serum was added to the 
bottom of the wells in order to lap the DED under surface. Subsequently, 1x105 
fibroblasts and 5x105 keratinocytes, each in 250 mL of 10% Greens’ medium, were 
used to seed the DED. Again, after 24 h incubation at 37 °C, seeding medium was 
removed and replaced with fresh Greens’ medium. After a further 24 h, medium 
was removed from the inside of the inserts to let the constructs to be at an air-liquid 
interface. Greens’ medium in the tissue culture wells was replaced every 24 h. 
Finally, after 14 days at air-liquid interface, the constructs were used for the tests. 
2.8.3.2 Biocompatibility test on the 3D tissue engineered skin model  
Sample. Copper-containing nano-sized particles produced by the optimized sol-
gel synthesis (MBG_SG_Cu2%) were used in order to assess the potential cytotoxic 
effect exerted by the sample on the 3D skin construct.  
A 3D skin model without any type of treatment was used as control. 
Additionally, another 3D skin model was treated with a section (5x5 mm) of the 
commercially available standard silver-containing dressing Acticoat Flex 3® (Smith 
& Nephew). 
Methods. The particles were suspended in PBS with a final concentration of 
100 µg/mL prior to the test. 3D skin samples were incubated with 200 µL of the as-
prepared suspension for 24h at 37 °C in an incubator equilibrated with 5 % CO2. 
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The 3D construct was then tested for cell viability using PrestoBlue to investigate 
the metabolic activity of the cells. All media were removed and 100 µL of a 1:10 
dilution of PrestoBlue:DMEM was added for 2 hours. By using 560nm/590nm as 
excitation/emission wavelengths respectively, the resulting fluorescence was read 
using a spectrophotometer (Tecan) as an index of the cell metabolism, as well as of 
the cell vitality. 
 
2.8.3.3 Investigation of antibacterial effect on S. aureus and P. aeruginosa 
biofilm on infected 3D tissue engineered skin model  
Sample. With the aim to investigate the antibacterial potential of copper-
containing nano-particles (MBG_SG_Cu2%) in a more biologically relevant 
environment, the 3D skin model produced by MacNeil’s group was infected and 
treated with the sample suspension in PBS (100 µg/mL). Since the Acticoat Flex 
3® (Smith & Nephew) is considered a gold standard in the treatment of infected 
wound, other infected skin models were treated with the silver dressing as 
comparison. 
Methods. First of all, the 3D skin models produced as described above were 
infected as follows.  
Constructs were washed in antibiotic-free Greens’ medium for 72 h prior to 
infection. They were then burnt using a surgical cauterizer for 8 s immediately prior 
to the infection in order to allow the bacteria to entry into the dermal tissue. 
Subsequently, 1x106 of P. aeruginosa or S. aureus bacteria, prepared as described 
in section 2.8.2.3, dispersed in 20 μl of BHI broth per construct were placed into 
the inserts covering the epidermal surface. Finally, infected constructs were 
incubated at 37 °C in incubator equilibrated with 5% CO2. 
After infection, the constructs were adopted for testing the antibacterial effect 
exerted by the copper-containing MBG particles on the bacterial biofilm.  
In brief, to analyse the disruptive biofilm forming ability of the sample, 200 µL 
of the suspension at 100 µg/mL was added simultaneously to the S235 and SOM1 
bacteria and incubated for 24 hours before testing; whilst, the ability of the matrix 
to disrupt a pre-existing biofilm was explored by adding the same amount of 
suspension 24 h after infection. In both experiments, the skin models were left 
incubating at 37 °C/5%CO2 for 24 h before surviving bacterial colony numbers 
were counted. At the testing point the tissue was weighed and homogenised in 1 
mL of BHI broth. The viable counts of bacteria in the samples were performed on 
the resulting homogenates, after serial dilutions, using standard Miles & Misra 
methods, as described above.  
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CHAPTER 3  
Results and discussion 
3.1 Introduction 
With the final aim to produce a library of nanomatrices containing therapeutic 
ions to be used as multifunctional platform in the treatment of delayed bone healing 
and non-healing skin wounds, several ion-containing mesoporous inorganic 
systems were obtained by different synthesis approaches. With the general aim to 
obtain scalable nanomatrices and enhance the synthesis yield, several synthesis 
approaches were conducted, and the results related to the morphological, structural 
and chemical characterization of the obtained systems are presented. 
In order to obtain particles in the range of 100-200 nm with pores ranging 
between 2 and 4 nm, an ultrasonicator-assisted method using methanol as solvent 
was originally adopted to produce different ion-containing MBGs, whose results 
are presented in paragraph 3.2.1. Besides the morphological, compositional and 
structural data, the paragraph reports the antibacterial results of the as-produced 
copper-containing nano-sized particles. 
Despite the promising results of these nanomatrices, the involvement of a toxic 
solvent (methanol) caused the dismissal of this synthesis route and its replacement 
with ultrasonicator-assisted water-based sol-gel approaches. In paragraph 3.2.2, the 
results of the related characterization are described.  
With the aim to attain the scalability of the process, since the ultrasonication 
represented an additional energy-consuming step, the efforts were devoted to 
optimise a water-based sol-gel procedure using ammonia as catalyst, without the 
application of ultrasounds. The related data are described in paragraph 3.3.1. 
In section 3.3.2, the results concerning the nanomatrices obtained through an 
optimized water-based aerosol-assisted spray-drying approach are presented. This 
method, easily scalable at an industrial scale, allowed to obtain highly reproducible 
mesoporous nanomatrices in the form of microspheres with nanopores of around 8 
nm. 
 
 
 
3.2 Characterization of mesoporous nano-sized matrices 
produced by ultrasonicator-assisted synthesis 
Different nano-sized matrices (MBG_US) were produced by an ultrasonicator 
assisted sol-gel method using methanol (see Table 3.1 for compositions) or water 
(see Table 3.7 for compositions) as solvent. In the latter instance, two different 
water-based approaches were used: the first at almost neutral pH with NH4F as 
catalyst, and the second one involving the use of ammonia as catalyst with a final 
solution pH around 8. 
In the following paragraphs, the results of morphological and structural 
characterization of the obtained nanomatrices are reported, by referring with the 
acronym MBG_US_m and MBG_US_w the samples produced by using methanol 
and water as solvent, respectively.  
In the following paragraph, the description of morphological, compositional 
and structural features of the nanomatrices produced by the methanol-based sol-gel 
approach is presented. In particular, the results of mesoporous SiO2-CaO binary 
glass system without ions (named hereafter MBG_US_m_SiO2/CaO) will be 
presented in section 3.2.1.1. Subsequently, the characterization results of ion-
containing samples, divided as copper-containing sample, strontium-containing 
sample and strontium-copper co-substituted sample will be explained. 
Finally, the morphological, compositional and structural results of the 
nanomatrices synthesized through the water-based approaches will be presented in 
the paragraph 3.2.2. In this latter section, the samples coded as MBG_US_w_I 
represent the nanomatrices produced by the sol-gel procedure carried out at almost 
neutral pH with NH4F as catalyst, and the nanomatrices coded as MBG_US_w_II 
identify the ones synthesized by the sol-gel route which involved the use of 
ammonia as catalyst. 
3.2.1 Methanol-based synthesis results: MBG_US_m nanomatrices  
Nanomatrices with different compositions, both in term of incorporated ions 
and of molar concentrations (Table 3.1), were produced through a modification of 
a procedure reported in the literature [1]. 
The results of the SiO2-CaO binary glass sample without ion (85SiO2/15CaO 
%mol, named MBG_US_m_SiO2/CaO) will be presented as reference system. The 
ion-containing MBG particles were produced by substituting 1, 2, 5 % mol of CaO 
with specific ion precursors.  
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Figure 3.1: FE-SEM image, EDS spectrum and atomic % (inset) of MBG_US_m_SiO2/CaO 
 Table 3.1: List of MBG_US_m compositions  
 
 
 
 
 
 
3.2.1.1 MBG_US_m_SiO2/CaO matrix 
The sample, named in the following section MBG_US_m_SiO2/CaO 
(85SiO2/15CaO %mol), was used as reference system to study the influence of the 
different therapeutic ions on the morphology, chemical composition, bioactive 
response and on the structural features of the as-synthesized samples. 
3.2.1.1a Morphological and structural characterization of 
MBG_US_m_SiO2/CaO 
The morphological and compositional information were obtained by FE-SEM 
and EDS technique, respectively. FE-SEM analysis revealed particles with size 
ranging between 40 and 80 nm, characterized by quite irregular spheroidal 
morphology (Figure 3.1) with a tendency to aggregate and form agglomerates. EDS 
characterization (Figure 3.1-inset) confirmed the theoretical composition; the 
detected Ca/Si molar ratio resulted very close to the nominal ratio. 
The Cr peaks in the EDS spectrum are due to the chromium coating required to run 
the analysis, as described in the section 2.5.2 of “Materials and methods” chapter.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mesoporous structure of the sample was investigated by N2 adsorption-
desorption measurement. As shown in Figure 3.2 the isotherm confirmed the 
mesoporous structure of MBG_US_m_SiO2/CaO with a IV type curve, typical of 
Name Composition (%mol) 
MBG_US_m_SiO2/CaO 85 SiO2/15 CaO 
MBG_US_m_Cu2% 85 SiO2/13 CaO/2 CuO 
MBG_US_m_Cu5% 85 SiO2/10 CaO/5 CuO 
MBG_US_m_Sr1% 85 SiO2/14 CaO/1 SrO 
MBG_US_m_CuSr2% 85 SiO2/13 CaO/1 CuO/1 SrO 
 Element Atomic % 
O 67.91 
Si 27.23 
Ca 4.86 
Total: 100.00 
 
 
mesoporous material, according to the IUPAC classification [2]. The presence of a 
step at p/p0 < 0.3 represented the complete monolayer coverage and the beginning 
of the multilayer adsorption [2]. Related pore size distribution (inset in Figure 3.2) 
showed the presence of uniform mesopores with an average diameter of 2.9 nm, 
calculated through the DFT model, typical of CTAB templated system. The specific 
surface area (SSA) and pore volume, reported in Table 3.2 and equal to 621 m2/g 
and 1.05 cm3/g respectively, are remarkably higher than the non-templated 
bioactive glasses [3] and in fair agreement with systems produced using the same 
route [1]. 
 
 
Figure 3.2: N2 adsorption-desorption isotherm of MBG_US_m_SiO2/CaO and related DFT pore size 
distribution (inset) 
 
Table 3.2: Structural features of MBG_US_m_SiO2/CaO 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_US_m_SiO2/CaO 621 2.9 1.05 
 
 
The eventual presence of crystalline phases in the MBG_US_m_SiO2/CaO 
sample was analysed by wide-angle XRD and the resulted pattern (Figure 3.3) 
confirmed the amorphous structure, with the broad peak between 20° and 30° (2θ 
values) attributed to amorphous silica, without peaks corresponding to the 
segregation of calcium oxide phases.  
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Figure 3.3: Wide-angle XRD spectrum of MBG_US_m_SiO2/CaO 
3.2.2.1b Bioactive behaviour of MBG_US_m_SiO2/CaO in SBF  
The bioactivity of the sample was assessed by soaking the powder in SBF using 
the procedure reported in reference [4], as described in section 2.7 of “Materials 
and methods” chapter, and was investigated by FE-SEM and EDS analyses. 
As reported in Figure 3.4A, after only 1 day of soaking the sample 
MBG_US_m_SiO2/CaO started to be covered by needle-like structure. After 7 days 
of immersion (Figure 3.4B), the needle-like structures assumed a flake-like shape, 
typical of hydroxyapatite (HA), and formed a homogeneous layer which made the 
particles difficult to discern. 
The related EDS spectra (Figure 3.4C and 3.4D) evidenced the peak of 
phosphorus, not originally shown by the sample before soaking in SBF, which is 
attributed to the formation of the HA precipitates. The detected phase was 
characterized by Ca/P ratio equal to 1.38 after 1 day of incubation and equal to 1.79 
after 7 days in SBF. As the soaking time increased, the Ca/P ratio became very close 
to the stoichiometric value of HA (1.67), as observed in several studies [5,6], 
highlighting the increase of PO43- exchanges with SBF. 
The monitoring of the pH confirmed that it remained in the physiological range 
of 7.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
3.2.1.2 Copper-containing MBG_US_m: MBG_US_m_Cu2%, 
MBG_US_m_Cu5% 
The first ion selected to be incorporated into the SiO2-CaO system produced by 
methanol-based ultrasonicator-assisted sol-gel route was copper. As described in 
chapter “State of the art”, copper is largely studied for potential application in 
medical fields where antibacterial, pro-osteogenic and pro-angiogenic effects are 
needed [7].  
Two different compositions of copper-containing MBG_US_m were produced 
by adding different amounts of copper chloride during the synthesis procedure.  
The as-synthesized samples are named hereafter MBG_US_m_Cu2% 
(85SiO2/13CaO/2CuO %mol) and MBG_US_m_Cu5% (85SiO2/10CaO/5CuO 
%mol) and the related results are described in the following sub-chapters. 
Part of the work described in this chapter has been already published by the 
candidate [8].  
3.2.1.2a Morphological and structural characterization of copper-containing 
MBG_US_m samples 
The FE-SEM images and related EDS characterization results are represented 
in Figure 3.5. 
A 
Figure 3.4: FE-SEM images of MBG_US_m_SiO2/CaO after 1 day (A) and 7 days of soaking in SBF (B) and 
related EDS spectra (C, D) 
C
C
V 
D
C
V 
B 
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The FE-SEM image of MBG_US_m_Cu2% (Figure 3.5A) revealed particles 
with uniform spheroidal morphology, with size ranging between 170 and 200 nm. 
EDS analysis confirmed the incorporation of Cu into the framework: the detected 
Cu/Si molar ratio, as average of three measurements, resulted in fair agreement with 
the nominal ratio (Figure 3.5B). The investigation by TEM demonstrated the 
presence of mesopores throughout the nanoparticle inner structure, in the form of a 
worm-like system (Figure 3.5C). Quantitative analysis using EDS mapping, 
coupled to TEM, was used to explore the element distribution in the sample and 
showed that Cu ions, like the other elements, were evenly distributed within the 
whole of the particle (Figure 3.5D). 
For what concerns the MBG_US_m_Cu5%, FE-SEM observation (Figure 
3.5E) showed spheroidal particles whose size ranged between 180 and 230 nm, on 
average slightly larger than what was observed for MBG_US_m_Cu2%. The 
incorporation of copper, with a molar ratio (Cu/Si) very close to the theoretical one, 
was confirmed by EDS analysis, reported in the inset of Figure 3.5E.  
TEM images of MBG_US_m_Cu5%, (Figure 3.5F) allowed discerning a core-
shell morphology for this sample, with a shell characterized by a regular 
mesoporous structure and an internal core characterized by larger and irregular 
cavities. In this case, EDS mapping analysis evidenced different Si, Ca and Cu 
atomic percentages in the core and shell regions of the particles, showing, a higher 
concentration of Ca and Cu ions in the core (Ca/Si = 0.13 and Cu/ Si = 0.15) 
compared to the outer shell (Ca/Si = 0.05 and Cu/ Si = 0.06).  
The TEM observation evidenced that the higher amount of doping cation had 
an evident impact on structural properties. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mesoporous structure of Cu-modified MBG systems was confirmed by the 
N2 adsorption-desorption isotherms (Figure 3.6), which revealed that the isotherm 
curves of MBG_US_m_Cu2% and MBG_US_m_Cu5% had type-IV isotherm with 
a well-defined step at relative pressure (p/p0) below 0.3, indicative of the filling of 
uniform mesopores. The capillary condensation observed at higher relative 
pressures for MBG_US_m_Cu5% (green curve) is ascribable to intra-particle voids 
or to the disordered porosity located in the particle core, discernible from TEM 
images. 
The values of BET specific surface area, mesopores volume and pore diameter 
for the investigated samples are reported in Table 3.3: a decrease of surface area 
and pore volume was found with the increase of the amount of copper ion. The 
mesopore diameter was approximately 2.6 nm in the Cu-containing samples, which 
is that typical of CTAB-templated systems.  
Hence, the increase of copper amount in the synthesis had a negative effect, 
affecting the formation of the mesostructure and leading to a significant decrease 
of both exposed surface area and pore volume. These results confirmed that the 
Figure 3.5: FE-SEM image of MBG_US_m_Cu2% (A), EDS spectrum (B), TEM image (C) and EDS 
mapping analysis of MBG_US_m_Cu2% (D); FE-SEM image of MBG_US_m_Cu5% (E), related EDS 
spectrum (inset), TEM image of MBG_US_m_Cu5% (F) 
E F 
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presence of an excess of metal ion species in the reaction plays a negative role on 
the condensation of the silica precursors and the assembly of the mesophase 
structure [9,10], leading to a significant decrease of the exposed surface area in the 
obtained nanomatrices. 
 
 
Figure 3.6: N2 adsorption-desorption isotherms of MBG_US_m_Cu2% (red) and MBG_US_m_Cu5% 
(green) 
 
Table 3.3: Structural features of copper-containing samples 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_US_m_Cu2% 550 2.6 0.26 
MBG_US_m_Cu5% 224 2.6 0.11 
 
In the wide-angle XRD patterns (Figure 3.7), the broad peak at 23° 
corresponded to amorphous silica, and no diffraction peaks of copper oxide (CuOx) 
were observed in the samples, indicating that the incorporated copper does not form 
oxide crystals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7: Wide-angle XRD spectrum of MBG_US_m_Cu2% (red) and MBG_US_m_Cu5% (green) 
In order to investigate the nature of the copper species incorporated inside the 
glass framework, XPS spectra were recorded on MBG_US_m_Cu2% and 
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MBG_US_m_Cu5%. Figure 3.8 shows the deconvoluted XPS spectra of 
MBG_US_m_Cu2% and MBG_US_m_Cu5% in the Cu2p3/2 region. The 
components at 935.7 eV and 933.3 eV obtained through the deconvolution and their 
integrated peaks areas are reported in Table 3.4: an evident difference in the relative 
amount of the two components was found. 
 
Figure 3.8: XPS deconvoluted spectra in the Cu2p3/2 region for MBG_US_m_Cu2% (A) and 
MBG_US_m_Cu5% (B) 
 
The first component at lower binding energy (933.3 eV) was consistent with 
values ascribed in the literature to Cu2+ cations in extra-framework sites [11]. At 
variance, the component at higher binding energy, at ca 935.7 eV, much higher than 
that for pure CuO (ca 933.8 eV) [12], was attributed to copper species with a strong 
electronic interaction with the lattice, in analogy with results obtained for Cu-
containing mesoporous silicas [13]. Specifically, for the MBG_US_m_Cu2% 
(Figure 3.8A) sample most of copper species were characterized by binding energy 
(933.3 eV) typical of extra-framework sites, with a limited contribution of species 
at higher values, whereas the MBG_US_m_Cu5% sample, as reported in Figure 
3.8B, shows a significant higher amount of Cu2+ at higher binding energy (935.7 
eV).  
Table 3.4: Deconvoluted contributions of Cu2p core level and relative percentages 
Name Peak position 
(eV) 
Peak area% Peak 
position (eV) 
Peak 
area% 
MBG_US_m_Cu2% 933.3 80.3 935.7 19.7 
MBG_US_m_Cu5% 933.3 48.5 935.7 51.5 
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3.2.1.2b Copper ion release from copper-containing MBG_US_m in SBF  
The ionic concentrations (ppm) of Cu2+ species in SBF medium after 14 days 
of soaking are reported in Figure 3.9. In the case of MBG_US_m_Cu2%, a 
sustained release of Cu2+ is observed during the 7 days of soaking and the 
percentage released resulted approximately 90% respect to the incorporated 
amount. Furthermore, the EDS analysis of the sample after the release tests did not 
reveal the presence of residual copper, confirming the effective release of the 
functional ion. At variance, the release test carried out with MBG_US_m_Cu5% 
evidenced a very low percentage of released Cu2+ (around 10%), suggesting that 
copper ions are mostly inaccessible. 
These different release behaviours could be ascribed to the different chemical 
environment of the incorporated copper species, resulting from XPS investigation. 
The MBG_US_m_Cu2% sample showed a sustained and almost complete release 
of the incorporated Cu2+, which supports the assignment proposed for the 
component at 933.3 eV to species present as counter-ions in the silica framework, 
located at the mesopore surface and thus accessible for cation-exchange reactions 
when soaked in SBF. On the other hand, the unexpected profile observed for 
MBG_US_m_Cu5%, characterized by a very limited release of Cu2+ species, could 
be interpreted assuming the inaccessibility of mostly of the incorporated metal, as 
it was likely located in the particle cores or embedded into the silica walls. 
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Figure 3.9: Cu2+ release profiles of MBG_US_m_Cu2% (black) and MBG_US_m_Cu5% (red) in SBF 
3.2.1.2c Bioactive behaviour of MBG_US_m_Cu2% in SBF  
Based on the obtained release kinetics for Cu2+ species, the investigation about 
the bioactive properties was uniquely performed on MBG_US_m_Cu2%. The 
sample showed a remarkable bioactivity when soaked in SBF. The precipitation of 
HA was assessed after only 3 h of immersion and a conspicuous amount of it could 
be easily detected after 24 h of soaking. Figure 3.10 shows FE-SEM images of 
 
 
MBG_US_m_Cu2% nanoparticles after 3 (Figure 3.10A) and 7 days (Figure 
3.10B) of SBF soaking, and related EDS spectra (Figure 3.10D’ and D’’): globe-
shaped agglomerates are easily distinguishable on the nanoparticles surface. The 
phase nucleated after 3 h of soaking, as assessed by EDS analysis, can be identified 
as Ca-deficient HA (Ca/P = 1.51). The Ca content in the newly formed phase 
gradually rose as soaking time increased and after 7 days, a molar Ca/P ratio of 1.62 
was detected, which was in the range of calcium-deficient biological apatite. The 
pH of SBF remained in the physiological range during particles soaking (between 
7.4 and 7.5). The wide-angle XRD spectrum of MBG_US_m_Cu2% after 24 h of 
soaking in SBF is reported in Figure 3.10C. Marked peaks at 32° and 26° and other 
less intense reflections at about 40°, 47° and 49° were assigned to the (002), (211), 
(300), and (213) reflections of HA (external reference code 01-074-0565). The 
other narrow peaks are ascribable to calcite (external reference code 01-083-1762). 
The latter is often found when bioactive glasses with a high content of calcium (at 
least 30% mol of CaO) are soaked in SBF. These glasses, when in contact with 
water-based solutions, release immediately a high amount of Ca2+ ions, which, in 
the case of SBF, react with the carbonate ions present, leading to calcite 
precipitation within the very first hours of immersion [14–16]. Although the 
calcium content for MBG_US_m_Cu2% sample is not as high as reported in the 
literature, the very high exposed surface, due to the presence of the mesopores, is 
expected to allow a high release of calcium ions in terms of both the total amount 
and the kinetics. Calcite has been reported to be resorbable [17] and 
osteoconductive, even without the formation of a Ca-P-rich layer [18]. Therefore, 
the co-precipitation of apatite and calcite can be considered as an index of the 
mesoporous glass bioactivity [19]. 
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Figure 3.10: FE-SEM images of MBG_US_m_Cu2% after 3 days (A) and 7 days (B) of soaking in SBF 
and XRD pattern of MBG_US_m_Cu2% after soaking in SBF for 7 days (C); EDS spectra of 
MBG_US_m_Cu2% after 3 days (D’) and 7 days (D’’) of soaking in SBF 
3.2.1.2d Antibacterial potential evaluation of MBG_US_m_Cu2% 
Considering the MBG_US_m_Cu2% the best copper-containing candidate 
produced by methanol-based ultrasonicator-assisted sol-gel route, the antibacterial 
assessment was uniquely performed on this sample. 
As described in the “Materials and methods” chapter, the microorganisms used 
to test this matrix were the following: the Gram negative Escherichia coli RB (E. 
coli RB) and two Gram positive bacteria Staphylococcus aureus 8325-4 (S. aureus 
8325-4) and Staphylococcus epidermidis (S. epidermis RP62A), being the later a 
strong biofilm-producing strain. 
Two different experimental conditions were used to evaluate the antibacterial 
activity of MBG_US_m_Cu2%. The same experiments were carried out on the 
MBG_US_m_SiO2/CaO as control, in order to be able to ascribe the antibacterial 
potential to the released copper species. As described in the chapter 2, the first 
experimental condition implied the use of particle suspension (named hereafter 
“suspension”), in order to take into account the nanoparticle effect, while the second 
one was conducted with the extracts of the nanoparticles in order to evaluate the 
antibacterial properties due only to the released Cu2+ ions from 
MBG_US_m_Cu2%. 
Both experimental conditions were used in order to evaluate the antibacterial 
effect on bacterial planktonic growth and on S. epidermidis biofilms. In the latter, 
the effect of the nanoparticle suspensions and of the extracts was investigated in 
order to evaluate their effects during biofilm formation and on the formed biofilm. 
 
 
Antibacterial property of MBG nanoparticles and their extracts on bacterial 
planktonic growth 
The synthesized nanoparticles (first experimental condition) and their extracts 
(second experimental condition) were tested for their antibacterial activity against 
human pathogenic bacteria, namely, E. coli RB, S. aureus 8325-4 and S. epidermidis 
RP62A (Figure 3.11 and 3.12).  
For the first condition (Figure 3.11), all the bacterial strains were incubated 
with different concentrations of both MBG_US_m_SiO2/CaO and 
MBG_US_m_Cu2% particles for 1 and 3 days of culture, respectively. The results 
in Figure 3.11 evidenced a similar trend on all bacteria cultures after the incubation 
with the MBG_US_m_Cu2% nanoparticles, showing that the bacterial growth 
suppression was clearly correlated to the presence of copper and its increasing 
availability for higher concentration. After 1 day of incubation with a concentration 
above 250 mg/mL, approximately 30–40% of growth inhibition was observed for 
all types of bacteria, in comparison to the control (cultures without nanoparticles). 
In particular, the obtained results showed that at longer incubation times (3 days) 
with the higher suspension concentration (2 mg/mL), the reduction of viability for 
both E. coli RB and S. aureus 8325-4 cultures was 70–75%, and for S. epidermidis 
around 50%. Compared to MBG cultures both at short and long incubation times, 
E. coli RB and S. aureus showed a slightly lower cell viability using 2 mg/mL or 
500 mg/mL of MBG_US_m_Cu2%, respectively. At variance, with S. epidermidis, 
the difference in cell viability was dose-dependent, starting from the lower 
concentrations and becoming more evident at the higher doses (Figure 3.11). 
Interestingly, the results showed that MBG_US_m_SiO2/CaO, although not 
containing copper, exhibited a slight antibacterial effect against the E. coli RB and 
S. aureus (around 25%) remaining persistent at all the tested concentrations (not 
dose-dependent). On the contrary, with S. epidermidis cultures, the obtained results 
highlighted a clear effect related to copper, suggesting a different sensitivity of 
bacteria to the MBG composition and most likely a different antibacterial 
mechanism of action (Figure 3.11).  
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Figure 3.11: Dose-dependence viability of E. coli RB, S. aureus 8325-4 and S. epidermidis RP62A 
bacterial strains cultured with MBG_US_m_SiO2/CaO and MBG_US_m_Cu2% suspensions 
 
In order to evaluate the influence of the released copper on the antibacterial 
effect, the same experiments were performed in parallel with both 
MBG_US_m_SiO2/CaO and MBG_US_m_Cu2% extracts (Figure 3.12). Overall, 
it was clear that there was a positive correlation between the extract concentrations 
and bacteria growth inhibition, showing the same trend observed in the experiments 
based on the direct contact with nanoparticles. Interestingly, in all bacteria cultures, 
a cell viability reduction was observed in the samples treated with extract of 
MBG_US_m_Cu2% collected after 24 h (Figure 3.12B), if compared with extracts 
from MBG_US_m_SiO2/CaO, hence confirming the role of copper in the observed 
antibacterial activity. The same experiments carried out with extracts of 
MBG_US_m_Cu2% and MBG_US_m_SiO2/CaO collected after 3 h revealed a 
rather varying trend in the bacterial viability for all the tested strains, which did not 
 
 
allow a reliable interpretation of the data obtained for such short incubation times 
(Figure 3.12A). 
Figure 3.12: Dose-dependence viability of E. coli RB, S. aureus 8325-4 and S. epidermidis RP62A 
bacterial strains cultured with MBG_US_m_SiO2/CaO and MBG_US_m_Cu2% extracts collected after 3h 
(A) and after 24h (B) 
The antibacterial effect and the mechanism of action of copper on bacteria 
viability is not fully elucidated yet, however, it seems to be mainly associated to the 
pleiotropic effects of copper on bacterial cells, through multiple mechanisms of 
action. The results obtained in this work evidenced that Cu-containing glass 
nanoparticles showed antimicrobial effect, highly dependent upon the dose and 
bacterial strains. The remarkable difference might be attributed to the different 
properties of bacteria surfaces [20]. In Gram positive bacteria, the absence of an 
outer membrane and the presence of surface negatively charged teichuronic and 
lipoteichoic acids within a single lipid bilayer surrounded by a thick but porous 
layer of peptidoglycan (20–80 nm), make them attractive to positive charges [21]. 
Therefore, the inhibiting process is supposed to be most likely associated to the 
action of released metal ions, which might be easily moved inside the microbial 
cells or attached to the charged outer surfaces by electrostatic attraction, resulting 
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in cell apoptosis via protein denaturation and disruption of cell membrane [22]. By 
contrast, Gram negative bacteria expose a highly organized compact structure, 
which acts as a permeability barrier and prevents diffusion to the inner plasma 
membrane for high molecular weight compounds, making them less attractive to 
the metal cations. Moreover, the presence of copper tolerance mechanisms in E. 
coli [23], including the activation of copper export occurring from cytoplasm into 
the periplasmic space or into the extracellular milieu and the copper sequestration 
by metallothioneins, can further explain the requirement of a higher copper-
containing MBG concentrations to inhibit E. coli cultures in comparison to the other 
bacterial strains. At variance in E. coli and S. aureus bacteria, the copper-containing 
MBG antibacterial effect seems not to be merely due to the release of metal ions in 
solution, but most likely also to the small size and the high surface-to-volume ratio 
of MBG_US_m_Cu2% particles that account for the activation of cell death 
mechanisms [24,25]. 
 
Antibacterial effect of nanoparticles and their extracts on S. epidermidis 
S. epidermidis RP62A is known to produce considerable quantities of 
polysaccharide intercellular adhesions, inducing biofilm formation [26,27]. To 
evaluate the antibacterial activity on staphylococcal biofilms, S. epidermidis 
cultures were incubated with MBG_US_m_SiO2/CaO and MBG_US_m_Cu2% 
suspensions (2 mg/mL) or with related extracts collected after 24 h of incubation, 
either during the biofilm formation or in the presence of pre-formed biofilms 
(Figure 3.13 and 3.14).  
A significant reduction of biofilm growth was determined when the cultures 
were performed in the presence of MBG_US_m_Cu2% particles if compared to 
MBG_US_m_SiO2/CaO (Figure 3.13A, indicated by ***) and untreated cultures 
(data not shown). Moreover, a significant difference in cell viability was obtained 
when a stable formed biofilm was treated with MBG_US_m_SiO2/CaO or 
MBG_US_m_Cu2% nanoparticles (Figure 3.13C, indicated by **).  
Figure 3.13: Bacterial viability and morphology of biofilms treated with MBG_US_m_SiO2/CaO and 
MBG_US_m_Cu2% suspensions (2 mg/mL): effect on S. epidermidis RP62A biofilm formation cultures (A, B) 
and effect on the formation of a stable staphylococcal biofilm (C, D) 
 
 
Conversely, these effects were less marked in the presence of only copper 
containing extracts (released by nanoparticles) when incubated during the biofilm 
formation (Figure 3.14A) or on the pre-formed biofilms (Figure 3.14C). 
Furthermore, in order to visualize the biofilms morphology after these treatments, 
SEM studies were carried out. As expected, large cellular aggregates were observed 
in the biofilms produced by S. epidermidis RP62A in all samples used as control 
(Figure 3.13B and D; Figure 3.14B and D). Conversely, the presence of 
nanoparticles during S. epidermidis biofilm formation prevented and reduced the 
number of adherent bacteria and cluster formation, more distinctly for 
MBG_US_m_Cu2% nanoparticles (Figure 13B’’’). The addition of 
MBG_US_m_Cu2% suspension to an already formed staphylococcal biofilm, 
promoted a visible dispersion of biofilm aggregates (Figure 13D’’’) whereas the 
contact with MBG_US_m_SiO2/CaO suspension produced a less noticeable 
influence on the biofilm morphology. Similar results were observed for biofilm 
growing cultures (Figure 14B’’’) or for formed biofilms (Figure 14D’’’) incubated 
with MBG_US_m_Cu2% extracts, although the bacterial reduction was less 
evident in comparison to biofilms treated with MBG_US_m_Cu2% suspensions. 
Figure 3.14: Bacterial viability and morphology of biofilms treated with extracts of 
MBG_US_m_SiO2/CaO and MBG_US_m_Cu2%: effect of undiluted supernatants collected at 24 h on S. 
epidermidis RP62A biofilm growing cultures (A, B) and on the formation of a stable staphylococcal biofilm 
(C, D) 
 
3.2.1.3 Strontium-containing MBG_US_m: MBG_US_m_Sr1% 
Strontium was the second investigated ion due to its role in bone metabolism. 
In this context, strontium is gaining increasing attention thanks to the related 
osteoblast stimulation activity and the osteoclast inhibition property [28].  
In this work, strontium-containing MBG nano-particles were produced through 
methanol-based ultrasonicator-assisted sol-gel route by substituting a small amount 
of calcium with strontium. The obtained particles (85SiO2/14CaO/1SrO %mol, 
named hereafter MBG_US_m_Sr1%) were studied in their morphology, 
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composition, structural features, ion release and bioactive properties. The results of 
the Sr-modified MBGs will be useful for interpreting those of the double-ion 
(strontium and copper) containing system that combined in a single matrix the 
antibacterial and the pro-osteogenic effect (see following section 3.2.1.4). 
3.2.1.3a Morphological and structural characterization of MBG_US_m_Sr1% 
First of all, the morphological investigation through FE-SEM analysis was 
performed. 
As visible in Figure 3.15, the incorporation of the Sr therapeutic ion did not 
alter the morphology of the particles, as already evidenced in copper-containing 
MBGs, which appeared slightly aggregated, with a spheroidal shape and size 
ranging between 130 and 180 nm. 
 
EDS investigation was conducted on Sr-containing powders to evaluate the 
chemical composition of the sample, however, due to the very close binding energy 
shown by Si and Sr elements, the corresponding peaks partly overlapped, and the 
evaluation of Sr content was unreliable (Figure 3.16). 
The chromium peaks, as reported for the MBG_US_m_SiO2/CaO, are 
ascribable to the coating deposited on the sample to make it conductive for the EDS 
investigation. 
Figure 3.16: EDS spectrum of MBG_US_m_Sr1% 
 
Figure 3.15: FE-SEM image of MBG_US_m_Sr1% 
 
 
Hence, the incorporation of strontium was investigated by XRF spectroscopy 
which provided a molar ratio Sr/Si equal to 0.7 %mol, lower compared to the 
nominal value (1.18 %mol), highlighting a partial incorporation of the substituent 
ion. A similar discrepancy was reported in the literature in several strontium-
containing systems [29–31] and was ascribed to the electronic properties of 
strontium. As the strontium ionic radius (1.16 Å) is larger than the calcium radius 
(0.94 Å), the strontium incorporation into the silica framework could be more 
difficult than the calcium one. Moreover, the lower charge density of strontium ion 
compared to calcium ion may determine weaker interactions between Sr2+ and the 
framework resulting in the observed lower Sr2+ incorporation efficiency. 
The N2 adsorption-desorption measurements were used to study the pore 
features. The curve in Figure 3.17 revealed a IV type isotherm associated with 
mesoporous structure, according to IUPAC [2]. The corresponding pore size 
distribution (inset graph of Figure 3.17) exhibited a narrow distribution centred in 
2.5 nm. The ordered mesostructure and the high value of SSA (Table 3.5) are in 
agreement with SiO2-CaO mesoporous nanoparticles obtained with the same 
procedure [1], further confirming that the incorporation of strontium occurred 
without hindering the mesoporous structure formation process. 
 
 
Figure 3.17: N2 adsorption-desorption isotherm of MBG_US_m_Sr1% and related DFT pore size 
distribution (inset) 
 
Table 3.5: Structural features of MBG_US_m_Sr1% 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_US_m_Sr1% 470 2.5 0.23 
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3.2.1.3b Strontium ion release from MBG_US_m_Sr1% in SBF  
The strontium release was tested in SBF following the procedure reported in 
section 2.6.1 of “Materials and methods”. The strontium release profile (Figure 
3.18) showed a burst release within the first 3 h of soaking. The lower diffusion rate 
evidenced after 1 day of soaking was previously found in similar ion-modified 
systems [32,33] and it was ascribed to the partial occlusion of the mesopores caused 
by the dissolution of the silica framework. Other authors [34] found similar profile 
by studying the release from MCM-41 spheres which was attributed to the re-
precipitation of the silica in the form of silica-gel at the pore entrance. 
The MBG_US_m_Sr1% release trend tended to increase progressively: the 
released concentration after 14 days of incubation was 7 ppm and corresponded to 
88% of the incorporated strontium amount, calculated by XRF analysis, suggesting 
the presence of a residual amount of strontium ion inside the network. Considering 
the curve slope at 14 days, it could be speculated that a further amount of ion might 
be released in a longer period.  
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Figure 3.18: Sr2+ release profile of MBG_US_m_Sr1% in SBF 
 
3.2.1.3c Bioactive behaviour of MBG_US_m_Sr1% in SBF  
The bioactive behaviour of the strontium-containing mesoporous particles was 
analysed by soaking the sample in SBF for different time points up to 14 days. After 
1 day of immersion, the particles did not show modification in their surface 
morphology and element composition. Needle-like structures, visible after 3 days 
of soaking, tended to cover all particles after 7 days (Figure 3.19). The influence of 
strontium on the bioactive response of glass is a controversial issue: different 
researches discovered that the substitution of Sr for Ca accelerated the HA 
deposition onto the bioactive glasses [35,36]. On the contrary, some other authors 
[37] found that the addition of strontium within glass composition represented an 
obstacle for the calcium phosphate nucleation sites, causing a delay in the 
hydroxyapatite precipitation rate.  
 
 
In this work, the presence of strontium did not affect the bioactive response of 
the system whose ion exchange ability during soaking in SBF was confirmed by 
morphological observation.  
Furthermore, from EDS measurements, the Ca/P ratio became similar to the 
Ca/P value characteristic of HA over the tested time. As stated in chapter “State of 
art”, the bioactive response of the material is composed by several surface ion 
exchange reactions which lead to the formation of the calcium phosphate layer [38]. 
According to the literature [31], the Ca/P ratio, starting from higher values during 
the first hours, becomes comparable to the stoichiometric value of hydroxyapatite 
(1.67) [5,6] over the time. In the present system, the same evidence was found: the 
detected Ca/P ratio, which was equal to 2.3 after 1 day of soaking, reached the value 
of 1.78 after 14 days of incubation in SBF.  
 
 
Figure 3.19: FE-SEM image of MBG_US_m_Sr1% after 7 days of soaking in SBF and its magnification 
 
3.2.1.4 Strontium-copper co-containing MBG_US_m: MBG_US_m_CuSr2% 
With the aim to obtain multifunctional biomaterials which synergistically 
combine the ability to promote bone formation and angiogenesis and to impart an 
antibacterial effect, double-ion co-substituted mesoporous bioactive particles were 
obtained by using strontium and copper as therapeutic species. The sample, named 
MBG_US_m_CuSr2%, was produced by modifying the composition as follows: 
85SiO2/13CaO/1SrO/1CuO %mol. 
Part of the work described in this chapter has been already published by the 
candidate [33]. 
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3.2.1.4a Morphological and structural characterization of 
MBG_US_m_CuSr2% 
The FE-SEM analysis demonstrated that MBG_US_m_CuSr2% particles were 
spheroidal, slightly aggregated, with a size of about 100 nm (Figure 3.20). EDS 
analysis (inset of Figure 3.20) revealed a molar concentration in fair agreement with 
nominal ratio for what concerns copper ions, at variance with strontium, whose 
incorporation resulted less effective. However, as already reported for 
MBG_US_m_Sr1%, the EDS technique does not provide reliable results on the 
incorporated Sr amount, due to the overlapping of Sr and Si peaks and the relatively 
low amount of the strontium species.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: FE-SEM image of MBG_US_m_CuSr2% and related EDS spectrum (inset) 
In this regard, a different compositional investigation was deemed necessary. 
Hence, the amount of incorporated ion was evaluated by dissolving the powder in 
a mixture of nitric and hydrofluoric acids (0.5 mL of HNO3 and 2 mL of HF for 10 
mg of powder) and the resulting solutions were analysed via ICP analysis, as 
described in the section 2.5.2 of “Materials and methods” chapter. 
As already evidenced by EDS data, almost the 100% of copper added during 
the synthesis was incorporated within the glass network. The strontium loading, 
instead, corresponded to 50% of the amount added during the synthesis procedure. 
As reported above for MBG_US_m_Sr1% sample, the reason can be related to the 
slightly higher ionic radius and the lower charge/ionic radius (charge density) of 
Sr2+compared to those of Ca2+, which account for the lower Sr2+ incorporation, as 
found in other works [30,39]. On the contrary, it can be speculated that the lower 
ionic radius of Cu2+ (0.71 Å) respect to that of Ca2+ allows the observed total 
incorporation of copper. 
N2 adsorption-desorption measurements showed IV type isotherm (Figure 
3.21), confirming the mesoporous structure of the sample. MBG_US_m_CuSr2% 
curve exhibited a well-defined step between 0.1 and 0.2 p/p0, indicative of the filling 
 
 
of regular mesopores. The data reported in Table 3.6 highlighted that the ion co-
substitution did not significantly affect the structural properties of the final powder 
that resulted only slightly different from Sr- or Cu-containing MBGs [8,30]. The 
DFT pore size distribution, reported in the inset of Figure 3.21, evidenced a narrow 
distribution around 2.6 nm, which is the same value of the one found in Sr- and Cu-
containing sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.6: Structural features of MBG_US_m_CuSr2% 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_US_m_CuSr2% 549 2.6 0.28 
 
3.2.1.4b Strontium and copper ion release from MBG_US_m_CuSr2% in SBF 
The incorporated Cu2+ and Sr2+ were successfully co-released in SBF by 
MBG_US_m_CuSr2% particles.  
The curve profile (Figure 3.22) showed a burst release of both Cu2+ and 
Sr2+ ions within the first 3 h of incubation, reaching 9 and 11 ppm, respectively. 
After 1 day of soaking, a lower diffusion rate was observed and could be ascribed 
to the progressive occlusion of mesopores due to the dissolution of silica framework 
and its re-precipitation in the form of silica gel at the pore entrance [34]. 
Subsequently, after 7 days the constant release might be ascribed to the precipitation 
of HA (see the following section 3.2.1.4c) layer which could partially block the ion 
release. This aspect is more evident in the Cu2+ release profile than in that of Sr2+, 
which showed higher released concentration for the entire test. This observation 
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Figure 3.21: N2 adsorption-desorption isotherm of MBG_US_m_CuSr2% and related DFT pore size 
distribution of (inset) 
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suggests a higher accessibility and ion-exchange ability of Sr2+ within the silica 
framework compared to Cu2+ species, most likely due to its similarity with calcium 
as network modifier [28]. 
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Figure 3.22: Ion release curve of MBG_US_m_CuSr2% 
 
3.2.1.4c Bioactive behaviour of MBG_US_m_CuSr2% in SBF  
In vitro bioactivity assessment highlighted that partial replacing of Ca with Cu 
and Sr ions did not significantly hamper the hydroxyapatite nucleation and 
deposition. After 1 day of soaking, the Ca/P ratio revealed by EDS analysis was 
2.89 for MBG_US_m_CuSr2%. After 7 days of soaking in SBF the sample was 
fully covered by a layer of needle-like crystals (Figure 3.23) and the Ca/P ratio was 
in good accordance to the stoichiometric value of hydroxyapatite (1.67) [5,6].  
 
 
 
Figure 3.23: MBG_US_m_CuSr2% after 7 days of soaking in SBF with EDS spectrum (inset) 
The formation of hydroxyapatite layer was also analysed by wide-angle XRD 
analysis. In Figure 3.24 the two spectra of MBG_US_m_CuSr2% before (Figure 
3.24A) and after (Figure 3.24B) 7 days of soaking in SBF confirmed the bioactive 
response of the sample. In details, the spectrum of MBG_US_m_CuSr2% with the 
characteristic broad peak between 20° and 30° (2θ values) evidenced the amorphous 
structure of the sample. Figure 3.24B demonstrated the deposition of 
hydroxyapatite on the sample through the presence of new peaks which matched 
the hydroxyapatite external reference (00- 001-1008). 
The pH value of SBF was below 7.8 during the entire test, which is considered 
an optimal value for osteoblasts [40]. 
 
Figure 3.24: Wide-angle XRD spectra of MBG_US_m_CuSr2% before soaking in SBF(A) and 
MBG_US_m_CuSr2% after 7 days of soaking in SBF (B) 
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3.2.2 Water-based synthesis results: MBG_US_w nanomatrices 
Despite the promising results in terms of morphology, composition, structural 
features, release and bioactive properties of the nanomatrices described in section 
3.2.1 of the present chapter, alternative procedures were developed: in fact, water-
based routes were considered more suitable for the ion-containing matrix up-scaling 
compared to the previous procedures which involved the use of a toxic solvent 
(methanol). 
In details, two different water-based ultrasonicator-assisted synthesis were 
carried out in order to obtain particles in the range of 100-200 nm with pores 
ranging between 2 and 4 nm.  
In details, the first water-based procedure, using NH4F as catalyst, was adopted 
by modifying a synthesis method reported by Shi et al. [9]. The as-synthesized 
samples, indicated with the acronym MBG_US_w_I followed by the %mol of the 
substituent species, were produced by adding different types of therapeutic ion 
(Table 3.7). In addition, two samples, indicated with the * in Table 3.7, were 
obtained with the same synthesis route, without the addition of calcium, resulting 
in ion-containing mesoporous silica nanoparticles (MSn).  
The second water-based procedure, involving the use of ammonia as catalyst, 
was used to produce the sample MBG_US_w_II_SiO2/CaO by adding the 
ultrasonication step to a procedure already reported in the literature [41]. 
 
Table 3.7: Composition of samples produced by water-based ultrasonicator-assisted sol-gel routes 
 
 
 
 
 
 
3.2.2.1 Copper-containing MBG_US_w_I: MBG_US_w_I_Cu2% 
MBG nanoparticles were produced by adapting a water-based sol-gel procedure 
reported by Shi et al. [9] through the addition of CaNO3 and the ultrasonication step 
during the synthesis.  
As reported above, the copper was chosen in view of the obtainment of MBG 
matrix with antibacterial, pro-angiogenic and pro-osteogenic potential [7] for tissue 
applications. The sample, named hereafter MBG_US_w_I_Cu2%, was synthesized 
with the following molar composition: 85SiO2/13CaO/2CuO %mol. 
 
Name Composition (%mol) 
MBG_US_w_I_Cu2% 85 SiO2/13 CaO/2 CuO 
MSn_US_w_I_Ag2%* 98 SiO2/2 AgO 
MSn_US_w_I_Ce2%* 98 SiO2/2 CeO 
MBG_US_w_II_SiO2/CaO 85 SIO2/15 CaO 
 
 
Figure 3.26: EDS spectrum of MBG_US_w_I_Cu2% 
3.2.2.1a Morphological and structural characterization of 
MBG_US_w_I_Cu2% 
The FE-SEM investigation (Figure 3.25) showed agglomerated particles with 
smaller size and irregular shape and size compared to the methanol-based samples 
described in section 3.2.1.  
 
 
Figure 3.25: FE-SEM image of MBG_US_w_I_Cu2% 
The EDS analysis (Figure 3.26) evidenced the presence of fluoride (blue arrow 
in Figure 3.26) on this sample ascribed to residual fluoride species of NH4F used as 
catalyst during the synthesis procedure. It could be speculated that the fluoride have 
formed a very stable compound with elements of the framework (e.g. with calcium 
to form calcium fluoride) which remained as contaminant even after several 
washing steps.  
In addition, the atomic percentage data, resulting from EDS characterization, 
showed a not uniform distribution of the calcium element: the detected Ca/Si ratio, 
as average of three different measurements, was three times higher than the 
theoretical ratio. Differently, the Cu/Si ratio was very close to the theoretical one. 
 
 
 
 
 
 
 
 
The same evidence resulted from the EDS mapping analysis coupled with 
STEM technique. As shown in Figure 3.27, Cu and Si elements were 
homogeneously distributed (blue and yellow signal, respectively). At variance, the 
calcium signal was not detected in the area marked in red. Calcium ions were 
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detected only in the area marked in blue where the powder seemed to form a 
disorganized phase which can be tentatively ascribed to calcium fluoride salt.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.27: EDS mapping of MBG_US_w_I_Cu2% 
The issues encountered in the calcium distribution might be attributed to the 
sol-gel procedure carried out at almost neutral pH (~ 6). As stated in the “State of 
the art” chapter, the pH is a process influencing factor during the hydrolysis and 
condensation sol-gel phases. In details, with the increase of pH, the hydrolysis stage 
proceeds slowly, while the condensation is more rapid [42]. Valliant et al. [42] 
conducted a study on the role of pH on the silica network formation and calcium 
incorporation inside the sol-gel bioactive glasses. By synthesizing sol-gel glasses 
from sols at different pH, they found that at pH 5.1 the gelation stage took only 30s 
and resulted in a more disordered network. In the present work, it might be assumed 
that the fast gelation stage resulted in uneven incorporation of calcium inside the 
MBG_US_w_I_Cu2% framework. 
The mesopore structure was confirmed by N2 adsorption-desorption 
measurements. The isotherm (Figure 3.28) revealed a IV type curve with a well-
defined step between 0.2-0.4 p/p0 indicative of the order of the mesostructure. The 
pore size distribution was centred around 4 nm (Figure 3.28-inset), bigger than the 
analogous mesoporous nanosphere silica system [9]. The SSA and the pore volume 
are reported in Table 3.8. 
 
 
 
                 
 
                 
Si O 
Ca Cu-K Cu-L 
 
 
 
Figure 3.28: N2 adsorption-desorption isotherm of MBG_US_w_I_Cu2% and DFT pore size 
distribution of MBG_US_w_I_Cu2% (inset) 
 
Table 3.8: Structural features of MBG_US_w_I_Cu2% 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_US_w_I_Cu2% 518 3.7 - 4 0.53 
 
 
3.2.2.1b Copper ion release from MBG_US_w_I_Cu2% in DMEM 
The copper release from MBG_US_w_I_Cu2% was assessed in DMEM 
following the procedure described in section 2.6.2 of the “Materials and methods” 
chapter. As stated in that chapter, the DMEM medium was selected since it 
represents a mimetic cell culture environment suitable for the in vitro biological 
assessment. 
The release kinetics is shown in Figure 3.29. The profile evidenced a burst 
release within the first 3 h of incubation in DMEM, followed by a slower release 
kinetics. After 7 days of soaking, the released copper concentration reached the 
maximum of 7.8 ppm, corresponding to 40% of the theoretical incorporated 
amount. The partial release of copper species could be ascribed to the complex 
composition of DMEM solution. Other authors [9,43], in fact, speculated that the 
species contained in that medium may interfere with the bioactive response and the 
release kinetics of the sample. 
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Figure 3.29: Cu2+ release profile of MBG_US_w_I_Cu2% in DMEM 
 
3.2.2.2 Silver-containing MSn: MSn_US_w_I_Ag2%* 
The mesoporous silicas show the same well-known advantages of the MBG 
(i.e. large surface area, high pore volume, tunable pore size, huge amount of silanol 
groups on the surface) [44], but they are characterized by very slow bioactive 
response [45]. Since the fast bioactivity is not demanded in wound healing 
application, silver-containing MSn (98SiO2/2AgO %mol, named hereafter 
MSn_US_w_I_Ag2%*) was investigated as promising agent to be used in infected 
wound, due to the antibacterial effect of silver ion [46]. 
 
3.2.2.2a Morphological and structural characterization of 
MSn_US_w_I_Ag2%* 
The FE-SEM image in Figure 3.30 showed spherical particles with size ranging 
from 20 to 100 nm. The rough appearance, widely visible in the FE-SEM image, 
was ascribed to the conductive Cr coating covering the powder. The incorporation 
of the therapeutic ion was confirmed by the EDS analysis (inset in Figure 3.30). 
Moreover, the Cu and Al peaks visible in the spectrum (blue arrows) are attributed 
to the copper-coated carbon grid and the stub used for the EDS investigation, 
respectively. 
 
 
 
 
Figure 3.30: FE-SEM image of MSn_US_w_I_Ag2%* and related EDS spectrum 
The IV type isotherm (Figure 3.31) confirmed the mesoporosity of the sample, 
according to the IUPAC classification [2]. The lack of hysteresis is typical of 
mesoporous materials with pore size lower than a critical width, which, for nitrogen 
adsorption system at 77 K, corresponds to 4 nm [47]. Moreover, the step between 
0.2 and 0.4 p/p0 indicated the filling of uniform mesopores. 
The DFT pore size distribution reported in the inset of the graph in Figure 3.31 
evidenced a pore mean diameter of about 3.8 nm. The SSA and pore volume, listed 
in Table 3.9, were comparable to the un-doped mesoporous silica nanoparticles as 
reported in the literature [9]. 
 
Figure 3.31: N2 adsorption-desorption isotherm of MSn_US_w_I_Ag2%* and related DFT pore size 
distribution (inset) 
  
Table 3.9: Structural features of MSn_US_w_I_Ag2%* 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MSn_US_w_I_Ag2%* 517 3.8 0.49 
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The UV-visible analysis was used to identify the oxidation states of silver 
species in the silica matrix.  
In Figure 3.32, the UV-visible spectrum of MSn_US_w_I_Ag2%* showed the 
absence of peaks in the visible region, typically attributed to silver metallic particles 
[48]. In the ultraviolet region, the major peak at around 250 nm was assigned to 
4d10 to 4d9 5s1 transition of Ag+ ions [48]. The shoulder around 300 nm can be 
tentatively attributed to small Agnm+ clusters [49]. 
 
 
Figure 3.32: Diffuse reflectance UV–vis spectrum of MSn_US_w_I_Ag2%* 
The UV-visible observations were supported by wide-angle XRD 
characterization. As shown in Figure 3.33, the spectrum of MSn_US_w_I_Ag2%* 
is characterized by the typical broad peak between 20° and 30° (2θ values) 
characteristic of amorphous silicas. The peaks centred in 26.74, 30.97, 44.36, 52.61, 
55.08, 64.54 and 73.29 2θ values represented the contribution of small crystalline 
clusters and are matched by silver bromide (external reference 01-079-0149). 
Probably, the bromide present in the CTAB surfactant reacted with Ag+ ions in the 
synthesis medium  to form AgBr clusters [50]. 
Figure 3.33: Wide-angle XRD spectrum of MSn_US_w_I_Ag2%* 
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3.2.2.2b Silver ion release from MSn_US_w_I_Ag2%* in DMEM 
In order to assess the silver release from MSn_US_w_I_Ag2%*, the powders 
were soaked in DMEM following the procedure reported in section 2.6.2.  
As depicted in Figure 3.34, after reaching the maximum at 3 days of soaking 
(equal to 3.9 ppm), the release profile curve started to decrease over the remaining 
time. A similar behaviour was found in other silver-containing MBG systems [51] 
and it was ascribed to the tendency of silver to react with chlorides present in the 
DMEM medium, forming insoluble AgCl salts which precipitate. 
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Figure 3.34: Ag+ release profile of MSn_US_w_I_Ag2%* in DMEM 
3.2.2.3 Cerium-containing MSn_US_w_I: MSn_US_w_I_Ce2%* 
By following the same water-based ultrasonicator assisted procedure, Ce-
substituting nanoparticles (named hereafter MSn_US_w_I_Ce2%*) were produced 
with the molar composition of 98SiO2/2CeO %mol. 
This cerium-containing mesoporous silica matrix was produced pursuing the 
same objective of silver-containing MSn, which consisted in creating nanomatrices 
for wound healing application. As silver-containing samples, cerium-modifying 
systems are studied for the antibacterial effect imparted by cerium [52]. 
 
 
3.2.2.3a Morphological and structural characterization of 
MSn_US_w_I_Ce2%* 
The morphological and compositional characterizations were performed by FE-
SEM and EDS analysis. 
MSn_US_w_I_Ce2%* particles were spheroidal with dimension mostly 
around 100 nm, as visible in Figure 3.35. EDS analysis (data not shown) confirmed 
the incorporation of cerium with a Ce/Si molar ratio, calculated as average of three 
measurements, in fair agreement with the theoretical one.  
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Furthermore, the EDS characterization showed the presence of fluoride peaks, 
as already noticed in MBG_US_w_I_Cu2%, most likely due to the NH4F used as 
catalyst which remained as contaminant despite the washing steps. 
 
Figure 3.35 FE-SEM image of MSn_US_w_I_Ce2%* 
N2 adsorption-desorption measurements were performed on the powder in 
order to characterize the textural features of MSn_US_w_I_Ce2%*. 
The IV type isotherm in Figure 3.36 is typical of mesoporous material with the 
step around 0.3 p/p0. The capillary condensation, represented by the hysteresis loop 
in the multilayer range [2], is attributed to intra-particles voids. The narrow pore 
size distribution (inset of Figure 3.36), centred at 3.6 nm, was calculated by DFT 
method. The extremely high values of the SSA (763 m2/g) and pore volume (0.98 
cm3/g), reported in Table 3.10, are only slightly lower respect to non-doped 
mesoporous silica systems [45]. 
 
 
Figure 3.36: N2 adsorption-desorption isotherm of MSn_US_w_I_Ce2%* and related DFT pore size 
distribution (inset) 
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Table 3.10: Structural features of MSn_US_w_I_Ce2%* 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MSn_US_w_I_Ce2%* 763 3.6 0.98 
 
As cerium is highly sensitive to the change of oxidation state [53], UV-visible 
analysis was used to obtain qualitative data about the oxidation state of cerium in 
the MNs_US_w_I_Ce2%* and the spectrum is reported in Figure 3.37.  The peak 
around 297 nm corresponded to Ce3+ inter-configurational transitions (4f to 5d) 
[54]. 
 
 
Figure 3.37: Diffuse reflectance UV–vis spectrum of MSn_US_w_I_Ce2%* 
The phase composition of MSn_US_w_I_Ce2%* was analysed by wide-angle 
XRD technique. As visible in Figure 3.38, the presence of several peaks at 28.41, 
33.02, 47.19, 56.21, 58.92, 69.19 and 76.60 2θ degrees suggested the formation of 
crystalline phases within the amorphous matrix, represented by the broad peak 
around 20° (2θ values). The aforesaid peaks were in agreement with the CeO2 
external reference (01-081-0792). The broadening of these peaks can be due to the 
nanometer size of the cerium oxide clusters [55]. 
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Figure 3.38: Wide-angle XRD spectrum of MSn_US_w_I_Ce2%* 
3.2.2.2b Cerium ion release from MSn_US_w_I_Ce2%* in DMEM 
The capability of MSn_US_w_I_Ce2%* to release cerium ions was tested in 
DMEM solution. As visible in Figure 3.39, the cerium released amount was almost 
negligible during the entire duration of the test. This reduced released amount may 
be related to the high stability of the formed cerium oxide clusters. In this regard, 
several cerium-containing MBGs with a cerium content up to 3.5 %mol 
demonstrated a scarce ability to release cerium ion in SBF [10], with a maximum 
released concentration of 0.05 ppm after 8 days of soaking. 
Moreover, as already mentioned, the use of DMEM medium slowed down the 
dissolution process of the system causing a delay to the ion release, as previously 
observed in different ion-containing biomaterials [9,56]. 
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Figure 3.39: Ce3+ release profile of MSn_US_w_I_Ce2%* in DMEM 
3.2.2.4 Un-doped MBG_US_w_II: MBG_US_w_II_SiO2/CaO 
Considering that the samples produced by the water-based ultrasonicator-
assisted sol-gel route with NH4F as catalyst showed high amount of fluorine-based 
contaminants, the formation of clusters and the poor release properties, an 
alternative different water-based route was explored.  
 
 
In details, the sample with 85SiO2/15CaO %mol molar composition, named 
hereafter MBG_US_w_II_SiO2/CaO, was produced by adding the ultrasonication 
step to a base-catalysed sol-gel procedure already reported in the literature [41], as 
described in the related section in chapter 2. 
3.2.2.4a Morphological and structural characterization of MBG_US_w_II_ 
SiO2/CaO 
The as-synthesized sample was characterized in its morphology, composition 
and structural properties. 
In Figure 3.40, the FE-SEM technique showed dispersed particles, spherical 
shaped with size of about 100 nm. The chemical composition, analysed by EDS 
(inset graph in Figure 3.40), confirmed the presence of the Si and Ca with a nominal 
ratio (Ca/Si=0.17) equal to the theoretical one. Moreover, the EDS analysis did not 
reveal the presence of contaminants. The not assigned peaks in the EDS spectrum 
are attributed to Cu and Al due to the copper-coated grid and aluminium stub used 
during the FE-SEM/EDS investigation, respectively, and the Cr peaks are 
ascribable to the coating layer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.40: FE-SEM image of MBG_US_w_II_SiO2/CaO and related EDS spectrum 
The structural features of the sample were studied by N2 adsorption-desorption 
measurements. Comparing the textural feature results (Table 3.11) with those 
obtained by Wu et al. [41], it seems that the use of the high frequency 
ultrasonication step enhanced the exposed surface area and accessible pore volume. 
Nevertheless, the isotherm (Figure 3.41) and the pore size distribution (inset in 
Figure 3.41) did not reveal the formation of an ordered mesostructure. The pore size 
distribution obtained through the DFT method showed a broad distribution, with 
diameter ranging between 3 and 11 nm. 
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Figure 3.41: N2 adsorption-desorption isotherm of MBG_US_w_II_SiO2/CaO and DFT pore size 
distribution of MBG_US_w_II_SiO2/CaO (inset) 
 
Table 3.11: Structural features of MBG_US_w_II_SiO2/CaO 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_US_w_II_SiO2/CaO 418 3-11 0.65 
 
 
Hence, it is possible to speculate that the use of ultrasounds disturbed the 
mesophase assembly, leading to a disorganized porous structure.  
 
As the ultrasonication step was identified as the main influencing step on the 
mesostructure formation and is also an energy-consuming phase, a different 
synthesis procedure was developed, and the related results are presented in the 
following section.  
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3.3 Morphological and structural characterization of 
optimized sol-gel nanomatrices 
Following the aim to obtain scalable nanomatrices without using inflammable 
organic solvents and several synthesis steps, the selection process led to the 
optimization of two routes: a water-based sol-gel procedure using ammonia as 
catalyst to produce nano-sized MBG particles (see the following section 3.3.1) and 
an aerosol-assisted spray-drying approach in order to obtain micro-sized MBG 
spheres (see the following section 3.3.2). 
 
3.3.1 Morphological and structural characterization of base-
catalysed sol-gel nanomatrices 
The nano-sized MBG particles with pores of about 4 nm were finally produced 
by using a base-catalysed water-based sol-gel route by incorporating different 
amounts and types of therapeutic ions in a SiO2-CaO framework. Since the 
ultrasonication treatment (section 3.2.2.4) represented an energy-consuming step 
and accounted for not-fully satisfying results, the nano-sized matrices were 
produced by using the same sol-gel synthesis approach [41], avoiding the 
ultrasound step. In details, the as-synthesized samples are listed in Table 3.12. 
 
Table 3.12: List of MBG_SG compositions  
 
 
 
 
 
 
 
 
 
3.3.1.1 Copper-containing MBG_SG: MBG_SG_Cu2% 
In addition to the antibacterial property, the therapeutic potential of copper is 
also related to the induction of a pro-angiogenic and pro-osteogenic effect, which 
make copper a promising agent in wound and bone healing applications [7].  
In this section, the results concerning the copper-containing nano-sized 
particles (85SiO2/13CaO/2CuO %mol, named hereafter MBG_SG_Cu2%) are 
shown. 
Part of the work described in this chapter has been previously published in [32]. 
Name Composition (%mol) 
MBG_SG_Cu2% 85 SiO2/13 CaO/2 CuO 
MBG_SG_Ce1% 85 SiO2/14 CaO/1 CeO 
MBG_SG_Ce2% 85 SiO2/13 CaO/2 CeO 
MBG_SG_Ag0.1% 85 SiO2/14.9 CaO/0.1 AgO 
MBG_SG_Ag2% 85 SiO2/13 CaO/2 AgO 
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3.3.1.1a Morphological and structural characterization of MBG_SG_Cu2% 
FE-SEM image of MBG_SG_Cu2% (Figure 3.42A) showed particles with a 
uniform spherical morphology, with size ranging between 150 and 200 nm. EDS 
mapping analysis revealed a homogeneous distribution of silicon (yellow) and 
calcium (red) throughout the analysed particles (Figure 3.42B), at variance the 
analysis of copper was not reliable due to presence of the element in the sample 
holder. EDS spectrum of the powder dispersed on carbon tape (Figure 3.42C) 
confirmed the incorporation of copper inside the framework, with a Cu/Si molar 
ratio, as average of three measurements, in fair agreement with the nominal ratio. 
 
Figure 3.42: FE-SEM image of MBG_SG_Cu2% (A), EDS mapping analysis of MBG_SG_Cu2% single 
particle (B), EDS spectrum of MBG_SG_Cu2% (C)  
 
 
Wide-angle XRD (Figure 3.43) confirmed that copper did not form segregated 
oxide clusters after calcination treatment, as assessed by the absence of crystalline 
oxide-based phases. 
 
 
 
 
Figure 3.43: Wide-angle XRD spectrum of MBG_SG_Cu2% 
The N2 adsorption-desorption isotherm confirmed the mesoporous structure 
(Figure 3.44): the type IV isotherm curve showed a well-defined step around 0.4 
(p/p0), indicative of the filling of uniform mesopores. Related DFT pore size 
distribution (inset in Figure 3.44) confirmed the presence of uniform mesopores 
with a mean diameter centred at around 4 nm. The BET SSA and pore volume 
(reported in Table 3.13) resulted remarkably high, slightly lower than those reported 
for similar systems without copper [1]. 
 
 
Figure 3.44: N2 adsorption-desorption isotherm of MBG_SG_Cu2% and related DFT pore size 
distribution (inset) 
 
Table 3.13: Structural features of MBG_SG_Cu2% 
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3.3.1.1b Copper ion release from MBG_SG_Cu2% in Tris HCl 
The ionic concentration (ppm) of Cu2+ species from MBG_SG_Cu2% powder 
in Tris HCl medium is reported in Figure 3.45: almost the total amount of 
incorporated copper was released within the first 3 h of incubation with a final 
released concentration of about 4.7 ppm. After the first hours of soaking, the copper 
released concentration remained constant till the end of the test (14 days). 
The slightly decreasing trend after 3 days of soaking could be ascribed to the 
deposition of HA (see section 3.3.1.1c) which partially bother the Cu2+ release.  
The fast ion release kinetics of MBG_SG_Cu2% can be ascribed to the 
remarkably high surface area and the small particle size (short diffusion paths), 
which allow fast ion diffusion inside the porous structure.  
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Figure 3.45: Cu2+ release curve of MBG_SG_Cu2% in Tris HCl 
 
3.3.1.1c Bioactive behaviour of MBG_SG_Cu2% in SBF 
The bioactive response of the MBG_SG_Cu2% was tested by soaking the 
particles in SBF up to 14 days. 
New HA crystals appeared after 3 days of soaking, making the particle surface 
rough, which confirms the rapid bioactive response of the sample for Cu-containing 
systems. After 7 days of soaking (Figure 3.46), the deposition of HA became even 
more extended.  
From EDS investigation, new peak, ascribed to phosphorous, appeared, further 
suggesting the deposition of HA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.46: FE-SEM image of MBG_SG_Cu2% after 7 days of soaking in SBF 
Based on the wide-angle XRD analysis, a further confirmation of the formation 
of HA cluster was provided. The pattern obtained by analysing the powder after 7 
days of soaking (Figure 3.47) showed the presence of new peaks at 25.84, 29.32 
and 32.13 2θ degrees that matched those of HA (external reference 01-086-0740). 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.1.2 Cerium-containing MBG_SG: MBG_SG_Ce1% and MBG_SG_Ce2% 
Two different cerium-containing nanomatrices were produced by adding 
different amounts of cerium precursor during synthesis [41], in order to analyse the 
effects of substituting small amounts (1 or 2 %mol) of cerium to the MBG particles. 
The as-produced samples are called MBG_SG_Ce1% (with composition 
85SiO2/14CaO/1CeO %mol) and MBG_SG_Ce2% (with composition 
85SiO2/13CaO/2CeO %mol). The cerium was used as therapeutic ion due to the 
pro-osteogenic and antibacterial properties, as described in chapter 1 [57]. 
Figure 3.47: Wide-angle XRD of MBG_SG_Cu2% after 7 days of soaking in SBF 
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3.2.1.2a Morphological and structural characterization of cerium-containing 
MBG_SG samples  
Both cerium-containing samples were analysed in their morphology, 
composition and structural property. 
Figure 3.48 depicts the FE-SEM images of both samples. The incorporation of 
different amounts of cerium did not affect the spherical morphology of both 
samples. For what concerns the size, the diameter of the particles was in the range 
of 100 nm in MBG_SG_Ce1% particles (Figure 3.48A), slightly bigger than 
MBG_SG_Ce2% spheres (Figure 3.48B). 
 
The elemental composition of the samples was investigated by EDS analysis. 
The EDS spectra (data not shown) confirmed the incorporation of the therapeutic 
ion. Nevertheless, the analysis showed an uneven distribution of the substituent 
element, especially for the sample with the highest concentration.  
In addition, the increase of cerium content corresponded to a partial 
deterioration of the mesoporous structure order, as assessed by N2 adsorption-
desorption measurements. Both samples showed a IV type isotherm (Figure 3.49A 
and 3.49B), typical of mesoporous material [2]. Nevertheless, the MBG_SG_Ce2% 
hysteresis loop in Figure 3.49B indicated a broad pore size distribution confirmed 
also by Figure 3.49D. Whilst, the MBG_SG_Ce1% particles showed a single-mode 
pore size distribution centred at 4 nm, as shown in Figure 3.49C. In 
MBG_SG_Ce2%, the contribution of the pore family with size centred around 2 
nm is higher respect the one of MBG_SG_Ce1%, suggesting the formation of 
microporosity with the increase of Ce amount.  
 
 
 
 
 
 
 
 
 
A B 
Figure 3.48: FE-SEM images of MBG_SG_Ce1% (A) and MBG_SG_Ce2% (B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The structural parameters are reported in Table 3.14. The values of specific 
surface area and the pore volume are slightly bigger in MBG_SG_Ce2% compared 
to the sample with lower amount of cerium. This behaviour can be ascribed to 
the  above mentioned microporosity and the smaller size of MBG_SG_Ce2% 
particles compared to MBG_SG_Ce1% ones, as already found in cerium-
substituted hydroxyapatite nanoparticles [58]. 
 
Table 3.14: Structural features of cerium-containing of MBG_SG 
 
Based on wide-angle XRD spectra of both samples (data not shown), the 
introduction of cerium in two different concentrations did not induce the formation 
of crystalline phases. The characteristic peak of silica-based between 20° and 30° 
(2θ values) was evidenced. 
3.3.1.2b Cerium ion release from cerium-containing MBG_SG samples in Tris 
HCl 
The ionic concentration of Ce3+ species released by both cerium-containing 
MBG nanoparticles is reported in Figure 3.50.  
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_SG_Ce1% 440 4 0.39 
MBG_SG_Ce2% 505 2-6 0.58 
Figure 3.49: N2 adsorption-desorption isotherm of MBG_SG_Ce1% (A) and MBG_SG_Ce2% (B); DFT 
pore size distribution of MBG_SG_Ce1% (C) and MBG_SG_Ce2% (D) 
A B 
D C 
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MBG_SG_Ce1% curve (Figure 3.50A) showed an increase in the released 
amount till 3 days of soaking in Tris HCl, followed by a plateau until the end of the 
test (14 days). On the other hand, the Ce3+ released from MBG_SG_Ce2% (Figure 
3.50B) was almost negligible overtime. This behaviour was already evidenced in 
literature by several authors [59,60] who found that the increase in cerium content 
in different types of bioactive glasses was reflected in an improved chemical 
stability and in a delay in the degradation process. Furthermore, Salinas et al. [10] 
demonstrated that the cerium concentration released in the medium from the 
analysed MBGs was very low, irrespective of the amount of cerium added (up to 
3.5 %mol.). 
 
 
 
 
 
 
 
 
 
 
Figure 3.50: Ce3+ release profiles of MBG_SG_Ce1% (A) and MBG_SG_Ce2% (B) 
3.3.1.2c Bioactive behaviour of cerium-containing MBG_SG samples in SBF 
The bioactive response of cerium-containing samples was tested by soaking 
powders in SBF for different times, up to 14 days. The FE-SEM and EDS 
investigations (data not shown) were not significantly different from those before 
soaking. Moreover, the wide-angle XRD diagrams at 14 days of incubation did not 
present the typical peaks of HA. 
The poor bioactive response was noticed in other cerium-containing glasses 
[59,60] which demonstrated to be covered by crystalline HA only after 30 days of 
soaking in SBF. This behaviour was ascribed to the higher chemical stability due 
to the presence of cerium which resulted in a lower ion exchange ability and 
dissolution degree of the framework.  
 
3.3.1.3 Silver-containing MBG_SG: MBG_SG_Ag0.1% and MBG_SG_Ag2% 
Silver-containing nano-sized particles were produced by water-based sol-gel 
route using ammonia as catalyst, by adding two different amounts of AgNO3 during 
the synthesis reported by Wu et al. [41]. As stated above, silver was selected with 
the aim to impart an antimicrobial effect [46]. The choice of the molar concentration 
(listed in Table 3.15) was due to the known cytotoxicity of silver ions [61]. 
A B 
 
 
Table 3.15: Silver-containing MBG_SG nanoparticles 
 
 
 
 
3.3.1.3a Morphological and structural characterization of silver-containing 
MBG_SG samples  
As evidenced by FE-SEM investigations (Figure 3.51), the perfect rounded 
nano-spheres were not influenced in their morphology by the introduction of 
AgNO3 during the synthesis. By increasing the amount of the substituent, the 
particles became bigger, but always in the range of hundreds of nanometres (around 
150 nm and 100 nm for MBG_SG_Ag0.1% particles and for MBG_SG_Ag2% 
spheres, respectively).  
The EDS spectrum of MBG_SG_Ag0.1% (data not shown) did not present the 
peaks corresponding to the silver element likely for the low amount of silver which 
is below the detection range of the EDS equipment.  
As far as MBG_SG_Ag2% is concerned, the EDS element analysis (data not 
shown) showed the incorporation of silver. 
The textural features of the silver-containing samples were evaluated by N2 
adsorption-desorption measurements. The surface area values, calculated by the 
BET equation, decreased with the increase of the silver amount (Table 3.16), 
confirming previous data found in the literature for different ion substituents [10]. 
In spite this slight decrease, the mesoporous structures were confirmed for both 
samples by the IV type isotherm (Figure 3.52A and B) and the narrow pore size 
distributions centred at 4.2 nm (Figure 3.52C and D). 
 
 
 
 
 
 
Name Composition (%mol) 
MBG_SG_Ag0.1% 85 SiO2/14.9 CaO/0.1 AgO 
MBG_SG_Ag2% 85 SiO2/13 CaO/2 AgO 
A B 
Figure 3.51: FE-SEM images of MBG_SG_Ag0.1% (A) and MBG_SG_Ag2% 
141 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.16: Structural features of silver-containing MBG_SG 
 
 
Wide-angle XRD patterns revealed, besides the broad reflection typical of 
amorphous silica-based systems, several peaks, which, based on reference 01-079-
0149, are referred to silver bromide clusters resulting from the reaction between the 
bromide present in CTAB surfactant and the AgNO3. 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_SG_Ag0.1% 674 4.2 0.6 
MBG_SG_Ag2% 577 4.2 0.6 
A B 
D 
Figure 3.52: N2 adsorption-desorption isotherm of MBG_SG_Ag0.1% (A) and MBG_SG_Ag2% (B); DFT 
pore size distribution of MBG_SG_Ag0.1% (C) and MBG_SG_Ag2% (D) 
C 
 
 
0 2 4 6 8 10 12 14
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
A
g
+
 c
o
n
c
e
n
tr
a
ti
o
n
 (
p
p
m
)
Time (days)
Since in MBG_SG_Ag2% pattern (Figure 3.53B) the AgBr peaks are more 
evident over the amorphous alone respect those in MBG_SG_Ag0.1% 
diffractogram (Figure 3.53A), it is reasonable to state that the silver in 
MBG_SG_Ag2% formed higher amount of crystalline clusters compared to the 
ones in MBG_SG_Ag0.1%. 
 
3.3.1.3b Silver ion release from silver-containing MBG_SG samples in Tris 
HCl 
The silver release of the nanoparticles was assessed in Tris HCl following the 
procedure described in section 2.6.3. 
MBG_SG_Ag0.1% (Figure 3.54A) showed a sharply increase in the silver 
released concentration during the first day of soaking followed by a very slow 
release until the end of the test.  
In Figure 3.54B, the release kinetics of MBG_SG_Ag2% is shown. The profile 
curve evidenced a sustained release of silver ions within 14 days. Furthermore, the 
slope of the curve after 14 days suggested the capability of the nanoparticles to 
release a further amount of silver ions. Similar trend was already found in the 
literature with analogous systems [62]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.54: Silver ion release from MBG_SG_Ag0.1% (A) and from MBG_SG_Ag2% (B)  
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Figure 3.53: Wide-angle XRD spectrum of MBG_SG_Ag0.1% (A) and MBG_SG_Ag2% (B) 
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3.3.2 Morphological and structural characterization of aerosol-
assisted spray-drying nanomatrices  
In this section the results related to micro-sized MBGs produced by an aerosol-
assisted spray-drying approach are reported. As stated in the “Thesis goals” chapter, 
one of the key points of the present work was the optimization of a potentially 
scalable manufacturing approach for MBG preparation. To this aim, a water-based 
spray-drying procedure carried out under mild acidic conditions represents a very 
promising solution due to its scalability and automatisation in an industrial 
environment. Several ion-containing MBGs were synthesized and are listed in 
Table 3.17. Moreover, a mesoporous SiO2-CaO binary glass system without 
substituting ion (as reference sample) was produced by following the procedure 
already reported by Pontiroli et al. [63]. In addition, two mesoporous silica micro-
sized (MSm) particles were produced by following the same procedure, without the 
addition of the calcium precursor.  
 
 
 Table 3.17: List of MBG_SD compositions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2.1 Un-doped MBG_SD: MBG_SD_SiO2/CaO 
Before the ion incorporation, micro-sized particles without ions 
(85SiO2/15CaO, named hereafter MBG_SD_SiO2/CaO) were produced by spray-
drying approach through the replication of the procedure reported in [63]. 
 
Name Composition (%mol) 
MBG_SD_SiO2/CaO 85 SiO2/15 CaO 
MBG_SD_Cu2% 85 SiO2/13 CaO/2 CuO 
MBG_SD_Sr1% 85 SiO2/14 CaO/1 SrO 
MBG_SD_CuSr2% 85 SiO2/13 CaO/1 CuO/1 SrO 
MBG_SD_Ce1% 85 SiO2/14 CaO/1 CeO 
MBG_SD_Ce2% 85 SiO2/13 CaO/2 CeO 
MBG_SD_Ag0.1% 85 SiO2/14.9 CaO/0.1 AgO 
MBG_SD_Ag2% 85 SiO2/13 CaO/2 AgO 
MSm_SD_Ce2%* 98 SiO2/2 CeO 
MSm_SD_Ag2%* 98 SiO2/2 AgO 
 
 
3.3.2.1a Morphological and structural characterization of 
MBG_SD_SiO2/CaO 
The main results of MBG_SD_SiO2/CaO regarding its morphology, 
composition and structural features are summarized in this section. 
The FE-SEM image (Figure 3.55) of MBG_SD_SiO2/CaO showed particles 
with spherical morphology, mostly ranging between 500 nm and 5 µm. The 
chemical composition analysed by EDS (data not shown) confirmed the presence 
of silica and calcium, with a Ca/Si ratio corresponding to the theoretical one.  
 
 
Figure 3.55: FE-SEM image of MBG_SD_SiO2/CaO 
Nitrogen adsorption-desorption measurements on MBG_SD_SiO2/CaO 
revealed the mesoporous structure of the sample. The isotherm reported in Figure 
3.56 is a IV type curve with a hysteresis loop characteristic of mesoporous material 
with regular pores bigger than 4 nm [2]. In Table 3.18 the corresponding textural 
features of the samples are summarized. The BET SSA and pore volume are in fair 
agreement with the similar system [63]. The pore size distribution calculated by 
DFT method and centred at 8 nm is reported as insert in Figure 3.56.  
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Figure 3.56: N2 adsorption-desorption isotherm of MBG_SG_SiO2/CaO and related DFT pore size 
distribution  
 
Table 3.18: Structural features of MBG_SD_SiO2/CaO 
 
The amorphous structure of the MBG_SD_SiO2/CaO glass particles was 
investigated by the wide-angle XRD analysis and the corresponding spectrum is 
depicted in Figure 3.57. As expected, the only visible broad peak between 20° and 
30° corresponded to the amorphous structure of the sample. 
 
Figure 3.57: Wide-angle XRD analysis of MBG_SD_SiO2/CaO 
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3.3.2.1b Bioactive behaviour of MBG_SD_SiO2/CaO in SBF 
The bioactive response of micro-sized MBG_SD_SiO2/CaO was studied by 
soaking the particles in SBF by following the procedure described in section 2.7. 
The formation of hydroxyapatite started after 1 day of soaking. With the 
increase of incubation time, the micro-sized particles became fully covered by a 
rough layer reminiscent of hydroxyapatite formation. In Figure 3.58A, the FE-SEM 
characterization performed on particles after 7 days of soaking showed a layer of 
cauliflower formations. The presence of HA was also confirmed by EDS analysis 
(Figure 3.58B) which showed the P peak and a Ca/P ratio very close to the 
theoretical one (1.67) after 3 days of soaking. The wide-angle XRD spectrum (data 
not reported) further demonstrated the formation of hydroxyapatite with the 
corresponding major peak at 32°, confirming the already noticed high bioactive 
response of these types of systems [63]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2.2 Copper-containing MBG_SD: MBG_SD_Cu2% 
The first ion chosen for the incorporation into the calcium silicate MBG micro-
particles was copper, due to its recognised therapeutic effect [7].  
Figure 3.58: FE-SEM (A) and EDS spectrum (B) of MBG_SD_SiO2/CaO after 7 days of soaking in SBF 
A 
B 
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The copper-containing micro-sized particles (85SiO2/13CaO/2CuO %mol, 
named hereafter MBG_SD_Cu2%) were produced by modifying the procedure 
reported by Pontiroli et al. [63]. 
Part of the work described in this chapter has been previously published in [32]. 
 
3.3.2.2a Morphological and structural characterization of MBG_SD_Cu2% 
As shown in Figure 3.59A, the sample consisted of microspheres with size 
mostly in the range of 1–5 μm, showing silicon (yellow), calcium (green) and 
copper (light blue) homogeneously distributed into the framework, as revealed by 
the compositional mapping EDS analysis carried out on a single sphere (Figure 
3.59B). EDS spectrum (Figure 3.59C) of the powder supported on the carbon-based 
tape revealed the incorporation of copper with a molar concentration very close to 
the nominal ratio. 
 
 
Figure 3.59:  FE-SEM image of MBG_ SD_Cu2% (A), EDS mapping analysis of MBG_ SD_Cu2% 
single particle (B), EDS spectrum of MBG_ SD_Cu2% (C) 
Based on wide-angle XRD spectrum (Figure 3.60), copper did not form 
segregated oxide clusters after calcination treatment, as assessed by the absence of 
crystalline oxide-based phases.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mesoporous structure was confirmed by N2 adsorption-desorption 
measurement. The isotherm of the sample obtained by aerosol-assisted procedure 
also confirmed its mesoporous structure. The isotherm (Figure 3.61) is a IV type 
curve, with H1 hysteresis loop, typical of mesoporous material with pores larger 
than 4 nm [2]. The pore size distribution showed multi-sized pores with broad 
distribution, ranging between 8 and 11 nm (inset in Figure 3.61). The BET SSA of 
MBG_SD_Cu2% of 226 m2/g, although lower than the one shown by 
MBG_SG_Cu 2% (Table 3.13), is still very high compared to values typical of not-
templated sol-gel glasses (few m2/g), which confers a high reactivity to MBGs in 
the biological environment [64]. 
 
 
 
Figure 3.61: N2 adsorption-desorption isotherm of MBG_SD_Cu2% and related DFT pore size 
distribution (inset) 
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Figure 3.60: Wide-angle XRD analysis of MBG_SD_Cu2% 
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Table 3.19: Structural features of MBG_SD_Cu2% 
 
3.3.2.2b Copper ion release from MBG_SD_Cu2% in Tris HCl 
The Cu2+ release profile from MBG_ SD_Cu2% particles (Figure 3.62), 
assessed in Tris HCl, showed a burst effect in the first 3 h, followed by a sustained 
release of copper ions overtime. The observed release kinetics suggested that the 
diffusion of Cu2+ out of the mesopores is probably hindered or even blocked after 
the first hours (2–3 h) of incubation. A similar release profile has been already 
observed from silica-based mesoporous spheres [34] and was ascribed to the 
progressive occlusion of mesopores due to the dissolution of the silica framework 
and its reprecipitation as silica gel at the pore mouth [65,66]. The final 
concentration of released copper species from MBG_SD_Cu2% was about 2.5 
ppm, and corresponded to approximately the 60% of incorporated copper, 
suggesting the presence of a residual amount of copper into the MBG framework 
or re-precipitation phenomena.  
It is also worth mentioning that, since MBG_SD_Cu 2% particles are produced 
by an aerosol-assisted spray-drying process, where a rapid evaporation of the 
solvent takes place, the resulting powder is expected to show a less condensed 
framework compared to MBG_SG samples and thus much higher reactivity toward 
surface dissolution/re-precipitation reactions. This major tendency to the re-
precipitation phenomena could explain the difference between MBG_SD_Cu2% 
and MBG_SG_Cu2% ion release property: as described in section 3.3.1.1b, the 
final released concentration of MBG_SG_Cu2% (4.7 ppm) was almost twice 
compared the final concentration of MBG_SD_Cu2%. 
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Figure 3.62: Cu2+ release curve of MBG_SD_Cu2% in Tris HCl 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_SD_Cu2% 226 8-11 0.24 
 
 
3.3.2.2c Bioactive behaviour of MBG_SD_Cu2% in SBF 
The remarkable bioactivity of MBG_SD_Cu2% when soaked in SBF was 
clearly revealed by FE-SEM observations (Figure 3.63). After only 1 day of 
soaking, the particles started to be covered by a rough layer of globular 
agglomerates of Ca-deficient HA phase (Ca/P=1.51), as shown by EDS analysis 
(data not shown). After 14 days, MBG particles were almost fully covered by a 
compact layer of needle-like nanocrystals, composed by calcium and phosphorus. 
Figure 3.63 shows MBG_SD_Cu2% after soaking for 14 days. EDS analysis 
performed on powders evidenced a Ca/P ratio of 1.7, typical of HA [5,6].  
 
Figure 3.63: FE-SEM of MBG_SD_Cu 2% after 14 day of soaking in SBF (A) and high magnification of 
A image (B) 
Wide-angle XRD analysis performed on the MBG particles after the bioactivity test 
confirmed the formation of crystalline HA (Figure 3.64): marked peaks appeared at 
25.87° and 31.73° (2θ value) and other less intense reflections at 49.39 ° and 53.17° 
(2θ value) matched by hydroxyapatite reference (01-089-6440). 
Figure 3.64: Wide-angle XRD analysis of MBG_SD_Cu2% 
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3.3.2.3 Strontium-containing MBG_SD: MBG_SD_Sr1% 
In order to obtain advanced devices for bone healing application, strontium  was 
incorporated into the micro-sized MBG particles, due to its ability to impart pro-
osteogenic effect, through osteoblast stimulation and osteoclast inhibition [28].  
The results of the Sr-modified MBGs (85SiO2/14CaO/1SrO %mol, named 
hereafter MBG_SD_Sr1%) will be useful for interpreting those of the double-ion 
(strontium and copper) containing system (see following section 3.3.2.4). 
Part of the work described in this chapter has been previously published in [29]. 
 
3.3.2.3a Morphological and structural characterization of MBG_SD_Sr1% 
Figure 3.65 shows a representative FE-SEM image of the MBG_SD_Sr1% 
particles which were spherically shaped with size ranging from 0.4 to 5 µm. The 
morphological features of sprayed MBG_SD_Sr1% powders were comparable to 
those obtained for samples produced by similar approach [63,67], thereby 
confirming the high reproducibility and versatility of this method.  
As previously discussed, the EDS analysis (inset in Figure 3.65) of 
MBG_SD_Sr1% revealed a lower value of Sr/Si ratio (0.85 mol%) compared to the 
nominal one (1.18 mol%), suggesting that strontium precursor is only partially 
incorporated within the glass network. 
 
Figure 3.65:FE-SEM image of MBG_SD_Sr1% and related EDS spectrum 
Since the detection of strontium through EDS could be unreliable because of 
the overlapping of Si and Sr peaks, MBG_SD_Sr1% was also analysed through 
XRF spectroscopy which confirmed the partial incorporation of strontium (Sr/Si = 
0.77 mol%). As stated above, this discrepancy may be likely due to the larger ionic 
radius of strontium (1.16 Å) compared to calcium (0.94 Å) [39], which can limit its 
incorporation into the network during silica polymerization. Furthermore, the larger 
ionic radius of Sr2+ implies a lower charge-to-size ratio compared to Ca2+, with 
consequent less effective ionic interactions with the oxygen atoms of the network 
 
 
[39]. Compositional mapping obtained with EDS technique revealed that all the 
elements were uniformly distributed in the powder (Figure 3.66): the colour maps 
of a particle, in fact, show homogeneous intensities for silicon (yellow), calcium 
(blue) and strontium (red).  
 
 
Figure 3.66: Elemental mapping of MBG_SD_Sr1% particle: SEM image of the analysis area (A), and 
distribution of silicon (B), calcium (C) and strontium (D) 
Nitrogen adsorption-desorption measurements confirmed the mesoporous 
structure of the spray-dried material: a IV type isotherm with H1 hysteresis loop, 
typical of mesoporous materials with pores larger than 4 nm, is shown in Figure 
3.67 [2]. The pore size distribution obtained through the DFT method (inset in 
Figure 3.67) confirmed that the pore size of MBG_SD_Sr1% ranged between 4 and 
10 nm. The SSA calculated through the BET method was 152.9 m2/g (Table 3.20), 
a very high value which conferred high reactivity to MBGs in the biological 
environment [64].  
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Figure 3.67: N2 adsorption-desorption isotherm of MBG_SD_Sr1% and related DFT pore size 
distribution (inset) 
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Table 3.20: Structural features of MBG_SD_Sr1% 
Name Specific surface area (m2/g) Pore size (nm) Volume (cm3/g) 
MBG_SD_Sr1% 153 5.5 0.25 
 
3.3.2.3b Strontium ion release from MBG_SD_Sr1% in SBF 
Strontium release profile from MBG_SD_Sr1% was assessed by soaking the 
powders in SBF (Figure 3.68). The curve revealed a burst release of Sr ions after 
the first 3 h of soaking, consisting of about the 80% of the strontium released during 
the whole test. The fast release kinetics suggested high accessibility and availability 
to ion exchange reactions of Sr2+ species throughout the framework.  After 3 h, the 
release reached a plateau, settling on the final concentration of 11 µg/mL, value 
that, according to the literature data [28], allows cell survival and could stimulate 
the biological response of pre-osteoblastic cells. In order to assess the amount of 
non-released strontium after 14 days of soaking in SBF, ICP analysis was 
performed on the sample after its complete dissolution in acidic environment. The 
analysis revealed the presence of 0.3 wt% of residual strontium and, based on the 
measured initial strontium content (ca 1 wt%), the overall released percentage was 
approximately 70%.  
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Figure 3.68: Sr2+ release curve of MBG_SD_Sr1% in SBF 
3.3.2.3c Bioactive behaviour of MBG_SD_Sr1% in SBF 
The peculiar characteristic of MBGs is their ability to quickly form a surface 
apatite layer as a result of a series of ionic exchanges with body fluids, where the 
ion calcium plays a crucial role. In this regard, the substitution of calcium with 
strontium in the glass composition did not alter the fast bioactive behaviour of 
MBGs. In fact, the bioactivity test revealed the presence of numerous calcium 
phosphate deposits on the surface of Sr-containing powder just after 1 day of 
immersion in SBF (Figure 3.69A). After 1 week, these deposits covered completely 
the particles and had the typical ‘‘cauliflower’’ morphology of nano-crystalline HA 
(Figure 3.69B). Phosphorous peaks appeared in the EDS spectrum of the sample 
 
 
after 7 days of immersion in SBF (data not shown): since P was not present in the 
original composition of MBG_SD_Sr1%, its detection could be attributed to the 
formation of a new phase, i.e. HA. The Ca/P atomic ratio of this newly formed 
phase, extrapolated from EDS data, was in good accordance with the stoichiometric 
value of hydroxyapatite (1.67) [5,6].  
 
 
 
 
 
 
 
 
 
 
 
XRD analysis performed on the MBG powder after the bioactivity test (Figure 
3.70) further confirmed the formation of crystalline HA: new peaks appeared at 
25.68, 31.99, 39.85, 46.53 and 49.36 2θ degrees and were matched by 
hydroxyapatite reference (00- 001-1008). During the test, the pH of SBF remained 
always below 7.8, which is considered the threshold value for allowing osteoblasts 
to maintain their physiological activity [68]. The pronounced bioactive behaviour 
of these mesoporous glasses, despite their high silica content (85 mol%), was the 
result of their large SSA (above 150 m2/g) which increases their reactivity in the 
body fluid. The fast deposition of the HA crystals, which can obstruct the entrance 
of the pores, can account for the incomplete release of the strontium ions, as 
evidenced for other previously described samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.70: Wide-angle XRD analysis of MBG_SD_Sr1% after 7 days of soaking in SBF 
 
B A 
Figure 3.69: FE-SEM images of MBG_SD_Sr1% after 1 day (A) and 7 days (B) of soaking in SBF 
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3.3.2.4 Strontium-copper co-containing MBG_SD: MBG_SD_CuSr2% 
With the aim to obtain multifunctional biomaterials combining the ability to 
promote bone formation and angiogenesis and to impart an antibacterial effect, 
double-ion co-substituted mesoporous bioactive micro-particles were obtained by 
incorporating strontium and copper ions. The co-modified system, produced by 
aerosol-assisted spray-drying approach, was called MBG_SD_CuSr2% 
(85SiO2/13CaO/1SrO/1CuO %mol). 
Part of the work described in this chapter has been previously published in [33]. 
3.3.2.4a Morphological and structural characterization of MBG_SD_CuSr2% 
The Sr-Cu co-containing micro-sized particles were investigated in their 
morphology, composition and structural properties. 
MBG_SD_CuSr2% showed spherical particles ranging between 500 nm and 5 
µm, as depicted in Figure 3.71. The EDS spectrum (inset in Figure 3.71) revealed 
that the incorporation occurred for both ions. Since the EDS analysis was 
considered unreliable to know the exact concentration of Sr2+ ions, as already 
pointed out for all the Sr-containing systems, the incorporated ion concentration 
was analysed by ICP after dissolution in acidic environment (as described in section 
2.5.2). The detected ion content corresponded to 95% and 70% for the copper and 
strontium ion, respectively. Hence, as previously noticed, the incomplete 
incorporation of strontium could be ascribed to the electronic properties of the 
strontium [30,39]. 
 
 
Figure 3.71: FE-SEM image of MBG_SD_CuSr2% with related EDS spectrum (inset) 
N2 adsorption-desorption measurements showed IV type isotherm (Figure 3.72) 
which confirmed the mesoporous structure of the sample. The presence of H1 
hysteresis loop is ascribable to the filling of ordered mesopores with diameter 
bigger than 4 nm. The inset in Figure 3.72 revealed a single-mode pore size 
distribution with an average pore diameter of 5 nm.  
 
 
As already noticed for MBG_US_m_CuSr2% sample, the obtained results 
evidenced that the incorporation of two types of ions did not significantly affect the 
formation of an ordered structure and the textural features (Table 3.21) of the final 
powder resulted only slightly different from Sr- or Cu-containing MBGs [8,29]. 
 
 
Figure 3.72: N2 adsorption-desorption isotherm of MBG_SD_CuSr2% and related DFT pore size 
distribution (inset) 
 
Table 3.21: Structural features of MBG_SD_CuSr2% 
 
3.3.2.4b Strontium and copper ion release from MBG_SD_CuSr2% in SBF 
The ion release capability of MBG_SD_CuSr2% was assessed by soaking the 
sample in SBF up to 14 days. 
The incorporated Cu2+ and Sr2+ were successfully co-released by the micro-
sized MBG particles (Figure 3.73). A burst release within the first hours was 
observed for both Cu2+ and Sr2+ ions which reached 6 and 11 ppm, respectively. 
Then a slower increase in the released concentration (9 and 13 ppm for Cu2+ and 
Sr2+ ions, respectively) was shown. After 3 days of incubation, the trend of the curve 
suggested that the precipitation of a HA layer could partially hamper further ion 
release. The higher release of Sr2+ compared to Cu2+ suggests a higher accessibility 
and ion-exchange ability of Sr2+ within the MBG framework compared to the 
incorporated copper species, most likely due to its similarity with calcium as 
network modifier [28]. 
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Figure 3.73: Ion release curve of MBG_SD_CuSr2% 
 
3.3.2.4c Bioactive behaviour of MBG_SD_CuSr2% in SBF  
In vitro bioactivity assessment highlighted that partial replacing of Ca with Cu 
and Sr ions did not significantly hinder the hydroxyapatite nucleation and 
deposition. After 1 day of soaking, the Ca/P ratio revealed by EDS analysis was 
1.63. After 7 days of soaking in SBF the particles were fully covered by a layer of 
needle-like crystals (Figure 3.74) and the Ca/P ratio was in good accordance to the 
stoichiometric value of hydroxyapatite (1.67) [5,6].  
 
 
Figure 3.74: MBG_SD_CuSr2% after 7 days of soaking in SBF with EDS spectrum (inset). 
 
 
The formation of HA layer was confirmed by wide-angle XRD analysis (Figure 
3.75). The diffractogram in Figure 3.75B revealed the presence of new peaks which 
were matched by crystalline hydroxyapatite (external reference 00- 001-1008), not 
detected in the wide-angle XRD pattern performed on MBG_SD_CuSr2% before 
soaking (Figure 3.75A). 
Figure 3.75: MBG_SD_CuSr2% before soaking in SBF (A) and MBG_SD_CuSr2% after 7 days of 
soaking in SBF (B)  
 
3.3.2.5 Cerium-containing MBG_SD: MBG_SD_Ce1% and MBG_SD_Ce2% 
Aerosol-assisted spray-drying procedure was adopted in order to produce 
cerium-containing micro-sized particles in the following molar concentrations: 
85SiO2/14CaO/1CeO %mol (named hereafter MBG_SD_Ce1%) and 
85SiO2/13CaO/2CeO %mol (called MBG_SD_Ce2%). 
Cerium was selected as therapeutic ion due to its osteoconductive and 
antibacterial properties [57]. 
3.3.2.5a Morphological and structural characterization of cerium-containing 
MBG_SD 
The two different compositions of cerium-containing micro-sized samples were 
fully characterized in order to investigate the influence of the substituent ion. 
The FE-SEM images (Figure 3.76) revealed spherical particles with size 
ranging between 500 nm and 4 µm, in analogy with results found in the literature 
[30]. The FE-SEM characterization demonstrated that the presence of the double 
amount of cerium ion did not affect significantly the morphology of the samples.   
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The average of three measurements obtained by EDS investigation confirmed 
the presence of the cerium ion with Ce/Si ratio in fair agreement with the theoretical 
ratio. Moreover, it was possible to observe a uniform distribution of the substituent 
into the silica framework. These data demonstrated that the substitution of cerium 
for calcium did not affect the ion incorporation process. 
Both samples showed a IV type isotherm with a H1 hysteresis loop ranging 
between 0.4 and 0.8 p/p0 (Figure 3.77A and B) indicating the presence of cylindrical 
pores [2]. The pore size distributions obtained through DFT method are reported in 
Figure 3.77C and Figure 3.77D for MBG_SD_Ce1% and MBG_SD_Ce2%, 
respectively. As visible, both samples showed two families of mesopores, the first 
around 2 nm and the second around 8 nm. Considering the use of P123 as surfactant, 
the first family could be due to the presence of microporosity in the silica 
framework. According to Arcos et al. [69], in fact, P123-templated systems are 
usually characterized by pore size around 8 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B A 
B A 
D 
Figure 3.76: FE-SEM image of MBG_SD_Ce1% (A) and MBG_SD_Ce2% (B) 
Figure 3.77: N2 adsorption-desorption isotherm of MBG_SD_Ce1% (A) and MBG_SD_Ce2% (B); DFT 
pore size distribution of MBG_SD_Ce1% (C) and MBG_SD_Ce2% (D) 
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In Table 3.22, the textural parameters of the cerium-containing micro-particles 
are listed. As expected, the specific surface area values and pore volume decreased 
as the cerium content increased. The same evidence is reported in the literature both 
in cerium-doped system as well as in other metallic ion-doped matrices [10,30]. 
Table 3.22: Structural features of cerium-containing of MBG_SD 
 
Based on wide-angle XRD analysis (data not shown), the absence of peaks 
confirmed that the incorporated cerium did not form any crystalline phases.  
 
3.3.2.5b Cerium ion release from MBG_SD_Ce1% and from MBG_SD_Ce2% 
in Tris HCl 
The cerium release profile in Tris HCl of both samples is reported in Figure 
3.78. As expected, the released amount of Ce3+ is dependent on cerium 
concentration: higher cerium substitution resulted in higher released concentration 
in Tris HCl. Both cerium-containing samples showed an increasing trend up to a 
maximum settled at 0.33 ppm for MBG_SD_Ce1% and 1.21 ppm for 
MBG_SD_Ce2%. Then both curves presented a decreasing trend. It stands to 
reason that the curve of MBG_SD_Ce2% has the same trend of MBG_SD_Ce1%, 
only slightly delayed. As already evidenced in 3.3.1.2b, an improved chemical 
stability and a delay in the degradation process was found with the increase in 
cerium content in different types of bioactive glasses [59,60]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.78: Ce3+ release profiles of MBG_SD_Ce1% (A) and MBG_SD_Ce2% (B) 
 
Name Specific surface area 
(m2/g) 
Pore size (nm) Volume 
(cm3/g) 
MBG_SD_Ce1% 187 ~ 2 nm 
~ 8 nm 
0.21 
MBG_SD_Ce2% 77 ~ 2 nm 
~ 8 nm 
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3.3.2.5c Bioactive behaviour of cerium-containing MBG_SD samples in SBF 
Considering the MBG_SD_Ce2% more promising than the MBG_SD_Ce1% 
in terms of cerium release property (Figure 3.78) and assuming that the ion 
exchange capability of MBG_SD_Ce2% was better than MBG_SD_Ce1%, the 
bioactivity test was uniquely performed with MBG_SD_Ce2% sample. 
Based on wide-angle XRD investigation, the formation of crystalline HA phase 
was particularly discernible after 14 days of soaking (Figure 3.79) highlighting the 
bioactive behaviour of the cerium-containing micro-sized sample. 
Compared to MBG_SD particles (see section 3.3.2.1b), however, the 
MBG_SD_Ce2% showed a delay in the deposition of HA. As already evidenced in 
cerium-containing nano-sized particles (see section 3.3.1.2) and in other works 
[59,60], the presence of cerium slowed down the ion release kinetics and exchange 
of the MBG systems. At variance with cerium-containing nano-sized particles 
whose bioactive response was negligible after 14 days of soaking, the formation of 
HA layer in micro-sized MBG particles was due to the different synthesis process 
which, as asserted before, resulted in a less polymerized silica framework. 
 
Figure 3.79: Wide-angle XRD analysis of MBG_SD_Ce2% after 14 days of soaking in SBF 
 
3.3.2.6 Silver-containing MBG_SD: MBG_SD_Ag0.1% and MBG_SD_Ag2% 
Silver-containing materials were considered due to the well-known 
antibacterial effect of silver [20,70]. In order to synthesize Ag-modified micro-
sized particles, spray-drying route was used and CaNO3 was partially substituted 
with two different concentrations of AgNO3. In details, the as-synthesized samples 
are the following: MBG_SD_Ag0.1%, with the 85SiO2/14.9CaO/0.1AgO %mol 
and MBG_SD_Ag2%, with the 85SiO2/13CaO/2AgO %mol. 
 
 
3.3.2.6a Morphological and structural characterization of silver-containing 
MBG_SD samples 
MBG_SD_Ag0.1% and MBG_SD_Ag2% were studied in their morphology, 
composition and structural properties. 
The morphological characterization in Figure 3.80 showed the spherical 
particles with size ranging between 300 nm and 5 µm, confirming the potentiality 
of the nanomatrices to incorporate silver ions without affecting the morphology.  
 
The EDS technique, used to obtain compositional information, was not useful 
for the 0.1%mol-containing silver because of the too low concentration of the 
element. Based on the EDS analysis of MBG_SD_Ag2%, calculated as average of 
three measurements, the distribution of silver resulted not homogeneous.  
MBG_SD_Ag0.1% isotherm (Figure 3.81A) evidenced the mesoporous 
structure of the sample with a IV type isotherm and a H1 hysteresis loop. The IV 
type curve of MBG_SD_Ag2% in Figure 3.81B confirmed the mesoporosity and 
its H3 hysteresis loop, according to IUPAC classification [2], is associated to slit-
shaped pores.  
The pore size distribution obtained through DFT method is reported in Figure 
3.81C and 3.81D. Both samples showed not uniform pore size distribution. Most of 
the pores are characterized by dimension in the range of 11-12 nm. The other 
relevant peak centred around 3 nm could be associated to the internal voids of 
particle aggregates. 
 
 
 
 
 
 
 
 
 
 
Figure 3.80: FE-SEM images of MBG_SD_Ag0.1% (A) and MBG_SD_Ag2% (B) 
A B 
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The structural features of Ag-substituted MBG_SD are listed in Table 3.23. The 
specific surface area and pore volume values decreased by increasing the silver 
amount, as already observed with other ion-containing mesoporous materials [10]. 
Besides, the disordered mesoporous structure revealed by the isotherm of 
MBG_SD_Ag2% is reflected also in these values which were quite low if compared 
with analogous ion-containing systems [29,30,32,33]. 
 
Table 3.23: Structural features of silver-containing MBG_SD 
 
In order to investigate the formation of crystalline phases due to the presence 
of silver, both samples were analysed by wide-angle XRD. The patterns depicted 
in Figure 3.82 showed a peak ascribed to silver oxide (external reference code 00-
065-3289) over the amorphous alone. 
 
 
 
 
 
 
Name Specific surface area 
(m2/g) 
Pore size 
(nm) 
Volume 
(cm3/g) 
MBG_SD_Ag0.1% 211 10.6 0.45 
MBG_SD_Ag2% 99 10-12 0.27 
A B 
C 
Figure 3.81: N2 adsorption-desorption isotherm of MBG_SD_Ag0.1% (A) and MBG_SD_Ag2% (B); DFT pore 
size distribution of MBG_SD_Ag0.1% (C) and MBG_SD_Ag2% (D) 
D 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2.6b Silver ion release from MBG_SD_Ag0.1% and MBG_SD_Ag2% in 
Tris HCl 
Silver ion release from MBG_SD_Ag0.1% and from MBG_SD_Ag2% was 
assessed by soaking the samples in Tris HCl for different time points, up to 14 days. 
For what concerns the MBG_SD_Ag0.1% (Figure 3.83A), silver released 
concentration reached a plateau after 3 days of soaking and remained at 1.3 ppm 
overtime. As expected, the higher substituent concentration led to a higher amount 
of released ion concentration in the medium. The MBG_SD_Ag2%, in fact, 
released 7.53 ppm after 14 days of soaking. Furthermore, the ascending trend of the 
curve suggested the presence of residual amount of silver which could be still 
released. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.83: Ag+ release profiles of MBG_SD_Ag0.1% (A) and MBG_SD_Ag2% (B) 
3.3.2.7 Cerium-containing silica SD: MSm_SD_Ce2%* 
In view of the potential use in wound healing application where the bioactive 
response, mainly associated to calcium ions, is not a required property, cerium-
containing silica in form of micro-particles were produced by spray-drying assisted 
sol-gel route. In particular, MSm_SD_Ce2%* (98SiO2/2CeO) was obtained by 
removing calcium precursor and adding cerium precursor in the aerosol-assisted 
spray-drying approach [63]. 
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Figure 3.82: Wide-angle XRD spectra of MBG_SD_Ag0.1% (A) and MBG_SD_Ag2% (B) 
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Figure 3.85: EDS spectrum of MSm_SD_Ce2%* 
3.3.2.7a Morphological and structural characterization of MSm_SD_Ce2%* 
MSm_SD_Ce2% particles showed a morphology very close to the other spray-
drying MBG samples, with diameters ranging from 500 nm to 5 µm (Figure 3.84). 
 
Figure 3.84: FE-SEM image of MSm_SD_Ce2%* 
The detected Ce/Si ratio obtained through EDS analysis (Figure 3.85) and 
calculated as average of three measurements confirmed the incorporation of cerium 
ions in a ratio very close to the theoretical one. The chromium peak was ascribed 
to the layer used to make conductive the sample for the analysis. 
 
 
 
 
 
 
 
 
Graphs in Figure 3.86 depict the adsorption-desorption isotherm and the related 
DFT pore size distribution. The H1 large hysteresis loop between 0.4-0.9 p/p0 
observed in the IV type isotherm meant a mesoporous material with uniform pores 
larger than 4 nm, according to IUPAC classification [2]. 
The structural features listed in Table 3.24 highlight that the incorporation of 
cerium into silica framework did not interfere with the formation of an ordered 
structure which exhibited an excellent surface area value.  
Element Atomic % 
O 71.38 
Si 28.04 
Ce 0.58 
Total: 100.00 
 
 
 
Figure 3.86: N2 adsorption-desorption isotherm of MSm_SD_Ce2%* and related DFT pore size 
distribution (inset) 
 
Table 3.24: Structural features of MSm_SD_Ce2%* 
 
In order to identify the oxidic phases formed by cerium, diffuse reflectance UV-
vis spectroscopy was performed on the powder. The spectrum in Figure 3.87 shows 
the absence of peaks in the visible region characteristic of ceria in +4 oxidation state 
[71], thus excluding the presence of cerium in the oxidic phase.  
 
 
Figure 3.87: Diffuse reflectance UV–vis spectrum of MSm_SD_Ce2%* 
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In order to further exclude the formation of cerium oxidic phases, wide-angle 
XRD investigation was carried out and the pattern is depicted in Figure 3.88. The 
absence of relevant sharp peak characterized by high intensity confirmed the 
amorphous nature of the silica mesoporous micro-particles, with its characteristic 
broad peak between 20° and 30°. 
3.3.2.7b Cerium ion release from MSm_SD_Ce2%* in DMEM 
Cerium release profile from mesoporous silica micro-particles in DMEM 
further confirmed the observations about the use of DMEM and about cerium ion 
reported previously in this chapter. 
In details, the release kinetics is shown in Figure 3.89. In spite of the increasing 
trend of the curve, the ion released concentration, reached after 14 days of soaking, 
was 0.0025 ppm. The Ce3+ release properties still represent an open issue in the 
literature. Guangjian et al. [72] found some evidences about the formation of 
hydrogen bonds between hydrated Ce3+ and -OH on the surface of zirconium 
phosphate. Hence, it is reasonable to assume that the formation of bonds between 
the silica surface and cerium, in combination with the already observed negative 
influence of DMEM medium hampered the Ce3+ ion release from the cerium-
containing micro-particles. 
 
Figure 3.88: Wide-angle XRD spectrum of MSm_SD_Ce2%* 
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Figure 3.89: Ce3+ release profile of MSm_SD_Ce2%* in DMEM 
 
3.3.2.8 Silver-containing silica SD: MSm_SD_Ag2%* 
To the same purpose of MSm_SD_Ce2%*, Ag-substituted mesoporous silica 
micro-sized particles (98SiO2/2AgO, named hereafter MSm_SD_Ag2%*) were 
synthesized by spray-drying approach in order to produce an agent for non-healing 
wound infected by bacteria [48].  
3.3.2.8a Morphological and structural characterization of MSm_SD_Ag2%* 
The morphology of the sample was not affected by both the addition of the 
substituent and the removal of calcium during the synthesis. The spherical particles 
shown in Figure 3.90 were in the range of 500 nm-5 µm. 
Furthermore, the EDS investigation (Figure 3.91) revealed the silver 
incorporation with a molar ratio very close to the theoretical one.  
 
Figure 3.90: FE-SEM image of MSm_SD_Ag2%* 
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N2 adsorption-desorption measurements were used to identify the presence of 
an ordered mesoporous structure. As shown in Figure 3.92, a IV type isotherm was 
observed for this sample. Furthermore, the H1 hysteresis loop is discernible and is 
linked to the presence of pore larger than 4 nm. A further confirmation to this was 
given by the pore size distribution obtained through DFT method (inset in Figure 
3.92), which showed a single-mode pore diameter curve of about 7.4 nm. 
 
 
Figure 3.92: N2 adsorption-desorption isotherm of MSm_SD_Ag2%* and related DFT pore size 
distribution (inset)  
 
The structural parameters obtained through this technique are listed in Table 
3.25. The specific surface area value calculated through the BET model was smaller 
compared to the un-doped mesoporous silica systems [73], as expected. In addition, 
this value is rather low, if compared to SiO2-CaO matrices containing metallic ion 
and synthesized by aerosol-assisted spray-drying route [30,32,33]. 
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Figure 3.91: EDS spectrum of MSm_SD_Ag2%* and related element atomic % 
 
 
Table 3.25: Structural features of MSm_SD_Ag2%* 
 
As already done for the Ag-containing mesoporous silica nano-sized particles 
(see paragraph 3.2.2.2a), the UV-visible technique was used in order to investigate 
the formation of oxidic phases within the silica framework. Figure 3.93 displayed 
the diffuse reflectance UV–vis spectrum of MSm_SD_Ag2%*. The broad peak in 
the visible band (around 420 nm) was assigned to the surface plasmon resonance of 
silver metallic particles. A first evidence of the presence of silver in oxide form 
could be derived from the colour of the powder after calcination, which showed 
slightly grey colour. The same correlation and observation were previously reported 
by others [48]. 
 
Figure 3.93: Diffuse reflectance UV–vis spectrum of MSm_SD_Ag2%* 
 
The presence of several peaks in the wide-angle XRD pattern (Figure 3.94) 
suggested the formation of segregated oxidic phase, which matched by the 
crystalline form of silver silicate (external reference 01-076-0385). 
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Figure 3.94: Wide-angle XRD spectrum of MSm_SD_Ag2%* 
 
3.3.2.8b Silver ion release from MSm_SD_Ag2%* in DMEM 
The release curve (Figure 3.95) reached the maximum (1.4 ppm) after 1 day of 
soaking, followed by a decreasing trend till the end of the test. As highlighted 
previously in this chapter and observed in the literature, this behaviour could be 
ascribed to the DMEM which may interact with the materials and hinder the ion 
exchange and the bioactive response more widely than SBF or PBS [9,43]. 
Furthermore, the decreasing release rate observed after the first day of soaking can 
be tentatively linked to the formation of AgCl insoluble salt due to the reaction of 
Ag+ released from the micro-particles and the chloride present in DMEM solution 
[51]. 
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Figure 3.95: Ag+ release profile of MSm_SD_Ag2%* in DMEM 
3.4 Final considerations  
Several compositions of both micro- and nano-sized particles were successfully 
produced by aerosol-assisted spray-drying method and base-catalysed water-based 
 
 
sol-gel route, respectively. These two complementary approaches allowed to 
produce a wide and versatile library of nanomatrices with different morphology, 
size, structural features and ion release kinetics in order to develop systems for 
tissue applications.  
As far as morphology is concerned, the base-catalysed water-based sol-gel 
route allowed to obtain particles with quite uniform size ranging between 100 and 
200 nm, with a spheroidal shape and slightly aggregated. The spray-drying route, 
instead, produced spherical, well dispersed particles with size mostly ranging 
between 500 nm and 5µm.  
Both types of synthesis procedure enabled the formation of mesoporous 
structure with pores of about 4 nm for CTAB-templated system (MBG_SG 
samples) and around 8 nm for P123-templated nanomatrices (MBG_SD samples). 
The related specific surface area and pore volume, especially for MBG_SG 
samples, were higher compared to the not-templated conventional sol-gel glasses 
[74] and in line with similar ion-containing MBG particles [30,75]. 
The ion incorporation inside the silica framework was assessed in all 
nanomatrices. As a general trend, based on the compositional analysis, the ion 
incorporation yield was superior for spray-dried samples and might be attributed to 
the very fast kinetics of the process, which forces the incorporation of the ions into 
the silica framework during its polymerization. 
Based on the obtained results, the ion release property of the nanomatrices was 
influenced more by the chemical composition (i.e. type of ion) rather than the 
synthesis approach.  
In particular, the cerium-containing samples in both concentrations and 
produced by both synthesis approaches demonstrated a very low amount of released 
ion, confirming previous results reported in the literature [10]. The reason could be 
ascribed to the formation of stronger chemical bonds between Ce3+ and siloxanes 
present on the glass surface which slow down the cerium release kinetics. The same 
result was previously obtained by others [59,60] who found an improved chemical 
stability and a delay in the degradation process with the increase of cerium content 
in several bioactive glass compositions. 
As far as the bioactive response is concerned, both MBG_SG and MBG_SD 
samples showed a good reactivity after soaking in SBF and they started to be 
covered by a rough layer composed by structures which resembled hydroxyapatite. 
The bioactivity test confirmed that the incorporation of different metallic ion did 
not hamper the ion exchange with the SBF which led to the deposition of the CaP 
formation, except for cerium-containing systems which showed very low bioactive 
response. 
As a general conclusion, Cu-containing nanomatrices were evaluated as the 
most promising agents in terms of reproducibility for the potential applications in 
the tissue regeneration field.  
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CHAPTER 4 
Antibacterial tests of ion-
substituted nano- and micro-sized 
MBGs  
4.1 Introduction 
The nano- and micro-sized, referred as MBG_SG and MBG_SD, respectively, 
containing ions with recognized antibacterial property (copper, cerium and silver) 
were also tested through antibacterial assays. The tests were carried out against 
clinical isolates of Staphylococcus aureus (S235) and Pseudomonas aeruginosa 
(SOM1) , representative of Gram positive and Gram negative bacteria, respectively, 
which commonly cause infection in both chronic skin wounds and bone fractures 
[1,2].  
As already described in the “Materials and Methods” chapter, the antibacterial 
tests were initially attempted using standard MIC (minimum inhibitory 
concentration) tests in 96 well plates. The MIC is the lowest concentration of 
antimicrobial agent able to inhibit the bacterial growth. Since the bacterial growth 
leads to the cloudiness of the medium, the MIC is identified by evaluating the clarity 
of this medium by visual inspection. 
However, this method has proved to be unsuitable for the tested samples since 
the broth resulted cloudy even in the absence of microorganisms due to the presence 
of dispersed MBG particles. 
Subsequently, MIC test was attempted by placing the particles within transwell 
inserts (transwell-96 well, 0.4 μm pore sizes) in order to allow the diffusion of ions 
into broth containing the bacteria. Nevertheless, the smallest particles were able to 
go through the transwell pores, as well, causing the broth to turn cloudy even in 
absence of bacteria strains.  
 
 
Considering the issues related to MIC assay with the MBG nanomatrices, this 
standard bacterial viability test was replaced by the counting colony forming units 
(CFU) test. In microbiology, a “viable” organism is defined as an organism able to 
multiply via binary fission under controlled conditions.  
Two different experimental conditions were used to evaluate the antibacterial 
activity of ion-containing nanomatrices, as described in the “Material and methods” 
section. In details, the antibacterial potential of suspended nanomatrices (named 
hereafter “suspension”) and the antibacterial efficacy of the released ion extracts 
(named hereafter “extract”) were tested in order to ascribe the therapeutic effect to 
the particle itself or to the action of specific ion, or to a combination of both effects. 
The results are presented as reduction of viable bacteria compared to the control 
(bacterial samples incubated with PBS without the particles) using the following 
equation:  
(CFU sample x 100)/CFU control 
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4.2 Antibacterial property of MBG_SD_Cu2% and 
MBG_SG_Cu2% against planktonic bacteria  
The sensitivity of S235 and SOM1 against copper-containing micro- and nano-
sized particles and the related extracts are displayed in Figure 4.1 and Figure 4.2, 
respectively.  
The results shown in Figure 4.1 evidenced high antibacterial efficacy of both 
copper-containing particles (suspension) and the copper ion released from the 
samples (extracts). Both the experimental conditions demonstrated a reduction of 
the survival rate of S235 up to almost zero. After 1 day of soaking, 
MBG_SD_Cu2% did not cause relevant decrease in the bacteria viability. At 
variance, MBG_SG_Cu2% after 1 day of soaking provoked a 99% of reduction, as 
can be deduced by the absence of orange columns in Figure 4.1. This difference 
could be linked to the ion release property of the tested samples (Table 4.1): as 
shown in chapter 3, almost the total amount of incorporated copper in 
MBG_SG_Cu2% (see section 3.3.1.1b) was released within the first 3 h of 
incubation; while it was demonstrated that the diffusion of copper ions from 
MBG_SD_Cu2% (see section 3.3.2.2b) was blocked during the first hours of 
soaking most likely due to faster hydroxyapatite deposition. 
Table 4.1: Summary of Cu2+ released in Tris HCl 
Sample 3h of 
soaking 
(ppm) 
1d of 
soaking 
(ppm) 
3d of 
soaking 
(ppm) 
7d of 
soaking 
(ppm) 
14d of 
soaking 
(ppm) 
MBG_SG_Cu2% 4.45 4.50 4.77 4.50 4.77 
MBG_SD_Cu2% 1.86 1.86 2.24 2.44 2.44 
 
Figure 4.1: Survival rate of S235 after exposure to MBG_SD_Cu2%, MBG_SG_Cu2% and related extracts 
after 1 day, 3 days and the 8 days of soaking 
Antibacterial potential of copper-containing samples and copper ion released 
from the samples was tested against SOM1, as representative of Gram negative 
bacteria strain. Figure 4.2 depicts the results of both experimental conditions 
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(suspension and extracts). Although after 3 days of soaking, the ion released amount 
provoked a high reduction of survival rate (20%), the other columns in the graph 
show high percentage of viable bacteria colonies, highlighting the different mode 
of action of the sample against Gram positive (Figure 4.1) and Gram negative 
(Figure 4.2) bacteria. 
The different S235 and SOM1 bacteria sensitivity to copper-containing 
samples, attributed to the different bacteria structure of Gram positive and Gram 
negative bacteria strains, was already evidenced in ref. [3] using the 
MBG_US_m_Cu2%, as antimicrobial agent, and the related results are explained 
in the paragraph 3.2.1.2d. 
Figure 4.2: Survival rate of SOM1 after exposure to MBG_SD_Cu2%, MBG_SG_Cu2% and related extracts 
after 1 day, 3 days and 8 days of soaking 
 
4.3 Antibacterial property of MBG_SD_Ce2% and 
MBG_SG_Ce2% against planktonic bacteria  
The antibacterial activity of cerium-containing particles was tested against 
S235 and SOM1 and the results of the viable count method are shown in Figure 4.3 
and Figure 4.4.  
The suspension columns of both graphs evidenced a scarce antibacterial 
potential related to the particles themselves (first experimental condition). 
Differently, the survival rate of S235 (Figure 4.3) after contact with cerium-
compound extracts showed a marked reduction of viable colonies with longer 
incubation times (8 days). The effect of cerium ions on different bacteria strains 
was investigated by Morais et al. [4] by studying the antibacterial potential of 
cerium-containing hydroxyapatite composite. They speculated that the cerium ions 
may influence the bacteria metabolism and that the uptake of cerium into cytoplasm 
could block the cellular respiration. 
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Figure 4.3: Survival rate of S235 after exposure to MBG_SD_Ce2%, MBG_SG_Ce2% and related extracts 
after 1 day, 3 days and the 8 days of soaking 
 
As far as SOM1 sensitivity is concerned, the MBG_SD_Ce2% demonstrated 
different antibacterial activity respect to MBG_SG_Ce2%. The micro-sized 
particles (first experimental condition) led to a reduction of 60% of the survival 
rate. By comparison, no SOM1 viable reduction was encountered with the nano-
sized particles. Considering that the chemical composition of the samples is the 
same, the different behaviour could be attributed to the different size and the 
associated particle dispersion. Since the spray-dried micro-particles give a more 
stable suspension, evaluated by DLS measurements (data not shown) compared to 
the nano-sized particles, it is expected a more effective particle-bacteria interaction 
with higher antibacterial efficacy.  
The effect of the extracts from MBG_SD_Ce2% demonstrated a decrease of 
viable SOM1 as the soaking time increased. At variance, the antibacterial effect of 
Ce ions from MBG_SG_Ce2% showed the opposite trend: by increasing the 
incubation time of particles in PBS, the effect of the released ions became not 
sufficient to kill the bacteria. Considering that no refresh of the PBS solution 
containing the sample was performed during the entire test, the trend of 
MBG_SG_Ce2% shown in Figure 4.4 could be tentatively ascribed to the formation 
of cerium phosphate aggregates which subtracted Ce ions from the solution. The 
hypothesis of the formation of a mixed phase composed by cerium and calcium 
phosphate was already made by Shruti et al. [5] when evaluating the in vitro 
bioactive response of cerium substituted sol-gel bioactive glass. 
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Figure 4.4: Survival rate of SOM1 after exposure to MBG_SD_Ce2%, MBG_SG_Ce2% and related 
extracts after 1 day, 3 days and the 8 days of soaking 
4.4 Antibacterial property of MBG_SD_Ag2% and 
MBG_SG_Ag2% against planktonic bacteria  
The antibacterial properties of silver-containing compounds were proved 
following the viable count method explained in “Materials and methods” section 
and Figure 4.5 and Figure 4.6 showed the results concerning the S235 and SOM1 
survival rate, respectively.  
The first experimental condition using both micro- and nano-sized Ag-
substituted MBGs showed a reduction of >99% of both bacteria strains.  
After 1 day of incubation, the silver released from MBG_SD_Ag2% allowed 
the reduction of S235 survival rate to 10%, differently from MBG_SG_Ag2% at 
the same time point in accordance with the ion release kinetics (see paragraphs 
3.3.1.3b and 3.3.2.6b). The Ag-modified systems, in fact, showed a higher ion 
released concentration (Table 4.2) from MBG_SD_Ag2% compared to the nano-
sized particles at the same time point (see Figure 3.54B and Figure 3.83B). 
 
Table 4.2: Summary of Ag+ release in Tris HCl 
Sample 3h of 
soaking 
(ppm) 
1d of 
soaking 
(ppm) 
3d of 
soaking 
(ppm) 
7d of 
soaking 
(ppm) 
14d of 
soaking 
(ppm) 
MBG_SG_Ag2% 1.57 2.71 3.65 5.02 6.29 
MBG_SD_Ag2% 3.08 4.67 5.58 6.36 7.53 
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Figure 4.5: Survival rate of S235 after exposure to MBG_SD_Ag2%, MBG_SG_Ag2% and related 
extracts after 1 day, 3 days and the 8 days of soaking 
As far as SOM1 is concerned, the results are reported in Figure 4.6. 
As already noticed with S235, the antibacterial effect of silver-containing 
particles (first experimental condition) was more effective in reducing the bacteria 
viable colonies compared to the extracts. The results related to the second 
experimental condition showed a decreasing antibacterial effect with the increase 
of the soaking time for both samples. Considering that the second experimental 
condition was carried out without the refresh or the replace of PBS medium, the 
decreasing effect of the silver ion released could be ascribed to the formation of not 
soluble silver-aggregates (e.g. silver phosphates) through reaction between Ag+ 
released and phosphate ions from PBS. 
 
 
Figure 4.6: Survival rate of SOM1 after exposure to MBG_SD_Ag2%, MBG_SG_Ag2% and related 
extracts after 1 day, 3 days and the 8 days of soaking 
The evident difference between the two experimental conditions might be 
ascribed to the presence of Ag compounds, as described in chapter 3: the wide-
angle XRD spectra, reported in section 3.3.2.6a and 3.3.1.3a, evidenced the 
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formation of AgBr and AgO2 clusters in MBG_SG_Ag2% and in MBG_SD_Ag2% 
respectively.  
Several studies investigated the antimicrobial potential of silver-containing 
materials [6–8]. Never the less, the mechanism by which the silver affects the 
bacteria viability is not well understood and, moreover, the difference between the 
bactericidal activity of the silver nanoparticles and of the silver in ionic form still 
represents an open issue [9,10]. Several authors speculated that the presence of 
metallic silver cluster embedded in a matrix (e.g. silica glass [6,10]) showed 
remarkable antibacterial activity through the release of Ag+ from the clusters. In 
this frame, Ruparelia et al. [9] asserted that the antibacterial results of silver 
nanoparticles against both Gram positive and Gram negative bacteria strains were 
ascribed to the double effect of the nanoparticles themselves and the Ag+ released 
from the nanoparticles. It seems that the nanoparticles caused rupture of the plasma 
membrane and represented a continue source of silver ions which, by attaching to 
the negatively charged bacterial wall, led to the protein inactivation and bacteria 
death [9,10].  
Since AgO2 clusters were revealed in the MBG_SD_Ag2%, the same 
explanation could be done for the antibacterial results of MBG_SD_Ag2% 
assuming that the AgO2 clusters are whether on the particle surface or in an area 
accessible to the medium allowing the ion diffusion.  
Concerning the MBG_SG_Ag2%, the good antibacterial results of the first 
experimental condition could be ascribed to the presence of silver bromide clusters 
formed during the synthesis due to the reaction between the bromide present in 
CTAB surfactant and the AgNO3. Previously Sambhy and co-authors [11] realized 
silver bromide nanoparticles/polymer composites with the aim to produce an 
antibacterial material. The use of silver bromide in place of elemental silver and 
soluble silver salt should increase the long-lasting release of Ag+ ions. We can 
conclude that, in our study, the presence of silver bromide clusters induced the 
generation of active silver ions which provoked the reduction of SOM1 and S235 
viable species. 
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CHAPTER 5  
Biological assessment of optimized 
ion-containing nanomatrices 
5.1 Introduction 
After the optimization of the synthesis procedures and the confirmation of the 
ion incorporation and the related release properties, the optimized nanomatrices 
were tested in order to assess their biological effect. As stated in section 2.8 of the 
“Materials and methods” chapter, different assays were performed to investigate 
the effect on cell viability and the antibacterial properties of the ion-substituted 
MBGs. 
To this purpose, the biocompatibility assays, which involved both a 
qualitatively and a quantitatively evaluation, were carried out at Nobil Bio Ricerche 
Srl. As widely explained in “Materials and methods” chapter, the cytocompatibility 
of copper, cerium and silver containing nanomatrices was studied through the direct 
observation under the inverted microscope and MTT measurement using fibroblast 
L929 cells. Specifically, in this chapter, sub-paragraphs 5.1.1.1a, 5.1.1.2, 5.1.2 and 
5.1.3 report the in vitro biocompatibility results obtained for the Cu-containing, Ce-
containing and Ag-containing nanomatrices, respectively. 
Based on the overall results in term of morphology, structural features, 
bioactivity, ion release properties and biocompatibility, the Cu-containing (2% 
mol) systems in the form of nanoparticles were further tested by means of different 
antibacterial assays and cytocompatibility test using an alternative more advanced 
model, based on a 3D skin construct. These tests, whose results are discussed in the 
subsections of 5.1.1 paragraph, were performed at the Department of Materials 
Science and Engineering of the University of Sheffield by Prof. Sheila MacNeil’s 
research group. 
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5.1.1 Biological assessment of Cu-containing nano- and micro-sized 
MBGs 
Cu-substituted systems (MBG_SG_Cu2%, MBG_SD_Cu2%, 
MBG_SG_Cu0.5% and MBG_SD_Cu0.5%) were tested through the evaluation of 
the cell viability using fibroblast L929 cells (see the following section 5.1.1.1a and 
5.1.1.2).  
In addition, considering the promising ion release properties (see section 
3.3.1.1b) and the evidenced antibacterial potential (section 4.2) of the 
MBG_SG_Cu2%, the latter was selected to investigate the antibacterial action 
against the formation and the disruption of the bacterial biofilms, and the related 
results are described in the paragraph 5.1.1.2.  
Finally, the biological effect of this system was also investigated using a 3D 
skin model in order to analyse the biocompatibility and the antibacterial potential 
thought a more advanced biological model.  
Due to the biocompatibility issues related to MBG_SG_Cu2% and 
MBG_SD_Cu2% samples, the particles containing lower amount of copper (0.5% 
mol) were produced and their biocompatibility was tested (section 5.1.1.2). 
5.1.1.1a Biocompatibility of MBG_SG_Cu2% and MBG_SD_Cu2%  
The biocompatibility evaluation was performed both through MTT assay and 
visual inspection, and the related results are shown in Figure 5.1.  
As stated in “Materials and methods” chapter, the biocompatibility assessment 
was first carried out using a particle suspension at 1 mg/mL concentration through 
a Transwell® membrane insert. This concentration was selected in accordance to 
the ISO 10993-5: 2009, Biological Evaluation of Medical Devices Tests for In vitro 
cytotoxicity, which requires to evaluate the material performance in the worst case. 
At this concentration, the particles resulted cytotoxic on the L929, which evidenced 
a round morphology indicating the suffering and the death of the cells (data not 
shown). 
Therefore, further tests with a reduced (100 µg/mL) suspension concentration 
were performed in order to target the therapeutic window of released copper ions.  
By comparing the morphology of the fibroblast cells on polystyrene plate 
(image on the left in Figure 5.1B) with the fibroblast shape after the treatment with 
Cu-containing nanomatrices (middle and right images in Figure 5.1B), it could be 
asserted that negligible morphological changes occurred. MTT assay results, 
depicted in Figure 5.1A, confirmed the evidences of the optical image. The 
negligible cell viability reduction allowed to consider both MBG_SG_Cu2% and 
MBG_SD_Cu2% biocompatible at 100 µg/mL suspension concentration. The 
minimum value of cell viability to consider a material biocompatible is 70% [1], 
which is considerably smaller than the fibroblast viability percentages reached by 
contact with Cu-containing matrices.  
An important consideration resulted from these results is that the 
biocompatibility response of copper-containing biomaterial is strongly dependent 
 
 
on the Cu2+ released amount and on the condition used during the test (e.g. the 
sample concentration used for the test) [2,3]. To support this consideration, the 
same type of MBG particles containing strontium as therapeutic ion showed 
excellent biocompatibility using a concentration of 1 mg/mL, suggesting that the 
toxic response described above is linked to the substituting ion rather than to the 
particles themselves [1]. 
 
  
 
 
 
 
 
 
 
 
Figure 5.1: Quantification of cell viability through MTT assay for MBG_SG_Cu2% and MBG_SD_Cu2% 
compared with polystyrene (negative control) (A); optical images of cells after 72 h of incubation with 
MBG_SG_Cu2% and MBG_SD_Cu2% at concentration of 100 µg/mL, compared to cells seeded on 
polystyrene plate (B) 
 
5.1.1.1b Antibacterial activity of MBG_SG_Cu2% against bacterial biofilms 
S. aureus S235 and P. aeruginosa SOM1 were selected as bacterial strains to 
evaluate the antibacterial biofilm activity since they are the main biofilm developers 
[4]. 
As stated in “Materials and methods” chapter, the prevention of the biofilm 
formation and the disruption of the pre-formed biofilm were evaluated by 
incubating MBG_SG_Cu2% both at the same time of bacteria inoculum and after 
48h. In both experiments the antibacterial potential was assessed through the 
evaluation of the bacteria metabolic activity (to investigate the level of living 
bacteria) and the measurement of the optical density (to study the biofilm mass).  
Figure 5.2A and 5.2C depict the measurements of the metabolic activity and of 
the optical density in preventing biofilm formation experiment; whereas, Figure 
5.2B and 5.2D display the investigation of the potential in disrupting bacterial 
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biofilm through metabolic activity and optical density. In both experiments, the 
controls were represented by bacteria inoculum.  
Overall, the results suggest that the MBG_SG_Cu2% was highly effective 
against P. aeruginosa SOM1 in both preventive and disruptive bacterial biofilm, 
whilst the S. aureus S235 bacterial biofilm appears to be less affected by the 
presence of the Cu-containing particles.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The different antibacterial effect of MBG_SG_Cu2% against S235 and SOM1 
could be tentatively ascribed to an increase in S. aureus cell density [5] which 
provokes a higher resistance to killing. In this regard, further investigations are 
needed in order to fully explain the mechanisms involved in the antibacterial 
biofilm activity.  
Figure 5.2: MBG_SG_Cu2% preventive action on the formation of biofilms using the measure of 
bacterial metabolic activity (A) MBG_SG_Cu2% ability to disrupt pre-existing biofilms using the measure of 
bacterial metabolic activity (B) MBG_SG_Cu2% preventive action on the formation of biofilms using the 
measure of optical density of the biofilm with higher values indicating greater biofilm formation (C) 
MBG_SG_Cu2% ability to disrupt pre-existing biofilms using the measure of optical density of the biofilm with 
higher values indicating biofilm formation to larger extent (D).  n=3, error bars = SEM, ANOVA statistics 
A B 
C D 
 
 
5.1.1.1c Biological assessment of MBG_SG_Cu2% on 3D skin models  
The biocompatibility of MBG_SG_Cu2% was further tested on 3D skin 
construct, prepared according to the procedure described by MacNeil et al. [6] in 
order to assess the potential cytotoxicity in a more physiologically relevant 3D 
model.  
As reported in “Material and methods”, 3D skin model was incubated with 200 
µL of MBG_SG_Cu2% dispersed in PBS (concentration of 100 µg/ml) for 24h. 
Incubation of 3D skin model with 5x5 mm section of Acticoat Flex 3® (the gold 
standard in the treatment of infected wound) was also conducted and results used 
as comparison.  
Figure 5.3 confirms the cytocompatibility of Cu-substituted system which 
causes only a slight decrease in cell metabolism compared to the untreated 3D skin 
construct. At variance, the commercially available Ag-containing dressing 
demonstrated high toxic effect on the cell metabolism using the 3D tissue 
engineered skin construct. 
 
Figure 5.3: Cytotoxicity of MBG_SG_Cu2% sample and industrial standard Acticoat Flex 3® after 24 h 
of incubation with the tissue engineered skin models  
After confirming the cytocompatibility of the MBG_SG_Cu2% in 3D skin 
construct, its antibacterial potential (see section 5.1.1.1b) was explored in infected 
3D skin model. As reported in section 2.8.3.3, the 3D skin models were artificially 
infected by SOM1 and S235 bacteria strains prior to the viable count test.  
Figure 5.4 displays the bacteria CFU per gram of tissue after the treatment with 
the sample and the Acticoat Flex 3®. In particular, Figure 5.4A shows the ability of 
the matrix to prevent biofilm formation, Figure 5.4B, instead, the one to disrupt a 
pre-existing bacterial biofilm.  
In contrast to the previous results shown in section 5.1.1.1b, the impact of 
MBG_SG_Cu2% against SOM1 biofilm was less pronounced than against S235 
biofilm. As depicted in Figure 5.4, no significant differences were found between 
SOM1 bacteria control and the treated samples, both in preventive and disruptive 
biofilm experiments. The commercial standard Acticoat Flex 3®, instead, showed 
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better results in both SOM1 biofilm experiments compared to the Cu-containing 
sample. Whilst, the MBG_SG_Cu2% resulted to be as effective as the Acticoat Flex 
3® against S235 biofilm formation and disruption. 
The similar effect against S235 and the better results against SOM1 of the 
commercially available Acticoat Flex 3® with respect to MBG_SG_Cu2% has to 
be evaluated considering the above biocompatibility results shown in Figure 5.3.  
In addition to better antibacterial properties, the silver ion dressing resulted also 
more toxic than the tested Cu-containing sample.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: MBG_SG_Cu2% preventive action on the formation of biofilms on the infected 3D skin 
model (A) and MBG_SG_Cu2% ability to disrupt pre-existing biofilms on the infected 3D skin model (B). n = 
3, plotting mean ± standard deviation, ANOVA statistics used 
In contrast to the obtained antibacterial result in 2D model, the increased 
resistance to treatment showed by P. aeruginosa in the 3D skin model may be 
associated to the deeper penetration of the P. aeruginosa into the dermal layers of 
the tissue engineered skin, as previously observed by Shepherd et al. [7], which 
accounted for a weaker antibacterial action played by the Cu-containing 
nanomatrices. 
5.1.1.2 Biocompatibility test results of MBG_SG_Cu0.5% and 
MBG_SD_Cu0.5% 
Due to the biocompatibility issues related to copper (2% mol) containing 
nanomatrices, the particles containing lower amount of copper (0.5% mol) were 
analysed in accordance to the ISO 10993-5: 2009, Biological Evaluation of Medical 
Devices Tests for In vitro cytotoxicity.  
The first qualitative investigation using an inverted microscope (data not 
shown) demonstrated that nanomatrices containing lower amount of incorporated 
copper resulted more biocompatible, thus allowing to use a major amount of powder 
(1 mg/mL) without showing a toxic effect. 
B A 
 
 
5.1.2 Biocompatibility test results of Ce-containing nanomatrices 
The same quantitative and qualitative investigations were performed on 
cerium-containing particles at the facilities of Nobil Bio Ricerche Srl. 
In Figure 5.5B the healthy status of fibroblast L929 cells in contact with 1 
mg/mL of 1% and 2% mol of Ce-containing MBG_SG and SD was confirmed by 
the cell morphology.  By comparing the L929 shape deposited on polystyrene plates 
with the L929 morphology after the treatment with the Ce-containing nanomatrices, 
no relevant differences were observed.  
These data were confirmed by MTT test (Figure 5.5A) where 1% and 2% mol 
of Ce-modified systems demonstrated excellent biocompatibility: compared to 
polystyrene controls, the Ce-substituted systems seem to stimulate fibroblast 
proliferation. 
 
Figure 5.5: Quantification of cell viability through MTT assay for MBG_SG_Ce1%, MBG_SD_Ce1%, 
MBG_SG_Ce2% and MBG_SD_Ce2% compared with polystyrene (negative control) (A); optical images of 
cells after 72 h of incubation with MBG_SG_Ce1%, MBG_SD_Ce1%, MBG_SG_Ce2% and MBG_SD_Ce2% 
at concentration of 1 mg/mL, compared to cells seeded on polystyrene plates (B) 
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Although the promising data on biocompatibility, Ce-containing matrices the 
were not further investigated in terms of antibacterial tests, due to the scarce ion 
release properties of all the Ce-modified systems. Besides, in the literature, the best 
approach to obtain antibacterial effect in Ce-containing systems consists in the 
incorporation of ceria particles instead of cerium in ionic form within the MBG 
glass framework [10–12]. In this regard, further studies need to be considered.  
 
5.1.3 Biocompatibility test results of Ag-containing nanomatrices 
As already presented for the Cu-containing and Ce-containing samples, the first 
test performed on nanomatrices containing 0.1% mol and 2% mol of silver was the 
biocompatibility assay using fibroblast L929.  
 Ag-containing systems showed strong cytotoxicity effect both in the form of 
micro- and nano-particles. The visual inspection using the inverted microscope 
(Figure 5.6) evidenced fibroblast cells with round shape completely detached from 
the plate, demonstrating the suffering state of the cells after the contact with 
MBG_SG_Ag_2%.  
Moreover, the MTT assay (Figure 5.7) confirmed the high toxicity of the 
particles: less than 20% of cell viability was encountered with MBG_SG_Ag_2%. 
 
Figure 5.7: Quantification of cell viability through MTT assay for MBG_SG_Ag2% compared with 
polystyrene (negative control) 
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Figure 5.6: Optical images of cells after 72 h of incubation with MBG_SG_Ag_2%, 
at concentration of 1 mg/mL, compared to cells seeded on polystyrene plates 
 
 
 
Since the biocompatibility is considered a key aspect for any biomedical 
application, no further tests were performed using the silver-containing samples. 
 
5.2 Final considerations  
The biological assessment performed on the optimized ion-containing 
nanomatrices leads to the following considerations: 
- The cytotoxicity of MBG_SG_Cu2% and MBG_SD_Cu2% at 1 mg/mL 
suspension concentration and the biocompatible response of the same 
nanomatrices at 100 µg/mL suspension concentration allowed to conclude 
that the biocompatibility response of Cu-containing MBGs is strongly 
dependent on the concentration used during the test and on the Cu2+ released 
amount; 
- The MBG_SG_Cu2% was highly effective against P. aeruginosa SOM1 in 
both preventive and disruptive bacterial biofilm; 
- The tests conducted using a 3D skin construct further confirmed the 
biocompatibility of MBG_SG_Cu2% (100 µg/ml) and its antibacterial 
effect; 
- The biocompatibility showed by the particles containing lower amount of 
copper (0.5% mol) at 1 mg/mL suspension concentration suggested the 
possibility to tailor the biological response of the Cu-containing 
nanomatrices by incorporating different amount of therapeutic ion; 
- Ce-containing nanomatrices demonstrated excellent biocompatibility but, 
due to the poor ion release properties, they were not tested by means of 
antibacterial tests; 
- Ag-containing systems evidenced strong cytotoxicity. 
In conclusion, the Cu-containing nanomatrices are the most promising systems 
due to the possibility to find a proper therapeutic window within which they resulted 
both biocompatible and antibacterial.  
Among the Cu-containing nanomatrices, the MBG_SG_Cu0.5% and 
MBG_SD_Cu0.5%, providing the best results in terms of biocompatibility, deserve 
to be taken into account for further investigations, especially in terms of 
multifunctional systems able to release both therapeutic ion and specific drugs.  
In fact, since mesoporous matrices could be used as drug delivery systems [8,9], 
the possibility to use a major amount of powder (1 mg/mL) without showing a toxic 
effect, could be considered in view of potential drug loading inside the matrices, 
since a higher amount of powder, corresponding to a higher amount of drug. 
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CHAPTER 6 
Conclusions and perspectives 
The activities conducted during the present PhD work were mainly aimed to 
produce a library of mesoporous inorganic nanomatrices containing therapeutic 
ions for biomedical applications.  
In particular, the first aim of this PhD thesis was to produce mesoporous 
bioactive glass (MBG) particles based on silica-calcium oxide composition and 
containing different amount of therapeutic ions for the design of advanced 
biomedical devices for tissue regeneration (i.e. delayed bone healing and non-
healing skin wounds).  
The second aim was to find the best synthesis procedures in terms of materials 
properties, scalability, safety and cost-efficiency. 
The third objective was to investigate the therapeutic potential of these 
nanomatrices through different in vitro biological assessments, including 
biocompatibility assays and antibacterial tests. 
Specifically, MBGs in the binary system (SiO2-CaO) were produced by using 
different synthesis routes, in order to obtain nanomatrices with high specific surface 
area (in the range of hundreds m2/g) and accessible pore volume, characterised by 
different pore size and particle size/morphology. In details, a selection process of 
the synthesis procedures was performed in order to identify the best routes in terms 
of morphology, composition, ion release properties and scalability for obtaining 
micro- and nano-sized particles. 
In particular, with the aim to produce particles in the range of 100-200 nm with 
pores ranging between 2 and 4 nm, different routes were tested, and the selection 
process led to identify a water-based ammonia-catalysed sol-gel procedure as the 
most promising route in terms of reproducibility, structural results and final 
chemical composition. Moreover, a water-based spray-drying procedure carried out 
under mild acidic conditions was adopted to produce microspheres with pores of 
around 8 nm due to its easiness of scalability to an industrial environment. 
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On the basis of the obtained results, it can be affirmed that the substitution of 
small amount (1%, 2% or 5% mol) of CaO with specific ion precursors (i.e. copper, 
cerium and silver) did not significantly affect the MBG morphology and the textural 
properties. Moreover, the inclusion of different metallic ions did not hamper the 
deposition of HA layer.  
In details, the selection process of the synthesis routes started by adapting a method 
described in the literature by Kim and co-workers which consisted of an 
ultrasonicator-assisted sol-gel procedure using methanol solution as solvent. This 
first synthesis route allowed to obtain spherical ion-containing particles with size 
ranging between 100-200 nm and pores around 3 nm characterized by high specific 
surface area values and pore volume. Subsequently, the water-based sol-gel 
procedures were found to be more suitable for the up-scaling and represented a valid 
alternative route to the methanol-based procedure. Moreover, during the 
optimization process, it was proved that the ultrasonicator, introduced on the basis 
of the literature, represented a further energy-consuming step without providing 
substantial positive results in terms of morphological, textural and bioactive 
properties. 
Based on these findings, the final selection of the synthesis routes led to the 
optimization of the following two procedures: 
- The base-catalysed water-based sol-gel route to obtain mesoporous 
spheroidal particles with quite uniform size ranging between 100 and 200 
nm, pores of about 4 nm and excellent specific surface area values; 
- The spray-drying route produced spherical, well dispersed mesoporous 
particles with size mostly ranging between 500 nm and 5µm and pores 
around 8 nm. 
The structural/morphological characterization, the ion release and the bioactivity 
tests performed on the produced nanomatrices drove to the following conclusions: 
- The ion incorporation was successful in all the nanomatrices, with superior 
ion incorporation yield for spray-dried samples; 
- The ion release properties of the samples tested in different media (SBF, 
DMEM and Tris HCl) demonstrated that the species contained in DMEM 
medium (NaHCO3, glucose, HEPES, sodium pyruvate) may interfere with 
the surface ion-exchange reactions, slowing down the ion release kinetics.  
Among all the produced compositions, the most promising nanomatrices in 
terms of ion release capability and reproducibility are the copper-substituted MBGs 
both in the form of micro- and nano-sized particles. At variance, the Ce-containing 
samples (with two different cerium concentrations) demonstrated a very low 
amount of released ion and the reason of this behaviour was ascribed to the 
incorporation of cerium within the silica framework through the formation of strong 
chemical bonds with siloxanes, which improved the chemical stability of the 
resulting glass and can be accounted for the negligible release properties.  
 
 
The biological assessment performed on the optimized ion-containing 
nanomatrices evidenced that the cytocompatibility depends on the specific 
therapeutic ion and the suspension concentration used during the test. In details, the 
Cu-containing nanomatrices resulted biocompatible at 100 µg/mL suspension 
concentration, the Ce-containing nanomatrices demonstrated excellent 
biocompatibility, the Ag-containing systems evidenced, instead, strong 
cytotoxicity.  
Among the Cu-containing nanomatrices, the MBG_SG_Cu0.5% and 
MBG_SD_Cu0.5%, providing the best results in terms of biocompatibility, deserve 
to be taken into account for further investigations, especially in terms of 
multifunctional systems able to release both therapeutic ion and specific drugs.  
Furthermore, the optimized nanomatrices containing ion with recognised 
antibacterial properties were investigated through the antibacterial viable count test 
using two different experimental conditions. In detail, the antibacterial potential of 
suspended nanomatrices (named “suspension”) and the antibacterial efficacy of the 
released ion extracts (named “extract”) were tested in order to ascribe the 
therapeutic effect to the particle itself or to the action of specific ion, or to a 
combination of both effects. 
In details, the copper-containing samples evidenced remarkable differences in 
the results of the antibacterial test performed against Gram positive and Gram 
negative bacteria strains with a reduction of the survival rate of S. Aureus (Gram 
positive) up to almost zero and a less effectiveness against P. Aeruginosa (Gram 
negative). The different sensitivity shown by the bacteria strains was attributed to 
the differences in the bacteria structure and surfaces. 
Concerning the cerium-containing nanomatrices, although the antibacterial test 
demonstrated a reduction of both Gram positive and Gram negative bacteria strains, 
it was not possible to find a clear correlation between the results, the experimental 
conditions and the bacteria structure. 
Finally, the silver-containing nanomatrices showed a strong correlation 
between the antibacterial results and the specific experimental condition, 
evidencing that the antibacterial effect of silver-containing particles (suspension) 
was more effective in reducing the bacteria viable colonies compared to the 
extracts. The antibacterial effect of the particles was ascribed to the presence of 
insoluble and accessible metal Ag compounds which, through the direct contact and 
the formation of interactions between silver and the sulfhydryl groups of the 
bacterial wall, led to the reduction of Gram positive and Gram negative viable 
species by blocking their respiration. 
The combination of biocompatibility and antibacterial results further confirmed 
that the Cu-containing nanomatrices are the most promising systems due to the 
possibility to find a proper therapeutic window within which they resulted both 
biocompatible and antibacterial.  
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The high amount of silanol groups, the excellent specific surface area, the high 
pore volume and the opportunity to tailor the pore size further widen the possible 
applications of these biomaterials through the incorporation of specific drugs.  
Besides, the possibility to disperse these nanomatrices in materials of different 
nature, without the risk to lose the aforementioned advantages, paves the way to the 
creation of several hybrid formulations.  
In this context, the incorporation of the produced nanomatrices in an injectable 
gel could lead to the development of a new formulation able to release in situ and 
keep in place the therapeutic ions through a non-invasive procedure.  
The combination of these inorganic bioactive phases, as well as of other 
inorganic fillers (i.e. hydroxyapatite or calcium phosphate) with various polymeric 
matrices (i.e. natural and synthetic hydrogels) could be exploited in order to design 
composite scaffolds to be used in different biomedical applications. These hybrid 
materials could combine the flexibility of the polymer matrix with the stiffness and 
the bioactive property of the inorganic phase. Moreover, the possibility to 
incorporate and deliver both therapeutic ions and drugs makes these composites 
versatile agents. Considering the MBG key role in the bioactive response, the 
application in bone tissue engineering is certainly one of the most promising field 
of action of these new materials. Among the bone tissue engineering, the use in 
non-load-bearing bone applications (such as in dentin pulp regeneration) deserves 
special attention and further investigations.  
Apart from the bone tissue application, the bioactive inorganic/organic 
composites could represent a substantial innovation also in soft tissue application 
(i.e. diabetic wound healing). Due to the potentiality to induce angiogenesis, to 
impart antibacterial activity and to tailor the mechanical properties, these 
composites represent excellent candidates as wound dressings able to promote a 
healthy wound healing process.  
Due to the essential requirement of resembling the extracellular matrix pattern 
of both hard and soft tissue application, the innovative additive manufacturing 
techniques represent one of the most interesting fabrication routes to tailor the 
proportion of the organic/inorganic phases and to design specific structures able to 
better mimic the natural ones. 
In conclusion, the ion-containing MBGs could be exploited in order to enrich 
specific formulations and create hybrid systems to be used in several kinds of tissue 
treatments: the combination with different materials leads to the creation of 
versatile complex structures which resemble the natural ones. 
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